User Image Cart Icon 0 Search Image
  • Home > Blog > Hypotriglyceridemic Effect

Hypotriglyceridemic Effect

  1. Mechanisms for the hypotriglyceridemic effect of marine omega-3 fatty acids
  2. Evidence for mechanisms of the hypotriglyceridemic effect of n− 3 polyunsaturated fatty acids
  3. hypotriglyceridemic effect of corticotropin in man
  4. Eicosapentaenoic acid is primarily responsible for hypotriglyceridemic effect of fish oil in humans
  5. The hypotriglyceridemic effect of dietary n− 3 FA is associated with increased β‐oxidation and reduced leptin expression
  6. hypotriglyceridemic effect of Anka (a Fermented Rice Product of Monascus sp.) in Rats
  7. The hypotriglyceridemic effect of eicosapentaenoic acid in rats is reflected in increased mitochondrial fatty acid oxidation followed by diminished lipogenesis
  8. hypotriglyceridemic effect of dietaryn− 3 fatty acids in rats fed low versus high levels of linoleic acid
  9. Lack of hypotriglyceridemic effect of gemfibrozil as a consequence of age-related changes in rat liver PPARα
  10. The hypotriglyceridemic effect of fish oil in adult-onset diabetes without adverse glucose control.
  11. Can the hypotriglyceridemic effect of fish oil concentrate be sustained?
  12. Role of soy isoflavones in the hypotriglyceridemic effect of soy protein in the rat
  13. Antihyperlipidemic effect of flavonoids from Prunus davidiana
  14. effects of omega-3 fatty acids in hypertriglyceridemic states
  15. Metabolic basis of hypotriglyceridemic effects of insulin in normal men
  16. Metabolic effects of glucagon in endogenous hypertriglyceridemia
  17. Mitochondrion is the principal target for nutritional and pharmacological control of triglyceride metabolism
  18. The hypotriglyceridemic effect of chenodeoxycholic acid in type IV hyperlipemia.
  19. Estradiol is a potent inhibitor of the hypotriglyceridemic effect of levonorgestrel in female rats
  20. On the mechanism of the hypolipidemic effect of sulfur-substituted hexadecanedioic acid (3-thiadicarboxylic acid) in normolipidemic rats
  21. hypotriglyceridemic effect of globin digest on subjects with borderline hyperlipidemia.
  22. hypotriglyceridemic effect of dietary linseed oil in rats.
  23. effects of fructans-type prebiotics on lipid metabolism
  24. Experimental model of postprandial hypertriglyceridemia in sucrose-fed rats and the effectiveness of atorvastatin in the model
  25. Mechanism of the hypolipemic effect of clofibrate in postabsorptive man
  26. Potential on hypotriglyceridemic effect of Chloroform-Methanol Extract of Adlay Diabetic Rats
  27. hypotriglyceridemic effect of chenodeoxycholic acid after a short time of administration.
  28. Thiazolidinediones exert a hypotriglyceridemic effect by a distinct, but complementary mechanism relative to fibrates
  29. Clofibrate enhancement of mitochondrial carnitine transport system of rat liver and augmentation of liver carnitine and γ-butyrobetaine hydroxylase activity by thyroxine
  30. Can the hypotriglyceridemic effect of fish oil concentrate be sustained?
  31. Beneficial influence of dietary curcumin, capsaicin and garlic on erythrocyte integrity in high-fat fed rats
  32. Reciprocal responses to exercise in hepatic ketogenesis and lipid secretion in the rat
  33. Vitamin C and plasma triglycerides in experimental animals and in humans
  34. Atorvastatin increases hepatic fatty acid beta-oxidation in sucrose-fed rats: comparison with an MTP inhibitor
  35. The hypolipidemic action of bezafibrate therapy in hypertriglyceridemia is mediated by upregulation of lipoprotein lipase: no effects on VLDL substrate affinity to …
  36. The acute effects of a single very high dose of n− 3 fatty acids on plasma lipids and lipoproteins in healthy subjects
  37. effects of modest doses of omega-3 fatty acids on lipids and lipoproteins in hypertriglyceridemic subjects: a randomized controlled trial
  38. hypotriglyceridemic effect of the antler-shaped fruiting body of Ganoderma lucidum on the high-fat diet induced hyperlipidemia in Syrian hamsters
  39. Change in rats’ serum triglyceride concentration with graded levels of thyroxine and exercise
  40. effect of amaranth and oat bran on blood serum and liver lipids in rats depending on the kind of dietary fats
  41. Reciprocal effects of dietary sesamin on ketogenesis and triacylglycerol secretion by the rat liver
  42. Treatment of hypertriglyceridemia with metformin: effectiveness and analysis of results
  43. hypotriglyceridemic effect of flaxseed in rats
  44. Mechanism of triglyceride lowering in mice expressing human apolipoprotein A5
  45. Hypolipidemic 3-thia fatty acids: fatty acid oxidation and ketogenesis in rat liver under proliferation of mitochondria and peroxisomes
  46. effects of the hypolipidemic drugs clofibrate and gemfibrozil on palmitate and glucose oxidation by the isolated rat diaphragm
  47. effect of Aqueous Extract of Some Medicinal Plants on Plasma Lipid Profile in Diabetes Induced Rabbits.
  48. effect of NK-104, a new synthetic HMG-CoA reductase inhibitor, on triglyceride secretion and fatty acid oxidation in rat liver
  49. Dietary fish oil and blood lipids
  50. hypotriglyceridemic effect of Anka (a Fermented Rice Product of Monacus Sp.) in Rats
  51. Decrease of serum triglyceride in normal rat fed with 2000 ppm aluminum diet for 67 days: II. Feeding young and adult rats a sucrose diet with addition of aluminum …
  52. Physical training in diabetic rats: effect on glucose tolerance and serum lipids
  53. hypotriglyceridemic effect of anka (a fermented rice product of Monascus sp.) in rats.
  54. A review of studies on the mode of action of clofibrate and betabenzalbutyrate
  55. Suppressive effect of globin digest on postprandial hyperlipidemia in male volunteers
  56. Influence of background composition of the diet on the lipemic effect of fish oil vs. corn oil in rats
  57. Interaction between dietary protein and fat in triglyceride metabolism in the rat: effects of soy protein and menhaden oil
  58. The use of sulodexide in the treatment of peripheral vasculopathy accompanying metabolic diseases. Controlled study in hyperlipidemic and diabetic subjects
  59. Liver plasma membrane lipid composition and insulin receptor tyrosine kinase activity in HTG rat
  60. effect of a high-monounsaturated fat diet enriched with avocado in NIDDM patients
  61. Drug combination therapy for selected hyperlipidemic patients
  62. The mitochondrion is the principal target for nutritional and pharmacological control of triglyceride metabolism
  63. One‐year trials with halofenate, clofibrate, and placebo
  64. Hypolipidemic and glycogenolytic effect of clofibrate (CPIB) in hypothyroid mice: role of insulin and glucagon.
  65. effect of a high saturated fat and cholesterol diet supplemented with squalene or β-sitosterol on lipoprotein profile in fib hamsters
  66. PPARs in the regulation of gene expression and lipid metabolism in the liver
  67. Inhibition of acetyl-CoA carboxylase by cystamine may mediate the hypotriglyceridemic activity of pantethine
  68. Mechanism of action of fibrates on lipid and lipoprotein metabolism
  69. Influence of dietary curcumin, capsaicin and garlic on the antioxidant status of red blood cells and the liver in high-fat-fed rats
  70. The influence of dietary n-3 fatty acids on plasma lipids and lipoproteins.
  71. The hypotriglyceridemic effects of polyunsaturated fatty acids: pathogenetic hypothesis
  72. Docosahexaenoic acid shows no triglyceride-lowering effects but increases the peroxisomal fatty acid oxidation in liver of rats.
  73. n-3 fatty acid effects on lipids, lipoproteins, and apolipoproteins at very low doses: results of a randomized controlled trial in hypertriglyceridemic subjects
  74. Globin digest, acidic protease hydrolysate, inhibits dietary hypertriglyceridemia and Val-Val-Tyr-Pro, one of its constituents, possesses most superior effect
  75. Investigations on the covalent modification of thiolase by potential hypolipidemic agents
  76. The use of eiconol in the combined treatment of lichen ruber planus of the oral mucosa
  77. The comparative reductions of the plasma lipids and lipoproteins by dietary polyunsaturated fats: salmon oil versus vegetable oils
  78. Influence of a protein concentrate from Amaranthus cruentus seeds on lipid metabolism
  79. Improved lipid lowering activity of fibrates in combination with fish oil ethyl esters in hypertriglyceridemic hamsters
  80. effects of the soy protein level on plasma glucose, lipids, and hormones in streptozotocin-diabetic rats
  81. Treatment of hypercholesterolemia with pantethine and fenofibrate: an open randomized study on 43 subjects
  82. Comparing efficacy of fibrates and statins in isolated and combined hypertriglyceridemia and various types of oxidative metabolism
  83. Long-chain n-3 polyunsaturated fatty acids and triacylglycerol metabolism in the postprandial state
  84. Hypolipemic glucagon activity in isolated liver of genetic or acquired hypertriglyceridemic rats.
  85. Biofunctional activities of citrus flavonoids
  86. Comparative study on the in vivo and in vitro antilipolytic effects of etofibrate, nicotinic acid and clofibrate in the rat
  87. effects of glucose ingestion on postprandial lipemia and triglyceride clearance in humans.
  88. Differential effect of n6 and n3 Polyunsaturated Fatty Acids on Plasma Lipids in Rats Fed Low and High Fat Diets
  89. effects of gemfibrozil on triglyceride metabolism in Dahl salt-sensitive rats.
  90. effects of dextro-thyroxine, a preparation almost free of levo-thyroxine, on thyroid function, serum lipids and apolipoprotein AI in “Double pre-beta lipoproteinemia”
  91. Dietary 5-campestenone (campest-5-en-3-one) enhances fatty acid oxidation in perfused rat liver
  92. Heterogeneous effect of n-3 polyunsaturated fatty acids (PUFAs) on LDL in vitro oxidation in healthy subjects
  93. Enhancement of rat liver catalase activity dietary cholesterol
  94. Analysis of fatty acid, and lipoprotein, metabolism by GC and HPLC: effect of low-density lipoprotein apheresis
  95. Long-term trial with colestipol plus clofibrate in familial hypercholesterolemia
  96. Mechanisms of the hypolipidemic action of fibrates
  97. Feeding rats with liposomes or fish oil differently affects their lipid metabolism
  98. Lipolytic activity in blood plasma of patients with ischemic heart disease after administration of heparin on an empty stomach and with simultaneous fatty loading
  99. effects of fish oil on VLDL triglyceride kinetics in humans
  100. Interaction of tranylcypromine with bezafibrate on some aspects of lipids metabolism, in rats
  101. The hypolipidemic effect of calcium‐containing compounds and vitamin D2 in the rat
  102. effects of short-term treatment with coenzyme A or sulodexide on plasma lipids in patients with hypertriglyceridemia (type IV) or mixed hyperlipemia (type IIb).
  103. High doses of atorvastatin and simvastatin induce key enzymes involved in VLDL production
  104. Antioxidant activity of propionyl-L-carnitine in liver and heart of spontaneously hypertensive rats
  105. Dose effect of alpha-linolenic acid on lipid metabolism in the hamster
  106. Comparative clinical therapeutic trial with two hypolipidemic drugs: Clofibrate and nafenopin
  107. Comparative study on the in vivo and in vitro antilipolytic effects of etofibrate, nicotinic acid and clofibrate in the rat.
  108. Dietary manipulation of serum triglycerides.
  109. Fish oils in the treatment of hypertriglyceridemia.
  110. effect of dietary fish on the lipid profile of cholesterolstressed rats during copper overload
  111. Fish oils and plasma lipid and lipoprotein metabolism in humans: a critical review.
  112. Newly developed stenocardia: effect of diet with increased amount of polyunsaturated fatty acids of the omega-3 group on blood lipids and apolipoproteins
  113. Inhibition of lipid synthesis by beta beta’-tetramethyl-substituted, C14-C22, alpha, omega-dicarboxylic acids in the rat in vivo.
  114. Mechanism of action of fibrates on lipid and lipoprotein metabolism
  115. Studies with etofibrate in the rat. Part II: A comparison of the effects of prolonged and acute administration on plasma lipids, liver enzymes and adipose tissue lipolysis
  116. effect of simvastatin treatment on plasma apolipoproteins and hepatic apolipoprotein mRNA levels in the genetically hypercholesterolemic rat (RICO)
  117. Mechanism of lipid lowering in mice expressing human apolipoprotein A5
  118. Role of lipolytic enzymes in the development of hyperlipidemia induced by administration of heterologous albumin in rabbits
  119. PLASMA LIPIDS AND APOLIPOPROTEINS IN RATS FED DIETS WITH TYPE OF FAT (FISH OIL CORN OIL) AND FIBER (PECTIN VERSUS CELLULOSE) AS …
  120. Clinical importance of new insights into the mechanism of activation of fibrates
  121. Variability of the hypolipidemic action of simvastatin and fluvastatin in patients with primary hyperlipoproteinemia
  122. effect of a long-chained fructan Raftiline HP on blood lipids and spontaneous atherosclerosis in low density receptor knockout mice
  123. Regulation of lipoprotein metabolism by thiazolidinediones occurs through a distinct but complementary mechanism relative to fibrates
  124. Prebiotics and probiotics: are they functional foods?
  125. Influence of short-term administration of clofibrate on insulin and glucagon response to protein ingestion in man.
  126. effects of citrus aglycone flavonoids, hesperetin and naringenin, on triacylglycerol metabolism in hamsters fed with a cholesterol diet
  127. n‐3 fatty acids and lipoproteins: Comparison of results from human and animal studies
  128. Refeeding after ingestion of diets containing 10% soybean protein associated with various concentrations of alginate or sodium carrageenan. effects on growth and …
  129. Fish proteins moderate triacylglycerols, activities of hepatic triacylglycerol lipase and tissue lipoprotein lipases in hypertensive and diabetic rats
  130. effects of Chronic Ethanol and Fish Oil on Plasma and Liver Lipids and Plasma Apoproteins
  131. effect of fibric acid derivatives on blood lipid and lipoprotein levels
  132. Combination use of statins and omega-3 fatty acids: an emerging therapy for combined hyperlipidemia
  133. Dietary fish oils modify adipocyte structure and function
  134. Regulation of fatty acid oxidation and triglyceride and phospholipid metabolism by hypolipidemic sulfur-substituted fatty acid analogues
  135. on the plasma glucose and lipids levels in streptozotocin-induced diabetic rats
  136. effect of fructose overfeeding and fish oil administration on hepatic de novo lipogenesis and insulin sensitivity in healthy men
  137. Regulation of gene expression for lipogenic enzymes in the liver and adipose tissue of hereditary hypertriglyceridemic, insulin-resistant rats: effect of dietary sucrose …
  138. Eicosapentaenoic acid at hypotriglyceridemic dose enhances the hepatic antioxidant defense in mice
  139. effect of methandienone on free fatty acid and triglyceride turnover in normal females
  140. The protease‐resistant fraction of smoked, dried bonito lowers serum cholesterol in ovariectomized rats fed cholesterol‐free diets
  141. Prebiotics: preferential substrates for specific germs?
  142. Cod protein lowers the hepatic triglyceride secretion rate in rats
  143. Cholesterol and triglycerides lowering activities of caraway fruits in normal and streptozotocin diabetic rats
  144. Fish-oil esters of plant sterols improve the lipid profile of dyslipidemic subjects more than do fish-oil or sunflower oil esters of plant sterols
  145. Liver mechanisms for the elimination of lipoproteins of intestinal origin
  146. effect of Chicory Extract on Triglyceride Metabolism in Rats
  147. jļ5| E| ā5-50|| Eļļ9|| 3527|| 5 Microsoma] Triglyceride
  148. Syndecan-1 expression is regulated in an isoform-specific manner by the farnesoid-X receptor
  149. Hypocholesterolemic and antioxidant effects of aqueous extracts from the dried calyx of Hibiscus sabdariffa L. in hypercholesterolemic rats
  150. Polyunsaturated fatty acids interact with the PPARA-L162V polymorphism to affect plasma triglyceride and apolipoprotein C-III concentrations in the …
  151. Plant stanol ascorbate esters reduce body weight gain through decreased energy absorption in hamsters
  152. Lowering effects of four different statins on serum triglyceride level
  153. Dietary proteins modulate the effects of fish oil on triglyceridemia in the rat
  154. Fatty acids and expression of adipokines
  155. Acute modulation of rat hepatic lipid metabolism by sulphur-substituted fatty acid analogues
  156. Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in …
  157. Differential effects of fish oil, safflower oil and palm oil on fatty acid oxidation and glycerolipid synthesis in rat liver
  158. A high cholesterol,(n-3) polyunsaturated fatty acid diet induces hypercholesterolemia more than a high cholesterol,(n-6) polyunsaturated fatty acid diet in hamsters
  159. Glucagon and lipoprotein metabolism
  160. ApoAV reduces plasma triglycerides by inhibiting very low density lipoprotein-triglyceride (VLDL-TG) production and stimulating lipoprotein lipase-mediated VLDL-TG …
  161. effects of Spirulina platensis on plasma lipoprotein lipase activity in fructose-induced hyperlipidemic rats
  162. Experimental studies on the hypolipidemic activity of chloridarol
  163. effect of supplementation with different doses of DHA on the levels of circulating DHA as non-esterified fatty acid in subjects of Asian Indian background
  164. Omega-3 fatty acid supplementation accelerates chylomicron triglyceride clearance
  165. The effect of bezafibrate and long-chain fatty acids on peroxisomal activities in cultured rat hepatocytes
  166. Hypolipidemic arylthioalkanoic acids
  167. Fish oil fatty acid esters of phytosterols alter plasma lipids but not red blood cell fragility in hamsters
  168. effect of the source of fiber in bread‐based diets on blood and liver lipids in rats
  169. Dietary flaxseed meal is more protective than soy protein concentrate against hypertriglyceridemia and steatosis of the liver in an animal model of obesity
  170. Influence of atorvastatin on apolipoprotein E and AI kinetics in patients with type 2 diabetes
  171. Synthesis and hypolipidemic and antidiabetogenic activities of. beta.,. beta.,. beta.’,. beta.’-tetrasubstituted, long-chain dioic acids
  172. Long-term effects of fish oil on lipoprotein subfractions and low density lipoprotein size in non-insulin-dependent diabetic patients with hypertriglyceridemia
  173. Dietary and nutraceutical options for managing the hypertriglyceridemic patient
  174. Fish oil consumption reduces hypertriglyceridemia in psoriatic patients receiving etretinate therapy
  175. Doxazosin reduces prevalence of small dense low density lipoprotein and remnant-like particle cholesterol levels in nondiabetic and diabetic hypertensive patients
  176. Fish oil increases bile acid synthesis in male patients with hypertriglyceridemia
  177. Dietary taurine supplementation reduces plasma and liver cholesterol and triglyceride levels in rats fed a high-cholesterol or a cholesterol-free diet
  178. Cytotoxic effect of peroxisome proliferator fenofibrate on human HepG2 hepatoma cell line and relevant mechanisms
  179. effect of fish oil concentrate on lipoprotein composition in NIDDM
  180. effect of high‐fat cholesterol enriched diets on hypolipemic action of Oenothera paradoxa oil in rats. Part 1. Blood serum and liver lipids
  181. Eicosapentaenoic acid, but not docosahexaenoic acid, increases mitochondrial fatty acid oxidation and upregulates 2, 4‐dienoyl‐CoA reductase gene expression in …
  182. On the effect of peroxisomal β‐oxidation and carnitine palmitoyltransferase activity by eicosapentaenoic acid in liver and heart from rats
  183. Protective effects of green tea polyphenols on human HepG2 cells against oxidative damage of fenofibrate
  184. effects of ciprofibrate and fenofibrate on liver lipids and lipoprotein synthesis in normo-and hyperlipidemic rats
  185. Pinnipeds: animal models for studying the effects of dietary fats on lipoproteins and platelets
  186. Suppression of hepatic fatty acid synthase by feeding α-linolenic acid rich perilla oil lowers plasma triacylglycerol level in rats
  187. Controlled evaluation of pantethine, a natural hypolipidemic compound, in patients with different forms of hyperlipoproteinemia
  188. Oxygenation of ω-3 fatty acids by human cytochrome P450 4F3B: effect on 20-hydroxyeicosatetraenoic acid production
  189. Regulation of triglyceride metabolism by PPARs: fibrates and thiazolidinediones have distinct effects
  190. Reassessing the effects of simple carbohydrates on the serum triglyceride responses to fat meals
  191. Early effects on mitochondrial and peroxisomal β-oxidation by the hypolipidemic 3-thia fatty acids in rat livers
  192. effects of dietary α-linolenic, eicosapentaenoic and docosahexaenoic acids on hepatic lipogenesis and β-oxidation in rats
  193. Specificity in the action of hypolipidemic drugs: increase of peroxisomal beta-oxidation largely dissociated from hepatomegaly and peroxisome proliferation in the rat.
  194. effect of hypolipidemic drugs on key enzyme activities related to lipid metabolism in normolipidemic rabbits
  195. Short-term effects of fish oil on human plasma lipid levels
  196. Regulation of lipid and lipoprotein metabolism by PPAR activators
  197. Serum uric acid levels: a useful but not absolute marker of compliance with fenofibrate treatment
  198. effects of dietary methionine and cystine on lipid metabolism in hepatoma-bearing rats with hyperlipidemia
  199. hypotriglyceridemic activity of 5, 5′-diphenyl-2-thiohydantoin (DPTH)
  200. Lipid metabolism response to a single, prolonged bout of endurance exercise in healthy young men
  201. Drugs and lipid metabolism
  202. Contribution of apo CIII reduction to the greater effect of 12-week micronized fenofibrate than atorvastatin therapy on triglyceride levels and LDL size in dyslipidemic …
  203. Influence of saturated and polyunsaturated egg yolk phospholipids on hyperlipidemia in rats
  204. effect of fresh garlic (Allium sativum) on lipid metabolism in male rats
  205. Laboratory studies of 1-methyl-4-piperidyl bis (p-chlorophenoxy) acetate (SaH 42-348)—A new hypolipidemic agent
  206. Anti-diabetic property of ethanolic extract of Andrographis paniculata in streptozotocin-diabetic rats.
  207. Plasma lipoproteins and apolipoproteins B and E in rats fed a high-fiber fructose-based diet
  208. Differential effects of benzodioxane, chroman and dihydrobenzofuran analogs of clofibrate in a triton hyperlipemic rat model
  209. effect of soy and milk whey protein isolates and their hydrolysates on weight reduction in genetically obese mice
  210. Why do polyunsaturated fatty acids lower serum cholesterol?
  211. Nondigestible oligosaccharides
  212. Type of dietary fat and insulin resistance
  213. Differential effects of dietary flaxseed protein and soy protein on plasma triglyceride and uric acid levels in animal models
  214. Glucagon and hypertriglyceridemia
  215. Recent Advances in the Etiology and Treatment of Disorders of Lipid Metabolism
  216. Serum Lipid and Lipoprotein Changes in Fish Oil Supplemented Pregnant WHHL Rabbits
  217. Lipoprotein lipase mRNA in white adipose tissue but not in skeletal muscle is increased by pioglitazone through PPAR-γ
  218. Omega 3 fatty acids-supplementation to competition athletes: impact on the biochemical indicators related to the lipid metabolism
  219. The effect of treatment with clofibrate on hepatic triglyceride and lipoprotein lipase activities of post heparin plasma in male patients with hyperlipoproteinemia
  220. Hypolipidemic effect of pulse seed coats in rats
  221. Reduced LPA expression after peroxisome proliferator-activated receptor alpha (PPARα) activation in LPA-YAC transgenic mice
  222. effects of various combinations of ω3 and ω6 polyunsaturated fats with saturated fat on serum lipid levels and eicosanoid production in rats
  223. effect of 4, 7, 10, 13, 16, 19-docosahexaenoic acid on triglyceride accumulation and secretion in rat hepatocytes in culture
  224. effects of four doses of n-3 fatty acids given to hyperlipidemic patients for six months.
  225. On the effect of 2-deuterium-and 2-methyl-eicosapentaenoic acid derivatives on triglycerides, peroxisomal β-oxidation and platelet aggregation in rats
  226. Diacylglycerol: Efficacy and mechanism of action of an anti‐obesity agent
  227. Methylated eicosapentaenoic acid and tetradecylthioacetic acid: effects on fatty acid metabolism
  228. effects of fibrates on the altered lipoprotein system in hypertriglyceridemia
  229. Phenolics-rich extracts from Silybum marianum and Prunella vulgaris reduce a high-sucrose diet induced oxidative stress in hereditary hypertriglyceridemic rats
  230. Enhanced level of n-3 fatty acid in membrane phospholipids induces lipid peroxidation in rats fed dietary docosahexaenoic acid oil
  231. Peroxisome proliferator activated receptor agonists
  232. Dietary taurine supplementation reduces plasma and liver cholesterol and triglyceride concentrations in rats fed a high-cholesterol diet
  233. Is there an optimal diet for the hypertriglyceridemic patient?
  234. Fish oil-feeding prevents perfluorooctanoic acid-induced fatty liver in mice
  235. Fatty acid clearance by isolated perfused hindquarters of rats fed fish oil
  236. Drugs affecting triglycerides
  237. Substituting honey for refined carbohydrates protects rats from hypertriglyceridemic and prooxidative effects of fructose
  238. Dose-response relationships between dietary (n-3) fatty acids and plasma and tissue lipids, steroid excretion and urinary malondialdehyde in rats
  239. effects of fructooligosaccharides and long-chain inulin on serum lipids in rats.
  240. The influence of n-3 polyunsaturated fatty acids and very low calorie diet during a short-term weight reducing regimen on weight loss and serum fatty acid …
  241. effect of KC-9432, a new hypolipidemic compound, on high density lipoprotein cholesterol in rats
  242. Lipidemic responses in rats fed biscuits made with fish oil
  243. Pantethine stimulates lipolysis in adipose tissue and inhibits cholesterol and fatty acid synthesis in liver and intestinal mucosa in the normolipidemic rat
  244. Dietary oligofructose lessens hepatic steatosis, but does not prevent hypertriglyceridemia in obese Zucker rats
  245. The Consumption of Hibiscus sabdariffa Dried Calyx Ethanolic Extract Reduced Lipid Profile in Rats
  246. effects of dietary saturated, monounsaturated and n-3 fatty acids on fasting lipoproteins, LDL size and post-prandial lipid metabolism in healthy subjects
  247. Water‐soluble organosulfur compounds of garlic inhibit fatty acid and triglyceride syntheses in cultured rat hepatocytes
  248. The differential effect of eicosapentaenoic acid and oleic acid on lipid synthesis and VLDL secretion in rabbit hepatocytes
  249. Influence of Dietary n-3 Polyunsaturated Fatty Acids on Plasma Lipemic effect of Vitamin B6 Deficiency
  250. 9-Chloro-2, 3-dihydro-5H-1, 4-dioxepino [6, 5-b] benzofuran, a novel antilipidemic agent structurally related to clofibrate
  251. Polyunsaturated fatty acid regulation of gene expression
  252. Nonhypercholesterolemic effects of a palm-oil diet in Malaysian volunteers
  253. effect of clofibrate on postheparin plasma triglyceride lipase activities in patients with hypertriglyceridemia
  254. Reduction of postprandial triglyceridemia in humans by dietary n-3 fatty acids
  255. A randomized comparative open study of the effects of two oral contraceptives, Triphasil and Ortho 7/7/7, on lipid metabolism
  256. Fish diet, fish oil and docosahexaenoic acid rich oil lower fasting and postprandial plasma lipid levels.
  257. The pharmacological treatment of dyslipidemia
  258. Enhanced hepatic fatty acid oxidation and upregulated carnitine palmitoyltransferase II gene expression by methyl 3-thiaoctadeca-6, 9, 12, 15-tetraenoate in rats
  259. Studies on Hypolipidemic Agents. III. Comparison of the Hypolipidemic Properties of 5-Tridecylpyrazole-3-carboxylic Acid and Clofibrate
  260. The biological effects of β-cyclodextrin on antithrombotic activity and plasma lipid metabolism in rats
  261. The effects of Apolipoprotein (apo) E Alleles on Plasma Lipid, Lipoprotein and Apo E Levels in Normolipidemic Subjects
  262. effects of fenofibrate on plasma lipoproteins in hypercholesterolemia and combined hyperlipidemia
  263. Lymphatic absorption of seal and fish oils and their effect on lipid metabolism and eicosanoid production in rats
  264. Hypolipidemia and peroxisome proliferation induced by phenoxyacetic acid herbicides in rats
  265. Triglyceridemia and peroxisome proliferator-activated receptor-α expression are not connected in fenofibrate-treated pregnant rats
  266. Correlation of serum triglyceride and its reduction by ω-3 fatty acids with lipid transfer activity and the neutral lipid compositions of high-density and low-density …
  267. Long-term administration of glycerides rich in conjugated linoleic acid (CLA) to diabetic C57BLKS-Leprdb/leprdb mice
  268. Statins—Drugs of choice for primary and secondary prevention of coronary heart disease in patients with hypercholesterolaemia
  269. effects of p-Chlorophenoxyisobutyric Acid (CPIB) on Adipose Tissue Triglycerides Synthesis, Lipogenesis, and Some Related Enzymes
  270. Health benefits of non-digestible oligosaccharides
  271. Reduction of hyperlipidemia and proteinuria without growth retardation in nephritic rats by amino acids-fortified low casein diets
  272. Plant-and marine-derived n− 3 polyunsaturated fatty acids have differential effects on fasting and postprandial blood lipid concentrations and on the …
  273. Beneficial effects of fish-oil supplements on lipids, lipoproteins, and lipoprotein lipase in patients with glycogen storage disease type l
  274. effect of ethyl p-chlorophenoxyisobutyrate on rat adipose lipoprotein lipase activity
  275. Apolipoprotein E* 3-Leiden transgenic mice as a test model for hypolipidaemic drugs
  276. effects of statins on lipoprotein fractions
  277. Response surface optimisation of lipase-catalysed esterification of glycerol and n-3 polyunsaturated fatty acids from salmon oil
  278. Reduction of leptin gene expression by dietary polyunsaturated fatty acids
  279. Microcirculation, vitamin E and omega 3 fatty acids: an overview
  280. Triglyceride levels are ethnic-specifically associated with an index of stearoyl-CoA desaturase activity and n-3 PUFA levels in Asians
  281. effect of dietary fish oil on the sensitivity of hepatic lipid metabolism to regulation by insulin
  282. Pharmacological studies of Cordia salicifolia Cham in normal and diabetic rats
  283. Concepts in functional foods: the case of inulin and oligofructose
  284. Differential effects of benzodioxane, chroman, and dihydrobenzofuran analogs of clofibrate on various parameters of hepatic drug metabolism
  285. Factorial study of the effects of atorvastatin and fish oil on dyslipidaemia in visceral obesity
  286. Inhibition of lipid synthesis through activation of AMP kinase: an additional mechanism for the hypolipidemic effects of berberine
  287. Beneficial effects of alpha linolenic acid rich flaxseed oil on growth performance and hepatic cholesterol metabolism in high fat diet fed rats
  288. The potential for dietary polyunsaturated fatty acids in domestic animals
  289. Spices as influencers of body metabolism: an overview of three decades of research
  290. Dietary fats: A quantitative and qualitative approach to reducing risk of cardiovascular disease in the fasting and fed state
  291. Alkylthioacetic acids (3-thia fatty acids) as non-beta-oxidizable fatty acid analogues: a new group of hypolipidemic drugs. III. Dissociation of cholesterol-and …
  292. Stimulation of acyl-CoA oxidase by α-linolenic acid-rich perilla oil lowers plasma triacylglycerol level in rats
  293. ω-3 fatty acids selectively raise high-density lipoprotein 2 levels in healthy volunteers
  294. effects of dietary phytosterols on liver lipids and lipid metabolism enzymes
  295. 1. P. 199 The underlying mechanism of the hypolipidemic effect of 3-thia fatty acids
  296. effect of dietary fish oil on insulin sensitivity and metabolic fate of glucose in the skeletal muscle of normal rats
  297. The hypocholesterolemic effect of sulfur-substituted fatty acid analogues in rats fed a high carbohydrate diet
  298. effects of oat bran, rice bran, wheat fiber, and wheat germ on postprandial lipemia in healthy adults
  299. The human apolipoprotein AV gene is regulated by peroxisome proliferator-activated receptor-α and contains a novel farnesoid X-activated receptor response …
  300. n− 3 Fatty acids and the metabolic syndrome
  301. effects of gemfibrozil on insulin sensitivity and on haemostatic variables in hypertriglyceridemic patients
  302. effects of hight–fat and Chlorella vulgaris feeding on changes in lipid metabolism in mice
  303. Hypolipidemic effect of beta, beta’-methyl-substituted hexadecanedioic acid (MEDICA 16) in normal and nephrotic rats.
  304. Medium-chain triglycerides
  305. effect of dried immature leaves and fruit Ficus carcia On some biochemical parameters in normal rats
  306. Conjugated linoleic acid (CLA) isomers in heat-treated vegetable oils
  307. Modulation of PPAR in aging, inflammation, and calorie restriction
  308. α-Linolenic, eicosapentaenoic and docosahexaenoic acids affect lipid metabolism differently in rats
  309. Lactic acid bacteria increases hypolipidemic effect of crocin isolated from fructus of Gardenia jasminoides
  310. Opposite metabolic response to fenofibrate treatment in pregnant and virgin rats
  311. An Approach to Antiarteriosclerotic Pharmacology
  312. The beneficial effects of lipid-lowering drugs beyond lipid-lowering effects: a comparative study with pravastatin, atorvastatin, and fenofibrate in patients with type IIa …
  313. effects of treatment with clofibrate, bezafibrate, and ciprofibrate on the metabolism of cholesterol in rat liver microsomes.
  314. Clofibrate effect on catecholamine-induced metabolic changes in humans
  315. effects of bezafibrate on hepatic cholesterol metabolism
  316. The hypolipidemic activity of 3-iminophthalimidine in rodents
  317. Dietary n-3 polyunsaturated fatty acids and coronary heart disease-related mortality: a possible mechanism of action
  318. Sesamin and sesamolin: nature’s therapeutic lignans
  319. Current knowledge on potential health benefits of Spirulina
  320. Actions of non-digestible carbohydrates on blood lipids in humans and animals
  321. Naringenin 7-O-cetyl ether as inhibitor of HMG-CoA reductase and modulator of plasma and hepatic lipids in high cholesterol-fed rats
  322. Pharmacological profile of BR-931, a new hypolipidemic agent that increases high-density lipoproteins
  323. effect of p-chlorophenoxyisobutyrate on the antilipolytic action of insulin and insulin binding in isolated adipocytes
  324. effect of long-term fish oil supplementation on vitamin E status and lipid peroxidation in women
  325. effect of L-Carnitine Supplementation on Lipid Parameters in Hemodialysis Patients
  326. Lipid responses to a dietary docosahexaenoic acid supplement in men and women with below average levels of high density lipoprotein cholesterol
  327. Isotretinoin and fenofibrate induce adiposity with distinct effect on metabolic profile in a rat model of the insulin resistance syndrome
  328. effects of hypotriglyceridemic drugs on peroxisome proliferation-associated enzyme activities and glycerolipid biosynthesis in primary cultures of rat …
  329. The priming effect of gemfibrozil on reactive oxygen metabolism of phagocytic leucocytes. An intriguing side effect
  330. Therapy and clinical trials
  331. Lipid metabolism responses in rats fed docosahexaenoic acid given as monoacylglycerol, diacylglycerol, triacylglycerol, and ethyl ester
  332. effects of some hypolipidemic agents on biochemical values and hepatic peroxisomal enzymes in rats: Comparison of probucol, CGA, KCD-232, MLM-160, AL-369 …
  333. Dietary supplementation with Pluronic L-81 modifies hepatic secretion of very low density lipoproteins in the rat.
  334. Combination of circulating antilipoprotein lipase (Anti-LPL) antibody and heterozygous S172 fsX179 mutation of LPL gene leading to chronic hyperchylomicronemia
  335. Characterization of New Oral Antidiabetic Agent CS-045: Studies in KK and ob/ob Mice and Zucker Fatty Rats
  336. Fenofibrate prevents and reduces body weight gain and adiposity in diet-induced obese rats
  337. The influence of 1, 1-bis [4′-(1′-carboxy-1′-methylpropoxy)-phenyl] cyclohexane (a new aryloxy compound, S-8527) on cholesterol metabolism in rats
  338. Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: The KANWU Study
  339. Fish oil as an adjuvant in the treatment of hypertension
  340. Liver mitochondrial dysfunction and oxidative stress in the pathogenesis of experimental nonalcoholic fatty liver disease
  341. Reduction in plasminogen activator inhibitor-1 (PAI-1) with omega-3 polyunsaturated fatty acid (PUFA) intake
  342. The effects of high levels of vitamin E on the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit
  343. effects of methanol extract of prosomillet on cholesterol and fatty acid metabolism in rat
  344. Potential medicinal and nutritional uses of chicory roots and inulin
  345. Attenuated secretion of very low density lipoproteins from McA-RH7777 cells treated with eicosapentaenoic acid is associated with impaired utilization of …
  346. Triglyceridemia and peroxysome proliferator-activated receptor-a expresion are not connected in fenofibrate-treated pregnant rats.
  347. Docosahexaenoic and eicosapentaenoic acids are differently metabolized in rat liver during mitochondria and peroxisome proliferation
  348. N-3 fatty acids from fish oil
  349. effects of Soybean Oil and Fish Oil Emulsions on Glucose and Lipid Metabolism in Streptozotocin‐Induced Diabetic Rats Receiving Total Parenteral Nutrition
  350. Clinical interest of PPARs ligands: particular benefit in type 2 diabetes and metabolic syndrome
  351. A controlled study on the effects of n− 3 fatty acids on lipid and glucose metabolism in non-insulin-dependent diabetic patients
  352. Administration of n-3 fatty acids in the diets of rats or directly to hepatocyte cultures results in different effects on hepatocellular ApoB metabolism and secretion
  353. Triglyceride‐lowering effect of respiratory uncoupling in white adipose tissue
  354. effect OF WHEAT BRAN AND ITS SUBFRACTIONS ON LIPID METABOLISM IN CHOLESTEROL‐FED RATS
  355. Hypolipidemic analogs of ethyl 4-benzyloxybenzoate
  356. Hypolipidemic effects of clofibrate and selected chroman analogs in fasted rats: I. Chow‐fed animals
  357. Ascorbate administration to normal and cholesterol-fed rats inhibits in vitro TBARS formation in serum and liver homogenates
  358. Efficacy of combination of atorvastatin and micronised fenofibrate in the treatment of severe mixed hyperlipidemia
  359. Elevated Pancreatic Glucagon in Moderately Obese Patients Relationship of Fatty Liver and Hypertriglyceridemia
  360. Eicosapentaenoic acid is oxidized more rapidly than docosahexaenoic acid by muscle and liver
  361. effectsof Garlic Vinegar Supplementation on Body Weight, Blood glucose, and Serum Lipid Profile in Streptozotocin-induced diabetic Rats-fed High Cholesterol Diet
  362. Antiobesity effect of major Korean spices (red pepper powder, garlic and ginger) in rats fed high fat diet
  363. Incorporation of long‐chain n‐3 fatty acids in tissues and enhanced bone marrow cellularity with docosahexaenoic acid feeding in post‐weanling Fischer 344 rats
  364. Alternation of hepatic antioxidant enzyme activities and lipid profile in streptozotocin-induced diabetic rats by supplementation of dandelion water extract
  365. Fluvastatin, a new inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, suppresses very low-density lipoprotein secretion in puromycin aminonucleoside …
  366. effects of fish oil and vitamin E on the antioxidant defense system in diet-induced hypercholesterolemic rabbits
  367. A uniform alteration in serum lipid metabolism occurring during inflammation in mice
  368. Fasting lipoprotein and postprandial triacylglycerol responses to a low-carbohydrate diet supplemented with n-3 fatty acids
  369. Hypolipidemic activity of aqueous extract of Capparis spinosa L. in normal and diabetic rats
  370. Paradoxical exacerbation of combined hyperlipidemia in human apolipoprotein A-II transgenic mice treated with fenofibrate
  371. effects of polyphenolic fraction of silymarin on lipoprotein profile in rats fed cholesterol-rich diets
  372. Non‐soluble dietary fiber effects on lipid absorption and blood serum lipid patterns
  373. effect of fish oil pretreatment on isoproterenol-induced changes in myocardial membrane phospholipids
  374. Pharmacological Study of Hydroxy Bis-[2-(P-Chlorophenoxy)-Isobutyric Acid] Aluminium [II] the effect of Hydroxy Bis-[2-(P-Chlorophenoxy)-Isobutyric Acid] Aluminium …
  375. effects of clofibrate and dextrothyroxine singly and in combination on serum lipids
  376. effects of Japanese torreya (Torreya nucifera) seed oil on lipid metabolism in rats
  377. The acute and short-time effect of supplementation with the combination of n− 3 fatty acids and acetylsalicylic acid on platelet function and plasma lipids
  378. Inhibition by etomoxir of carnitine palmitoyltransferase I reduces hepatic glucose production and plasma lipids in non-insulin-dependent diabetes mellitus
  379. Treatment of hypertriglyceridemia by two diets rich either in unsaturated fatty acids or in carbohydrates: effects on lipoprotein subclasses, lipolytic enzymes, lipid …
  380. Hypolipidemic effect of beta, beta’-tetramethyl hexadecanedioic acid (MEDICA 16) in hyperlipidemic JCR: LA-corpulent rats.
  381. effects of garlic vinegar supplementation on body weight, blood glucose, and serum lipid profile in streptozotocin-induced diabetic rats-fed high cholesterol diet
  382. Inhibition of apolipoprotein secretion and phosphatidate phosphohydrolase activity by eicosapentaenoic and docosahexaenoic acids in the perfused rat liver
  383. Low density lipoprotein from humans supplemented with n-3 fatty acids depresses both LDL receptor activity and LDLr mRNA abundance in HepG2 cells.
  384. Mechanisms of regulation of gene expression by fatty acids
  385. Influence of drugs on liver mitochondria and peroxisomes
  386. Atorvastatin reverses age‐related reduction in rat hepatic PPARα and HNF‐4
  387. Blood pressure lowering in elderly subjects: a double-blind crossover study of ω-3 and ω-6 fatty acids
  388. The role and mode of action of apolipoproteins CIII and AV: synergistic actors in triglyceride metabolism?
  389. Evolutionary aspects of diet, essential fatty acids and cardiovascular disease
  390. Comparison of the conversion rates of α-linolenic acid (18: 3 (n− 3)) and stearidonic acid (18: 4 (n− 3)) to longer polyunsaturated fatty acids in rats
  391. Lack of interaction of apolipoprotein E phenotype with the lipoprotein response to lovastatin or gemfibrozil in patients with primary hypercholesterolemia
  392. Reduction of plasma lipids, lipoproteins, and apoproteins by dietary fish oils in patients with hypertriglyceridemia
  393. effects of alpha-linolenic acid versus those of EPA/DHA on cardiovascular risk markers in healthy elderly subjects
  394. The effect of calcium on plasma lipids and bile acid and fecal fat excretion in normolipidemic subjects
  395. Lipoprotein structure in type II diabetes
  396. Contrasting effect of fish oil supplementation on the development of atherosclerosis in murine models
  397. Apolipoprotein E genotype affects plasma lipid response to atorvastatin in a gender specific manner
  398. Dietary Treatment of Hyperlipidemia: Rationale and Benefit
  399. Determination of myricetin derivatives in Chrysobalanus icaco L.(Chrysobalanaceae)
  400. Associations between insulin sensitivity, and free fatty acid and triglyceride metabolism independent of uncomplicated obesity
  401. Hepatic triglyceride secretion in relation to lipogenesis and free fatty acid mobilization in fasted and glucose-refed rats
  402. effect of ciprofibrate in patients with primary hypercholesterolemia: a 6-year pilot study
  403. Resistant oligosaccharides
  404. Site-specific regulation of gene expression by n-3 polyunsaturated fatty acids in rat white adipose tissues
  405. Dietary macronutrients and cardiovascular risk
  406. Omega-3 fatty acids alter lipoprotein subfraction distributions and the in vitro conversion of very low density lipoproteins to low density lipoproteins
  407. The role of fatty acid saturation on plasma lipids, lipoproteins, and apolipoproteins: I. effects of whole food diets high in cocoa butter, olive oil, soybean oil, dairy butter …
  408. The lipid-lowering profile in rodents AZ-1355, A New Dibenzoxazepine Derivative
  409. Dietary (n-3) long chain polyunsaturated fatty acids prevent sucrose-induced insulin resistance in rats
  410. Assessment of diabetogenic drug activity in the rat: 5, 5‐Diphenyl‐2‐thiohydantoin
  411. effect of dietary fish oil on serum lipids and lipoproteins of rats fed diets differing in cholesterol and fat
  412. effect of statin therapy on remnant lipoprotein cholesterol levels in patients with combined hyperlipidemia
  413. effect of cyclodextrin on plasma lipids and cholesterol metabolism in the rat
  414. Green tea leaf extract improves lipid and glucose homeostasis in a fructose-fed insulin-resistant hamster model
  415. Dietary fiber properties and health benefits of non-digestible oligosaccharides
  416. Why do omega-3 fatty acids lower serum triglycerides?
  417. effect of dietary n-3 polyunsaturated fatty acids on plasma lipoproteins and eicosanoid production in the Syrian hamster
  418. A multicenter double-blind study comparing lovastatin and gemfibrozil in the treatment of primary hypercholesterolemia
  419. Differential effects of fenofibrate or simvastatin treatment of rats on hepatic microsomal overt and latent diacylglycerol acyltransferase activities
  420. On the mode of action of clofibrate on lipid metabolism. Inhibition of rat liver microsomal fatty acid synthesis
  421. effects of diets rich in fermentable carbohydrates on plasma lipoprotein levels and on lipoprotein catabolism in rats
  422. Differential eicosapentaenoic acid elevations and altered cardiovascular disease risk factor responses after supplementation with docosahexaenoic acid in …
  423. Dietary sunflower oil reduces plasma and liver triacylglycerols in fasting rats and is associated with decreased liver microsomal phosphatidate phosphohydrolase …
  424. Metabolic effects and clinical value of beet fiber treatment in NIDDM patients
  425. The role of fibric acids in atherosclerosis
  426. Biological Significance of Serum Albumin Binding Parameters Determined In Vitro for Clofibrate-Related Hypolipemic Drugs: Use of 2-(4′-Hydroxybenzeneazo) …
  427. Mechanisms of lipid-lowering agents
  428. Molecular mechanisms involved in the regulation of lipid and lipoprotein metabolism by fish oil
  429. Protective effects of dietary calcium and magnesium on platelet function and atherosclerosis in rabbits fed saturated fat
  430. Dietary effect of a symmetrical triacylglycerol, 1, 3‐biseicosapentaenoyl‐2‐γ‐linolenoyl glycerol, on fatty acid composition of guinea pigs
  431. effect of the interruption of enterohepatic circulation of bile acids by cholestyramine on apolipoprotein gene expression in the rat
  432. Therapeutic Potentials of Andrographolide from Andrographis paniculata : a Review
  433. The lowering of plasma lipids following a weight reduction program is related to increased expression of the LDL receptor and lipoprotein lipase
  434. Physicochemical Changes in HDL3 after Bezafibrate Treatment: Influence on Free Cholesterol Efflux from Human Fibroblasts
  435. Statin induction of liver fatty acid-binding protein (L-FABP) gene expression is peroxisome proliferator-activated receptor-α-dependent
  436. Inactivation of superoxide dismutase by several thiocarbamic acid derivatives
  437. effects of the type of dietary fat at two levels of vitamin E in wistar male rats during development and aging: I. Life span, serum biochemical parameters and …
  438. Influence of diet on lipid abnormalities in human renal disease
  439. Apolipoprotein E4 polymorphism as risk factor for coronary heart disease among Indian subjects
  440. Probiotics and prebiotics in prevention of chronic civilization diseases
  441. Plasma lipid and lipoprotein responses of rats to starch and sucrose diets with and without Brewer’s yeast
  442. The effects of ω3 and ω6 fatty acid-enriched diets on plasma lipoproteins and apoproteins in familial combined hyperlipidemia
  443. effects of clofibrate and tiadenol on the elimination of lipids and bile acids in rat bile
  444. effect of insulin and sulfonylurea therapy, at the same level of blood glucose control, on low density lipoprotein subfractions in type 2 diabetic patients
  445. effects of etofibrate upon the metabolism of chylomicron-like emulsions in patients with coronary artery disease
  446. Diabetes, fish oil, and vascular disease
  447. Induction of hamster hepatic peroxisomal β-oxidation and peroxisome proliferation-associated 80000 mol. wt. polypeptide by hypolipidemic drugs
  448. Dietary fat (virgin olive oil or sunflower oil) and physical training interactions on blood lipids in the rat
  449. effects of dietary fish oil supplementation on platelet aggregability and platelet membrane fluidity in normolipemic subjects with and without high plasma Lp (a) …
  450. N-3 fatty acids do not lead to an increased diabetic risk in patients with hyperlipidemia and abnormal glucose tolerance. Italian Fish Oil Multicenter Study
  451. effect of fish oil on lipid and lipoprotein metabolism in F1B hamsters
  452. effects of Saturated and Polyunsaturated Fatty Acids on Plasma Lipids, Platelets and the Vascular System
  453. Enteral feeding a structured lipid emulsion containing fish oil prevents the fatty liver of sepsis
  454. Rosuvastatin reduces plasma lipids by inhibiting VLDL production and enhancing hepatobiliary lipid excretion in ApoE* 3-leiden mice
  455. DGAT: novel therapeutic target for obesity and type 2 diabetes mellitus
  456. Role of acidic phospholipids in tissue distribution of quinidine in rats.
  457. Genetic variations of apolipoprotein A5 gene is associated with the risk of coronary artery disease among Chinese in Taiwan
  458. Antagonistic effects of dietary arachidonic acid and n-3 polyunsaturated fatty acids
  459. Comparative hypolipidemic effects of lovastatin and simvastatin in patients with heterozygous familial hypercholesterolemia
  460. Dietary α-linolenic acid lowers postprandial lipid levels with increase of eicosapentaenoic and docosahexaenoic acid contents in rat hepatic membrane
  461. effects of high-dose ethinyl estradiol on serum concentrations and hepatic secretion of the very-low-density lipoprotein, triacylglycerol, cholesterol, and apolipoprotein …
  462. effects of Dietary Prosomillet on Cholesterol and Fatty Acid Metabolism in Rats Fed High Cholesterol Diets
  463. effects of fish oil supplements in NIDDM subjects: controlled study
  464. effects of dietary alpha linolenic acid on cholesterol metabolism in male and female hamsters of the LPN strain
  465. PUBLISHED ONLY: INTEGRATED PHYSIOLOGY-FATTY ACID METABOLISM
  466. Restoration of normal insulinemia and insulin sensitivity in hyperinsulinemic normoglycemic men by a hypoenergetic high monounsaturated fat diet
  467. Long-term effects of clofibrate (Atromid-S) on serum lipids in man
  468. Sexual dimorphism in human lipid metabolism
  469. Long-term effect of tetradecylthioacetic acid: a study on plasma lipid profile and fatty acid composition and oxidation in different rat organs
  470. Comparative effects of dietary fat types on hepatic enzyme activities related to the synthesis and oxidation of fatty acid and to lipogenesis in rats
  471. effects of a diet rich in resistant starch on hepatic lipid metabolism in the rat
  472. Hypolipidemic activity of rifamycin derivatives
  473. effects of benfluorex on serum triacylglycerols and insulin sensitivity in the corpulent rat
  474. Hormone-fuel concentrations in anephric subjects. effect of hemodialysis (with special reference to amino acids).
  475. Incorporation of n-3 fatty acids into plasma lipid fractions, and erythrocyte membranes and platelets during dietary supplementation with fish, fish oil, and …
  476. Eicosapentaenoic acid (20: 5 n-3) increases fatty acid and glucose uptake in cultured human skeletal muscle cells
  477. Dietary fatty acids early in life affect lipid metabolism and adiposity in young rats
  478. Statin induction of Liver Fatty Acid-Binding Protein (L-FABP) gene expression is PPARα-dependent.
  479. Assessment of the possible adverse effects of oils enriched with n-3 fatty acids in rats: peroxisomal proliferation, mitochondrial dysfunctions and apoplexy
  480. effects of a fish oil-lard diet on rat plasma lipoproteins, liver FAS, and lipolytic enzymes
  481. effects of a novel anti-hyperlipidemic agent, S-2E, on blood lipid levels in rats with fructose-induced hypertriglyceridemia
  482. Influence of probucol on enhanced LDL oxidation after fish oil treatment of hypertriglyceridemic patients.
  483. Arachidonic acid inhibits lipogenic gene expression in 3T3-L1 adipocytes through a prostanoid pathway
  484. Comparison of the effects of adding fish high or low in n-3 fatty acids to a diet conforming to the Dietary Guidelines for Americans
  485. The effect of graded doses of ascorbic acid on the tissue carnitine and plasma lipid concentrations
  486. Modification of triacylglycerides and apolipoprotein B in rats fed diets containing whole milk, skim milk and milk proteins
  487. Influence of fibric acid derivatives on intermediate filament proteins in myocardiocyte cultures
  488. CHANGES INDUCED BY GEMFIBROZIL ON LIPIDIC, COAGULATIVE AND FIBRINOLYTIC PATTERN
  489. Potential hypolipidemic agents. 7. Synthesis and lipid-lowering properties of 2-(dibenzofuranyloxy)-2-methylpropionates and related compounds
  490. Modulation of rat liver apolipoprotein gene expression and serum lipid levels by tetradecylthioacetic acid (TTA) via PPARα activation
  491. Are fish oils beneficial in the prevention and treatment of coronary artery disease?
  492. PPAR-γ Activation Mediates Adipose Depot− Specific effects on Gene Expression and Lipoprotein Lipase Activity: Mechanisms for Modulation of Postprandial Lipemia …
  493. Marine oil capsule therapy for the treatment of hyperlipidemia
  494. Abundant expression of uncoupling protein-2 in the small intestine: up-regulation by dietary fish oil and fibrates
  495. Hypercholesterolemia, lipid lowering agents and the risk of brain infarction
  496. Regulatory function of glucose and insulin on high-density lipoprotein cholesterol in normolipidemic subjects
  497. Role of isoflavones in the hypocholesterolemic effect of soy
  498. New lipid-lowering agents acting on LDL receptors
  499. Association between fish consumption and all-cause and cause-specific mortality in Japan: NIPPON DATA80, 1980–99
  500. Fats from marine animals in human nutrition and prevention of cardiovascular diseases
  501. Antilipolytic effects of chlorophenoxyisobutyrate and warfarin in adipocytes.
  502. Viscous indigestible polysaccharides reduce accumulation of pentachlorobenzene in rats
  503. Metabolic consequences of weight cycling induced by high fat and protein feedings in female Sprague-Dawley rats
  504. effects of dietary fish oil on serum lipids and VLDL kinetics in hyperlipidemic apolipoprotein E* 3-Leiden transgenic mice
  505. Maternal erythrocyte omega-3 and omega-6 fatty acids, and plasma lipid concentrations, are associated with habitual dietary fish consumption in early pregnancy
  506. Differential effects of fish oil, safflower oil and palm oil on lipid-metabolizing enzymes of rat liver
  507. Suppression of fatty acid synthase by dietary polyunsaturated fatty acids is mediated by fat itself, not by peroxidative mechanism
  508. Interrelated effects of food lipids on steroid metabolism in rats
  509. The effect of dietary supplementation with eicosapentaenoic acid on the phospholipid and fatty acid composition of erythrocytes of marmoset
  510. Ovariectomy decreases plasma triglyceride levels and both prevents and alleviates glomerular disease in uninephrectomized female analbuminemic rats.
  511. Dietary cholesterol suppresses the ability of olive oil to delay the development of atherosclerotic lesions in apolipoprotein E knockout mice
  512. effects of fish oil fatty acids on low density lipoprotein size, oxidizability, and uptake by macrophages.
  513. The ratio of dietary (n-6) to (n-3) fatty acids influences immune system function, eicosanoid metabolism, lipid peroxidation and vitamin E status in aged dogs
  514. Tofu consumption: effects on plasma lipids in rats
  515. Fish oil prevents effect of high cholesterol diet on active intestinal transport of galactose
  516. The effect of manipulating the macronutrient composition of meals on postprandial lipid metabolism
  517. Nitric oxide deficiency, leukocyte activation, and resultant ischemia are crucial to the pathogenesis of diabetic retinopathy/neuropathy—preventive potential of …
  518. The effect of fatty acid composition of plant sterol esters on blood lipid profiles and plasma plant sterol levels in hypercholesterolemic subjects
  519. Why, what, and how to implement reduction of cardiovascular risk factors by diet.
  520. Insulin-mediated down-regulation of apolipoprotein A5 gene expression through the phosphatidylinositol 3-kinase pathway: role of upstream stimulatory factor
  521. A pilot study of the effects of omega-3 polyunsaturated fatty acids on blood lipids in hyperlipidemic patients
  522. Postprandial hyperlipidemia in streptozotocin-induced diabetic rats is due to abnormal increase in intestinal acyl coenzyme A: cholesterol acyltransferase activity
  523. Lack of predictability of classical animal models for hypolipidemic activity: a good time for mice?
  524. Peroxisome proliferator-activated receptor subtype-specific regulation of hepatic and peripheral gene expression in the Zucker diabetic fatty rat
  525. Vascular nitric oxide may lessen Alzheimer’s risk
  526. Biochemical basis of oligofructose-induced hypolipidemia in animal models
  527. effects of dietary protein and fat on cholesterol and fat metabolism in rats
  528. Mitochondrial 3-hydroxy-3-methylglutaryl coenzyme A synthase and carnitine palmitoyltransferase II as potential control sites for ketogenesis during mitochondrion …
  529. Exercise and postprandial lipid metabolism: an update on potential mechanisms and interactions with high-carbohydrate diets
  530. Reduction in plasma glucose after lipid changes in mice fed fish oil, docosahexaenoic acid, and eicosapentaenoic acid diets
  531. effects of long-chain monounsaturated and n-3 fatty acids on fatty acid oxidation and lipid composition in rats
  532. ApoE polymorphism and fish oil supplementation in subjects with an atherogenic lipoprotein phenotype
  533. White tuna canning, total fat, and fatty acid changes during processing and storage
  534. Relationship between fat cell size and number and fatty acid composition in adipose tissue from different fat depots in overweight/obese humans
  535. Endothelial membrane potential regulates production of both nitric oxide and superoxide–a fundamental determinant of vascular health
  536. Clofibrate increases hepatic triiodothyronine (T3)-and thyroxine (T4)-glucuronosyltransferase activities and lowers plasma T3 and T4 concentrations in pigs
  537. Present status of polyunsaturated fats in the prevention of cardiovascular disease
  538. Hepatic lipase gene expression is upregulated by a cystine-rich diet in male but not in female rats
  539. Divergent effects of d-norgestrel on the metabolism of rat very low density and low density apolipoprotein B.
  540. Dietary fish as a major component of a weight-loss diet: effect on serum lipids, glucose, and insulin metabolism in overweight hypertensive subjects
  541. Fish oil effects on tissular fatty acids and plasma lipid peroxidation in zinc deficient rats
  542. Eicosapentaenoic acid and atherosclerosis
  543. The influence of estrogen on hepatic cholesterol metabolism and biliary lipid secretion in rats fed fish oil
  544. Plasma and tissue lipids of piglets fed formula containing saturated fatty acids from medium-chain triglycerides with or without fish oil
  545. Diets rich in polyunsaturated fatty acids: effect on hepatic metabolism in rats
  546. PPAR-α effects on the heart and other vascular tissues
  547. Substituting dietary linoleic acid with α-linolenic acid improves insulin sensitivity in sucrose fed rats
  548. Complementary measures for promoting insulin sensitivity in skeletal muscle
  549. effects of dietary fat and carbohydrate on weight gain and serum lipids in rats
  550. Mulberry extract inhibits the development of atherosclerosis in cholesterol-fed rabbits
  551. Reduced hepatic triglyceride secretion in rats fed docosahexaenoic acid–rich fish oil suppresses postprandial hypertriglyceridemia
  552. effects of Fish Oil Supplements in NIDDM Subjects
  553. Nuclear receptors and the control of metabolism
  554. Sexually dimorphic metabolism of branched-chain lipids in C57BL/6J mice
  555. Hypolipidemic activity and toxicity studies of a styrl-hexahydroindolinol, 34–250
  556. Selective modification of rat hepatic microsomal fatty acid chain elongation and desaturation by fibrates: relationship with peroxisome proliferation
  557. effects of a low saturated fat, low cholesterol fish oil supplement in hypertriglyceridemic patients: a placebo-controlled trial
  558. Apolipoprotein B mRNA editing in the liver and small intestine of rats fed on beet fiber, soy protein, and fish oil
  559. Comparative study of the hypoglycemic effect of Azadirachta indica (Neem), Ocimum sanctum Tulsi) and Tinospora cordifolia (Chittamruthu) and their combination in …
  560. Gene–Diet Interactions, Blood Lipids, and Cardiovascular Disease Risk: The Rise of Nutrigenetics
  561. effects of PP-56 and vitamin E on platelet hyperaggregability, fatty acid abnormalities, and clinical manifestations in streptozocin-induced diabetic rats
  562. New pharmacological approaches to therapy of NIDDM
  563. effect of Dietary Calcium, Casein, and Soy on Plasma Cholesterol in the Japanese Quail (Coturnix Coturnix Japonica)
  564. Prevention of programmed hyperleptinemia and hypertension by postnatal dietary ω-3 fatty acids
  565. Short‐chain fatty acids: ready for prime time?
  566. Dietary Docosahexaenoic Acid Decreases Plasma Triglycerides with Mixed effects on the Indices of -oxidation
  567. Omega-3 fatty acid supplementation and lipoprotein (a) concentrations in patients with chronic glomerular diseases
  568. n-3 Fatty acids do not lead to an increased diabetic risk in patients with hyperlipidemia and abnormal glucose tolerance1
  569. Eicosapentaenoic acid reduces hepatic synthesis and secretion of triacylglycerol by decreasing the activity of acyl-coenzyme A: 1, 2-diacylglycerol …
  570. n-3 fatty acids and serum lipoproteins: human studies
  571. Aims of diet in diabetes management
  572. effects of dietary triacylglycerol structure on plasma and liver lipid levels in rats fed low-fat diets containing n-3 polyunsaturated fatty acids of marine origin
  573. effect of dietary seal and fish oils on triacylglycerol metabolism in rats
  574. Lipoprotein metabolism in diabetes
  575. Comparative changes in the fatty-acid composition of rat cardiac phospholipids after long-term feeding of sunflower seed oil-or tuna fish oil-supplemented diets
  576. The short-term effect of cortisone acetate upon fasting triglyceride and cholesterol in normal subjects and offspring of diabetic couples
  577. Daily supplementation with MaxEPA suppresses endotoxin-inducible monocytic procoagulation in dogs
  578. Dietary fish oil positively regulates plasma leptin and adiponectin levels in sucrose-fed, insulin-resistant rats
  579. effects of dietary fat sources on lipid metabolism in growing chicks (Gallus domesticus)
  580. Mechanisms for the serum lipid-lowering effect of n-3 fatty acids
  581. n-3 fatty acids and serum lipoproteins: animal studies
  582. Polyunsaturated fatty acids, hyperlipidemia, and thrombosis.
  583. Lisofylline causes rapid and prolonged suppression of serum levels of free fatty acids
  584. Atorvastatin Calcium: An Addition to HMG‐CoA Reductase Inhibitors
  585. PPARα, Lipoprotein Metabolism, Metabolic Diseases, and Atherosclerosis
  586. FXR, a multipurpose nuclear receptor
  587. 3-Thia fatty acid treatment, in contrast to eicosapentaenoic acid and starvation, induces gene expression of carnitine palmitoyltransferase-II in rat liver
  588. effect of frying and thermal oxidation on olive oil and food quality
  589. Synthesis and biological evaluation of novel hypolipemic compounds.
  590. Phosphorylation-dependent down-regulation of apolipoprotein A5 by insulin
  591. The effect of a free mackerel-supplemented diet on plasma and lipoprotein lipid concentrations in normolipidemic subjects
  592. SYNTHESIS AND ANTILIPIDEMIC PROPERTIES OF 3, 4, 4A, 9A-TETRAHYDRO-1H-PYRANO (3, 4-B) BENZOFURAN-1-ONES RELATED TO CLOFIBRATE.
  593. effects of dietary mulberry, Korean red ginseng, and banaba on glucose homeostasis in relation to PPAR-α, PPAR-γ, and LPL mRNA expressions
  594. effect of dietary fish oil on body fat mass and basal fat oxidation in healthy adults
  595. effect of fish oil treatment on plasma lipoproteins in type III hyperlipoproteinaemia
  596. Omega-3 fish oils and lipoprotein metabolism
  597. Lack of triglyceride-lowering properties of fish oil in apolipoprotein e–deficient mice
  598. Clofibrate-induced relocation of phosphatidylcholine transfer protein to mitochondria in endothelial cells
  599. Fish intake and blood lipids in fish eating vs non-fish eating communities of coastal south India
  600. The triglyceride connection in atherosclerosis
  601. YM‐53601, a novel squalene synthase inhibitor, reduces plasma cholesterol and triglyceride levels in several animal species
  602. Issues in hyperlipidemic pancreatitis
  603. Red yeast rice extracts suppress adipogenesis by down-regulating adipogenic transcription factors and gene expression in 3T3-L1 cells
  604. A comparison of the effectiveness of soy protein isolate and fish oil for reducing the severity of retinoid-induced hypertriglyceridemia
  605. Poultry-based alternatives for enhancing the ω3 fatty acid content of American diets
  606. Metabolic characteristics of healthy adult males as affected by ingestion of a liquid nutritional formula containing fish oil, oligosaccharides, gum arabic and antioxidant …
  607. effect of 3-thia fatty acids on the lipid composition of rat liver, lipoproteins, and heart
  608. The regulation of postprandial lipemia in man
  609. Dietary menhaden, seal, and corn oils differentially affect lipid and Ex vivo eicosanoid and thiobarbituric acid-reactive substances generation in the guinea pig
  610. A review of omega-3 ethyl esters for cardiovascular prevention and treatment of increased blood triglyceride levels
  611. Nutrition tid‐bites: Essential fatty acids in health and chronic disease
  612. effects of an ethyl ester preparation of fish oils (HIMEGAR) on lipids and lipoproteins in hyperlipidaemia
  613. Cardiovascular disease and long-chain omega-3 fatty acids
  614. effect of dietary fat type on β-oxidation of brown adipose tissue and Na+ channel density of brain nerve membrane in rats
  615. Further insight on the hypoglycemic and nonhypoglycemic effects of troglitazone 400 or 600 mg/d: effects on the very-low-density and high-density lipoprotein particle …
  616. Bile acid regulation of gene expression: roles of nuclear hormone receptors
  617. Polyunsaturated (n-3) fatty acids susceptible to peroxidation are increased in plasma and tissue lipids of rats fed docosahexaenoic acid–containing oils
  618. Replacement of digestible wheat starch by resistant cornstarch alters splanchnic metabolism in rats
  619. Composition of human VLDL triacylglycerols after ingestion of olive oil and high oleic sunflower oil
  620. Nutrient sensing, leptin and insulin action
  621. Regulation of apolipoprotein secretion by long-chain polyunsaturated fatty acids in newborn swine enterocytes
  622. Apolipoprotein B metabolism and the distribution of VLDL and LDL subfractions
  623. Dyslipidemia in Patients With CAD: How to Make Best Use of Drug Therapy
  624. effects of low dosage progestin-only administration upon plasma triglycerides and lipoprotein metabolism in postmenopausal women.
  625. DHA: can it benefit salmon marketing?
  626. effects of structured medium-and long-chain triacylglycerols in diets with various levels of fat on body fat accumulation in rats
  627. The effects of fish oil on lipid and lipoprotein metabolism in F1B and golden Syrian hamsters
  628. Long-term effects of n-3 fatty acids on serum lipids and glycaemic control
  629. n-3 Fatty acids from fish and plants: primary and secondary prevention of cardiovascular disease
  630. New insights on the role of lipids and lipoproteins in cardiovascular disease: the modulation effects of nutrition
  631. Inhibiting Δ9-desaturase activity impairs triacylglycerol secretion in cultured chicken hepatocytes
  632. effects of consumption of fatty fish rich in omega-3 polyunsaturated fatty acids on plasma lipids and prothrombin time in hyperlipidemic subjects
  633. Treatment of mixed hyperlipidaemia using a combination of omega-3 fatty acids and HMG CoA reductase inhibitor
  634. effects of dietary fats on blood cholesterol and other measures related to CHD risk in male and female laboratory mice
  635. Gemfibrozil stimulates apolipoprotein AI synthesis and secretion by stabilization of mRNA transcripts in human hepatoblastoma cell line (Hep G2)
  636. effect of n-3 fatty acids on serum lipid levels and hepatic fatty acid metabolism in BALB/c. KOR-Apoeshl mice deficient in apolipoprotein E expression
  637. effect of long-chain mono-unsaturated and n-3 polyunsaturated fatty acids on postprandial blood and liver lipids in rats
  638. Nutrition and therapeutics
  639. The antidiabetic drug metformin decreases cholesterol metabolism in cultured human fibroblasts
  640. Role of single nucleotide polymorphisms of pro-inflammatory cytokine genes in the relationship between serum lipids and inflammatory parameters, and the lipid …
  641. Chronic administration of eicosapentaenoic acid and docosahexaenoic acid as ethyl esters reduced plasma cholesterol and changed the fatty acid composition in rat …
  642. Induction of overlapping genes by fasting and a peroxisome proliferator in pigs: evidence of functional PPARα in nonproliferating species
  643. Eicosapentaenoic acid inhibits hepatic production of very low density lipoprotein
  644. Dietary fish oil and experimental atherosclerosis
  645. effect of feeding onion (allium cepa var aggregatum g. don) and garlic (allium sativum linn) on lipid profile in Japanese quail (coturnix coturnix japonica)
  646. Fish oil supplementation in type 2 diabetes: a quantitative systematic review.
  647. Omega-3 fatty acids improve glucose tolerance and components of the metabolic syndrome in Alaskan Eskimos: the Alaska Siberia project
  648. Fish Oil Supplementation Versus Gemfibrozil Treatment in Hyperlipidemic NIDDM
  649. Omega-3 fatty acids from fish: primary and secondary prevention of cardiovascular disease
  650. Low doses of eicosapentaenoic acid, docosahexaenoic acid, and hypolipidemic eicosapentaenoic acid derivatives have no effect on lipid peroxidation in plasma
  651. Lipid management for patients with CAD, Part 2: A guide to drug therapy
  652. Dietary fish oil reverse epididymal tissue adiposity, cell hypertrophy and insulin resistance in dyslipemic sucrose fed rat model
  653. Psammomys obesus: primary insulin resistance leading to nutritionally induced type 2 diabetes
  654. Do n-3 fatty acids improve glucose tolerance and lipemia in diabetics?
  655. Microalgal docosahexaenoic acid decreases plasma triacylglycerol in normolipidaemic vegetarians: a randomised trial
  656. effects of various n-3/n-6 fatty acid ratios in diet on lipid metabolism in growing chicks
  657. Hypocholesterolemic action of fermented brown rice supplement in cholesterol‐fed rats: cholesterol‐lowering action of fermented brown rice
  658. Moderate alcohol consumption lowers risk factors for cardiovascular disease in postmenopausal women fed a controlled diet
  659. effects of fish oil on metabolic responses to oral fructose and glucose loads in healthy humans
  660. Diet, insulin resistance, and obesity: zoning in on data for Atkins dieters living in South Beach
  661. effect of Lipids from Erabu Sea Snake, Laticauda semifasciata, on Plasma Glucose, Insulin, and Adipocytokine Concentrations of Normal and Streptozotocin-Diabetic …
  662. Fructooligosaccharides of edible alliums: occurrence, chemistry and health benefits
  663. The Potential Application of Spirulina (Arthrospira) as a Nutritional and Therapeutic Supplement in Health Management
  664. Structure, function, and dietary regulation of Δ6, Δ5, and Δ9 desaturases
  665. Lack of effect of eicosapentaenoic acid in preventing cancer cachexia and inhibiting tumor growth
  666. Different response of senescent female Sprague–Dawley rats to gemfibrozil and rosiglitazone administration
  667. Oily fish reduces plasma triacylglycerols: a primary prevention study in overweight men and women
  668. effects of n− 3 fatty acids in subjects with type 2 diabetes: reduction of insulin sensitivity and time-dependent alteration from carbohydrate to fat oxidation
  669. an der.(2006, No ember 28)
  670. Normal subjects consuming physiological levels of 18: 3 (n-3) and 20: 5 (n-3) from flaxseed or fish oils have characteristic differences in plasma lipid and lipoprotein …
  671. Docosahexaenoic acid induces lipid accumulation in myocardial cells of rats
  672. Diet and coronary heart disease in diabetes
  673. The hepatobiliary axis and lipoprotein metabolism: effects of bile acid sequestrants and ileal bypass surgery
  674. Eggs enriched inω-3 fatty acids and alterations in lipid concentrations in plasma and lipoproteins and in blood pressure
  675. Essential fatty acids in health and chronic disease
  676. The Dietary Therapy of Hyperlipidemia: Its Important Role in the Prevention of Coronary Heart Disease
  677. Possible role of triacylglycerol-rich lipoproteins in the down-regulation of adipose obese mRNA expression in rats re-fed a high-fat diet
  678. alpha-Linolenic acid-and docosahexaenoic acid-enriched eggs from hens fed flaxseed: influence on blood lipids and platelet phospholipid fatty acids in humans
  679. Iatrogenic lipodystrophy in HIV patients–the need for very-low-fat diets
  680. Marine lipids normalize cholesteryl ester transfer in IDDM
  681. Assessment of the therapeutic use of n-3 fatty acids in vascular disease and thrombosis
  682. Regulation of gene expression by polyunsaturated fatty acids
  683. Safety considerations of polyunsaturated fatty acids
  684. Proliferation of mitochondria and gene expression of carnitine palmitoyltransferase and fatty acyl‐CoA oxidase in rat skeletal muscle, heart and liver by hypolipidemic …
  685. Sesamin, a sesame lignan, as a potent serum lipid-lowering food component
  686. Docosahexaenoic acid but not eicosapentaenoic acid lowers ambulatory blood pressure and heart rate in humans
  687. Metabolic fate of long-chain unsaturated fatty acids and their effects on palmitic acid metabolism and gluconeogenesis in bovine hepatocytes
  688. Peroxisome proliferators as adjuvants for the reverse-electron-transport therapy of obesity: an explanation for the large increase in metabolic rate of MEDICA 16 …
  689. The effect of the short-term administration of fish oil on serum lipoproteins in old people
  690. effects of n-3 polyunsaturated fatty acids on glucose homeostasis and blood pressure in essential hypertension: a randomized, controlled trial
  691. Fish oil ameliorates renal injury and hyperlipidemia in the Milan normotensive rat model of focal glomerulosclerosis.
  692. effects of fatty acids and growth hormone on liver fatty acid binding protein and PPARα in rat liver
  693. N-3 fatty acids from fish and plants: primary and secondary prevention of cardiovascular disease
  694. n-3 long-chain polyunsaturated fatty acids in type 2 diabetes: a review
  695. Aqueous Extract of Monascus purpureus M9011 Prevents and Reverses Fructose-Induced Hypertension in Rats
  696. Statins in diabetics, beyond cholesterol?
  697. Eicosapentaenoic and docosahexaenoic acid affect mitochondrial and peroxisomal fatty acid oxidation in relation to substrate preference
  698. effect of acute fish oil and soy isoflavone supplementation on postprandial serum triglycerides and biomarkers of oxidative stress in overweight and obese men
  699. Leads from Indian medicinal plants with hypoglycemic potentials
  700. effects of arachidonic and docosahexaenoic acids on secretion and degradation of bile salt-dependent lipase in AR4-2J cells
  701. Dietary fish oil and Undaria pinnatifida (wakame) synergistically decrease rat serum and liver triacylglycerol
  702. Growth and lipid metabolism responses in rats fed different dietary fat sources
  703. Dose-response effect of dietary docosahexaenoic acid on fatty acid profiles of serum and tissue lipids in rats
  704. Divergent effects of eicosapentaenoic and docosahexaenoic acid ethyl esters, and fish oil on hepatic fatty acid oxidation in the rat
  705. Polyunsaturated fatty acids: biochemical, nutritional and epigenetic properties
  706. Gender and hormonal status modulate the effects of psyllium on the mechanisms determining plasma lipids and lipoprotein metabolism
  707. Exercise and fish oil: Additive effect on postprandial lipemia?
  708. effects of fish oil and n-3 fatty acids on the regulation of Δ9-fatty acid desaturase mRNA and-activity in rat liver
  709. Eicosapentaenoic acid, but not oleic acid, stimulates β‐oxidation in adipocytes
  710. effect of dairy fat and milk product supplementation on plasma lipids and low-density lipoprotein metabolism in the guinea pig
  711. HPLC/colorimetry combination method for quantitative analyses of sclerotiorin produced by Penicillium sclerotiorum
  712. Polyphenol-mediated inhibition of AP-1 transactivating activity may slow cancer growth by impeding angiogenesis and tumor invasiveness
  713. Prevention of age-related changes in rat cortex transcription factor activator protein-1 by hypolipidemic drugs
  714. Extracts of Monascusus purpureus beyond statins—profile of efficacy and safety of the use of extracts of Monascus purpureus
  715. A solid dietary fat containing fish oil redistributes lipoprotein subclasses without increasing oxidative stress in men
  716. Fish consumption, fish oil, lipids, and coronary heart disease
  717. Historically and to the present time a vast amount of evidence in
  718. Omega-3 fish oils and insulin resistance
  719. Impact of feeding bread enriched with flaxseed on plasma profile of hyperlipidemic rats-a short report.
  720. Consumption of omega-3 fatty acid-enriched eggs and serum lipids in humans
  721. effects of human pharmaceuticals on cytotoxicity, EROD activity and ROS production in fish hepatocytes
  722. Eicosapentaenoic acid and sulphur substituted fatty acid analogues inhibit the proliferation of human breast cancer cells in culture
  723. The effect of fish oil supplementation on LDL cholesterol subclasses in patients with type 2 diabetes mellitus
  724. Dietary eritadenine modifies plasma phosphatidylcholine molecular species profile in rats fed different types of fat
  725. Factors influencing the effects of diet on insulin resistance and metabolic parameters in NIDDM
  726. Inhibitory effect of red koji extracts on mushroom tyrosinase
  727. Omega‐3 fatty acids in wild plants, nuts and seeds
  728. Fish oil: role of omega-3s in health and nutrition: January 1979-December 1990
  729. Changes in fatty acid metabolism in rat hepatocytes in response to dietary n-3 fatty acids are associated with changes in the intracellular metabolism and secretion of …
  730. Influence of dietary cholesterol on polyunsaturated fatty acid composition, fluidity and membrane-bound enzymes in liver microsomes of rats fed olive and fish oil
  731. effects of Dietary Fat Sources Containing n-3 and n-6 Polyunsaturated Fatty Acids on Lipid Metabolism in Growing Chicks (Gallus domesticus)
  732. Triglyceride-rich lipoprotein remnant particles and risk of atherosclerosis
  733. Triglyceride, High Density Lipoprotein, and Coronary Heart Disease: January 1989 Through February 1992 Plus Selected Earlier Literature: 1636 Citations
  734. Skeletal Muscle and Post-Heparin Plasma Lipoprotein Lipase Activities (Exercise, Triglyceride)
  735. effect of exposure to high isoflavone-containing diets on prenatal and postnatal offspring mice
  736. Lipase-catalyzed esterification of glycerol and polyunsaturated fatty acids from fish and microalgae oils
  737. CHOLESTEROL-LOWERING BY SULFONATE ESTERS: BIOCHEMICAL AND PHARMACOLOGICAL INVESTIGATIONS.
  738. Dietary effects of eicosapentaenoic acid and docosahexaenoic acid on lipid metabolism in black sea bream
  739. Cholesterol and lipoprotein metabolism in aging: reversal of hypercholesterolemia by growth hormone treatment in old rats
  740. EPA and DHA possess different metabolic properties
  741. Comparative effects of α‐and γ‐linolenic acids on rat liver fatty acid oxidation
  742. Soybean foods and their benefits: potential mechanisms of action
  743. Lipid metabolism and nutrient partitioning strategies
  744. Insulin secretion after dietary supplementation with conjugated linoleic acids and n-3 polyunsaturated fatty acids in normal and insulin-resistant mice
  745. Steatosis and collagen content in experimental liver cirrhosis are affected by dietary monounsaturated and polyunsaturated fatty acids
  746. The influence of ground flaxseed or flaxseed oil on indicators for diabetes in adults
  747. Recommendations for the nutritional management of patients
  748. Plasma testosterone and serum lipids in male survivors of myocardial infarction
  749. Investigation into the mechanism and treatment of atherogenic dyslipidemia in HIV+ patients with HIV metabolic syndrome
  750. Dietary management of elevated blood lipids
  751. Dietary fatty acids in the management of diabetes mellitus
  752. The metabolism and effects of different long chain fatty acids in the bovine liver
  753. Selectivity of fatty acids on lipid metabolism and gene expression
  754. Isolation of off-flavors and odors from tuna fish oil using supercritical carbon dioxide
  755. Docosahexaenoic acid is transferred through maternal diet to milk and to tissues of natural milk-fed piglets
  756. Lipids easy to accumulate in the liver and lipids hard to accumulate in it
  757. Fat kinetics and recommended dietary intake in burns
  758. Dietary fat, genes, and human health
  759. Extraction of lipids and cholesterol from squid oil with supercritical carbon dioxide
  760. Rosiglitazone Maleate< Prop INNM
  761. Development of hypertension in a rat model of diet-induced obesity
  762. Feeding scallop shell powder induces the expression of uncoupling protein 1 (UCP1) in white adipose tissue of rats
  763. Dietary fats, insulin resistance, and diabetes
  764. Soy isoflavones improve systemic arterial compliance but not plasma lipids in menopausal and perimenopausal women
  765. Serum lipid concentrations and mean life span are modulated by dietary polyunsaturated fatty acids in the senescence-accelerated mouse
  766. Hypocholesterolemic mechanisms of dihydrocapsaicin
  767. Stimulation of the activities of hepatic fatty acid oxidation enzymes by dietary fat rich in alpha-linolenic acid in rats
  768. Fasting and postprandial serum lipoprotein responses to a hypocaloric low-carbohydrate diet rich in monounsaturated fat and supplemented with n-3 fatty …
  769. Sexual dimorphism in lipid metabolic phenotype associated with old age in Sprague–Dawley rats
  770. THE ISOFLAVONE GLYCITEIN LOWERED PLASMA CHOLESTEROL IN FEMALE GOLDEN SYRIAN HAMSTERS
  771. Complementary and alternative therapies for the management of dyslipidemia
  772. High density lipoprotein (HDL): physiology, pathophysiology, and relationship to atherosclerosis
  773. Purification process for cod liver oil polyunsaturated fatty acids
  774. Potential Role of a Novel Vascular Modulator, Hepatocyte Growth Factor (HGF), in Cardiovascular Disease: Characterization and Regulation of Local HGF System
  775. Dietary canola oil modifies myocardial fatty acids and inhibits cardiac arrhythmias in rats
  776. 8 Polyunsaturated fatty acids and coronary heart disease
  777. effects of fatty acids and over-stimulation on insulin secretion in man
  778. effects of dietary fat and fatty acids on plasma LDL quantity and quality and differential regulation of LDL receptor gene expression by individual fatty acids
  779. Metabolic flux analysis of cultured hepatocytes exposed to plasma
  780. Mechanisms of the assembly of hepatic very low density lipoprotein in rat hepatoma McA-RH7777 cells.
  781. Influence of oligosaccharides and fish oil on gastrointestinal tract characteristics and metabolic profiles of humans, pigs, and rats
  782. Transcription profiling in rat liver in response to dietary docosahexaenoic acid implicates stearoyl-coenzyme a desaturase as a nutritional target for lipid …
  783. Incorporation of n-3 fatty acids into phospholipids of rat liver and white and brown adipose tissues: A time-course study during fish-oil feeding
  784. Novel fats for the future
  785. Use of deuterium oxide to measure very low density lipoprotein triglyceride synthesis in normal subjects consuming different diet fats
  786. Soy protein versus soy phytoestrogens in the prevention of diet-induced coronary artery atherosclerosis of male cynomolgus monkeys
  787. effects of training on cardiac function in the fatty Zucker rat
  788. Dietary co3 Fatty Acids
  789. Fatty acid chain length and degree of unsaturation are inversely associated with serum triglycerides
  790. effects of Fish Oil on Risk Factors for Cardiovascular Disease: Minireview Based on a Doctoral Thesis
  791. Dietary n-9, n-6 and n-3 fatty acids modify linoleic acid more than arachidonic acid levels in plasma and platelet lipids and minimally affect platelet thromboxane …
  792. An Overview of Peroxisome Proliferation
  793. Omega-3 fatty acids and antioxidants in edible wild plants
  794. Carvedilol inhibits reactive oxygen species generation by leukocytes and oxidative damage to amino acids
  795. Nutrition and therapeutics
  796. The independent effects of eicosapentaenoic acid and docosahexaenoic acid on cardiovascular risk factors in humans
  797. Dietary n-6 and n-3 fatty acid balance and cardiovascular health
  798. Proceedings of the AOCS Short Course on Polyunsaturated Fatty Acids and Eicosanoids
  799. effect of gamma-linolenate administration to previously obese humans
  800. Modification of experimental and clinical atherosclerosis by dietary fish oil
  801. 2000 George Lyman Duff Memorial Lecture: atherosclerosis is a liver disease of the heart
  802. Fish oils, eicosanoid biosynthesis and cardiovascular disease: an overview
  803. The effects of omega-3 and omega-6 polyunsaturated fatty acids on renal function and serum lipid profiles of uremic rats
  804. New Monascus Metabolites with a Pyridine Structure in Red Fermented Rice
  805. Dietary n-3 and n-6 fatty acids alter avian metabolism: metabolism and abdominal fat deposition
  806. effects of perfluorooctanoic acid on the synthesis of phospholipids in the liver of mice fed a dietary soybean oil, perilla oil or fish oil
  807. Omega-3 fatty acids: Physiological and nutritional consequences
  808. Lipoprotein Metabolism and Atherogenesis
  809. Lipoprotein heterogeneity and apolipoprotein B metabolism
  810. effects of N-3 fatty acids on lipid metabolism
  811. Hyperlipidemia: What to do when life-style changes aren’t enough
  812. The relationship between cation-induced substrate configuration and enzymatic activity of phosphatidate phosphohydrolase from human liver
  813. Dietary fat and fiber in human diets: impact on serum lipid profile, consumption patterns and food acceptability measurement
  814. Regulation of cholesterol, lipid and VLDL metabolism by saturated fatty acids in rat hepatocytes
  815. How enzymes may be helpful for upgrading fish by-products: Enhancement of fat extraction
  816. Metabolic effects of 3-thia fatty acid in cancer cells
  817. HMG-CoA Reductase Inhibitors
  818. Increased hepatic β‐oxidation of docosahexaenoic acid, elongation of eicosapentaenoic acid, and acylation of lysophosphatidate in rats fed a docosahexaenoic acid …
  819. Nutrition and Disease Update: Heart Disease
  820. Nutrition and therapeutics
  821. Intestinal absorption lipoprotein transport and clearance of free and esterified eicosapentaenoic acid
  822. Regulation of the insulin and asialoglycoprotein receptors via cGMP-dependent protein kinase
  823. Pharmacology, metabolism and nutrition
  824. Fatty Acid Metabolism in Isolated Enterocytes from Salmonid Fish
  825. Fatty acid supply and status of piglets from birth to two weeks post weaning
  826. Evidence for a peroxisome proliferator-activated receptor (PPAR)-mediated mechanism for conjugated linoleic acid (CLA)
  827. Supercritical Carbon Dioxide Extraction of SardineSardina pilchardusOil
  828. Semisynthetic cephalosporins. Synthesis and structure-activity relations of 7-mandelamido-3-cephem-4-carboxylic acids
  829. Alleviation of fatty liver by α-linolenic acid
  830. Lipids in human nutrition
  831. Photolimitation and photoinhibition as factors determining optimal dilution rate to produce eicosapentaenoic acid from cultures of the microalga Isochrysis galbana
  832. The effects of dietary soybean protein in comparison to casein on the renal function of uremic rats
  833. 24 Human Gut Microflora in Health and Disease: Focus on Prebiotics
  834. Integration of metabolism, energetics, and signal transduction: unifying foundations in cell growth and death, cancer, atherosclerosis, and Alzheimer disease
  835. The relationship of vitamin C and alcohol to lipid metabolism
  836. effects of a high-monounsaturated fat diet on glucose and lipid metabolisms in normal and diabetic mice
  837. New Monascus Metabolite Isolated from Red Yeast Rice (Angkak, Red Koji)
  838. The dietary essentiality of n-3 polyunsaturated fatty acids in infant nutrition
  839. Molecular activities of vitamin E
  840. Peroxisome Proliferator Activated Receptors: From Basic Science to Clinical Applications
  841. Evidence of a malonyl-CoA-insensitive carnitine palmitoyltransferase I activity in red skeletal muscle
  842. Influence of dietary and genetic factors on quality and fatty acid composition of beef and lamb
  843. effects of Angelica keiskei on lipid metabolism in rats
  844. Design of hydrogen-bonded networks for the separation of polyunsaturated fatty acids
  845. Identification of novel physiological roles for the farnesoid X receptor
  846. Survival of freeze-dried probiotics in soy protein powder
  847. Expression of peroxisome proliferator-activated receptors in zebrafish (Danio rerio) depending on gender and developmental stage
  848. The properties of the recombinant fructosyltransferase of streptococcus salivarius
  849. The effect of conjugated linoleic acid (CLA) isomers on leptin, adiponectin and peroxisome proliferator-activated receptor (PPAR) expression and their influence …
  850. Lipid metabolism and health
  851. Fish oils in health and disease: lessons from the eskimos
  852. DIETS FOR WEIGHT REDUCTION IN OBESITY, CARDIOVASCULAR DISEASE, HYPERTENSION AND THE METABOLIC SYNDROME: THE GUIDELINES, THE …
  853. Analyses of red fermented rice (angkak) and report of a newMonascus metabolite
  854. Dictionary of nutraceuticals and functional foods
  855. The identification of farnesoid-X receptor target genes: New insights into bile acid signaling
  856. Omega-3 fatty acids in health and disease and in growth and development
  857. Fish oil supplementation does not lower plasma cholesterol in men with hypercholesterolemia: Results of a randomized, placebo-controlled crossover study
  858. Nutrition for the Hospitalized Patient: Basic Science and Principles of Practice
  859. Adverse metabolic effect of omega-3 fatty acids in non-insulin-dependent diabetes mellitus
  860. Dietary associates of serum total, LDL, and HDL cholesterol and triglycerides in patients with coronary heart disease
  861. Fish oil treatment of interferon-alpha-induced dyslipidaemia: study in patients with chronic hepatitis C
  862. Flavonoids attenuate cardiovascular disease, inhibit phosphodiesterase, and modulate lipid homeostasis in adipose tissue and liver
  863. Association of hyperapobetalipoproteinemia with endogenous hypertriglyceridemia and atherosclerosis
  864. Fish oils in the prevention of atherosclerosis
  865. Optimum Conditions for Production of Mevinolin from the Soybean Fermented with Monascus sp.
  866. Nutrition and therapeutics
  867. Selenium, calcium channel blockers, and cancer risk—the Yin and Yang of apoptosis?
  868. Study on the rapid effects of SAMe in primary and secondary triglyceridemias
  869. The paradoxical effects of dietary fish oil on blood pressure
  870. Dietary fats and diabetes mellitus: is there a good fat?
  871. Diet, lipids, and coronary heart disease
  872. 2-Substituted-3-pyridinolethers as hypolipidemic and platelet aggregation inhibiting agents.
  873. Use of dietary fish oil–an alternative to drug therapy of dyslipidemia
  874. Influence of unstaturated dietary fatty acids on the distribution of cholesterol in the lipoprotein fractions and on serum lipids of rats
  875. Dyslipidemia in noninsulin-dependent diabetes mellitus
  876. Serum cholesterol, lipoproteins, and the risk of coronary heart disease: the Framingham Study
  877. Hepatothermic therapy of obesity: rationale and an inventory of resources
  878. Cholesterol in the prediction of atherosclerotic disease: new perspectives based on the Framingham study
  879. Omega-3 fatty acids and heart disease
  880. 8 Cardiovascular effects of ω-3 polyunsaturated fatty acids (fish oils)
  881. Quantitative RT-PCR: pitfalls and potential
  882. Results and prospects of therapy of type IV dyslipidemia with chenic acid
  883. Patient-directed, nonprescription approaches to cardiovascular disease
  884. Fatty Acids and Growth Regulation
  885. The role of dietary oligosaccharides in lipid metabolism
  886. Coronary-prone Behavior and Coronary Heart Disease: A Bibliography
  887. Omega-3 fatty acids in other diseases
  888. BALIK YAGININ KORONER KALP HASTALIKLARI UZERiNE ETKisi
  889. hypotriglyceridemic effect of Morus alba L., Moraceae, leaves in hyperlipidemic rats
  890. hypotriglyceridemic effects of apple polyphenols extract via up-regulation of lipoprotein lipase in triton WR-1339-induced mice
  891. hypotriglyceridemic effect of dietary vanillin in experimental rats
  892. The hypotriglyceridemic effect of biotin supplementation involves increased levels of cGMP and AMPK activation
  893. effects of supplemented diacylglycerol rich in docosahexaenoic acid on serum triacylglycerol in a diet-induced hyperlipidemic model of rats are essentially equivalent …
  894. Hypolipemic effect of Garcinia cambogia in Obese Women
  895. Dietary procyanidins lower triglyceride levels signaling through the nuclear receptor small heterodimer partner
  896. Dietary procyanidins enhance transcriptional activity of bile acid‐activated FXR in vitro and reduce triglyceridemia in vivo in a FXR‐dependent manner
  897. Hypolipidemic effect of dietary pea proteins: Impact on genes regulating hepatic lipid metabolism
  898. Mechanisms for the delayed effects of exercise on lipid and lipoprotein metabolism
  899. β-Conglycinin lowers very-low-density lipoprotein-triglyceride levels by increasing adiponectin and insulin sensitivity in rats
  900. effect of atorvastatin monotherapy and low-dose atorvastatin/ezetimibe combination on fasting and postprandial triglycerides in combined hyperlipidemia
  901. Potential of probiotics in controlling cardiovascular diseases
  902. Sex differences in VLDL‐triglyceride kinetics in the basal state and in response to high‐intensity interval exercise
  903. Kinetics of plasma apolipoprotein C-III as a determinant of diet-induced changes in plasma triglyceride levels
  904. IMPACT OF PPAR-Y AGONISM ON TRIGLYCERIDEMIA IN TRANSGENIC MICE EXPRESSING CARDIAC, BUT NOT ADIPOSE TISSUE OR SKELETAL …
  905. PPARβ/δ Activation prevents hypertriglyceridemia caused by a high fat diet. Involvement of AMPK and PGC-1α-Lipin1-PPARα pathway
  906. Farnesol decreases serum triglycerides in rats: identification of mechanisms including up-regulation of PPARα and down-regulation of fatty acid synthase in …
  907. PPAR-Y AGONISM IMPROVES TRIGLYCERIDEMIA IN RATS BY INCREASING ADIPOSE DEPOT-SPECIFIC LIPOPROTEIN LIPASE ACTIVITY AND …
  908. The PPARβ/δ activator GW501516 prevents the down-regulation of AMPK caused by a high-fat diet in liver and amplifies the PGC-1α-Lipin 1-PPARα pathway leading …
  909. The effect of EPA and DHA on metabolic syndrome patients: a systematic review of randomised controlled trials
  910. Atorvastatin and fenofibrate increase apolipoprotein AV and decrease triglycerides by up‐regulating peroxisome proliferator‐activated receptor‐α
  911. Blood lipids profile in lactating cows fed with supplement of OVOCAP®
  912. The use of Morus alba L.(mulberry) and Eucommia ulmoides (Tochu) leaves as functional foods: a promising approach in the management of hyperlipidemia
  913. Hypolipidemic effects of proanthocyanidins and their underlying biochemical and molecular mechanisms
  914. Independent and Combined effects of Menhaden Oil and High Fructose on Hepatic Lipid Metabolism
  915. Hypolipidemic effect of extracts from Abelmoschus esculentus L.(Malvaceae) on tyloxapol-induced hyperlipidemia in mice
  916. Aqueous extract of Hibiscus sabdariffa calyces reduces serum triglycerides but increases serum and egg yolk cholesterol of shika brown laying hens.
  917. Vegetal Dietary Protein: Amaranthus cruentus Seeds. Their Influence on Triglycerides Metabolism
  918. Omega-3 fatty acids and HDL. How do they work in the prevention of cardiovascular disease?
  919. Taiwanofungus camphoratus activates peroxisome proliferator-activated receptors and induces hypotriglyceride in hypercholesterolemic rats
  920. Dietary conjugated linoleic acid induces tissue-specific lipoprotein lipase mRNA modulation in high-sucrose-fed mice
  921. The Hypothalamic Sensing of Amino Adds Regulates Plasma Triglycerides.
  922. Recent findings on cardiovascular and mental health effects of krill oil and omega-3 phospholipids
  923. Comparison of hypolipidemic effects of three berries in diet‐induced obese C57BL/6J mice
  924. Red mold dioscorea has greater hypolipidemic and antiatherosclerotic effect than traditional red mold rice and unfermented dioscorea in hamsters
  925. Fenofibrate, a peroxisome proliferator-activated receptor α agonist, alters triglyceride metabolism in enterocytes of mice
  926. effects of Bixa orellana L. Seeds on Hyperlipidemia
  927. Administration of perilla oil coated with Calshell increases glucagon-like peptide secretion
  928. Atherosclerosis-preventing activity of lactic acid bacteria-fermented milk− soymilk supplemented with Momordica charantia
  929. Fast-twitch muscle hypertrophy partly induces lipid accumulation inhibition with Alaska pollack protein intake in rats
  930. Fatty acid compositions of fish oil extracted from different parts of Indian mackerel (Rastrelliger kanagurta) using various techniques of supercritical CO2 extraction
  931. effect of polyphenol-rich extract from walnut on diet-induced hypertriglyceridemia in mice via enhancement of fatty acid oxidation in the liver
  932. A New Lysosome-Mediated Degradation Mechanism for Hepatic Lipid Droplets Turnover
  933. Astaxanthin-rich extract from the green alga Haematococcus pluvialis lowers plasma lipid concentrations and enhances antioxidant defense in apolipoprotein …
  934. Hypolipidemic effect of extracts from Abelmoschus esculentus L.—Malvaceae on tyloxapol-induced hyperlipidemia in mice
  935. Antihypertensive effects of Novel Isoflavone-Free Black Soy Peptide Mixture as HO-1 Inducer
  936. Influence of silibor flavonoid substance on clinical course of acute CCl4 hepatitis
  937. Metabolic risk susceptibility in men is partially related to adiponectin/leptin ratio
  938. Acute effects of exercise and calorie restriction on triglyceride metabolism in women
  939. The effects of 8-week Nigella sativa supplementation and aerobic training on lipid profile and VO2 max in sedentary overweight females
  940. Research Journal of Pharmaceutical, Biological and Chemical Sciences
  941. Systemic delivery of estradiol, but not testosterone or progesterone, alters very low density lipoprotein-triglyceride kinetics in postmenopausal women
  942. Hypolipidemic and antioxidant effect of polyphenol-rich extracts from Moroccan thyme varieties
  943. Dietary spices as beneficial modulators of lipid profile in conditions of metabolic disorders and diseases
  944. Hypoglycemic effect of aqueous extract of seabuckthorn (Hippophae rhamnoides L.) seed residues in streptozotocin‐induced diabetic rats
  945. effect of etofibrate on bile production in the normolipidemic rat.
  946. Glycemia and lipidemia variations of the rabbits inoculated with bee venom.
  947. The role of polyunsaturated fatty acids (PUFA) in the treatment of dyslipidemias
  948. effects of Teucrium polium ethyl acetate extract on serum, liver and muscle triglyceride content of sucrose-induced insulin resistance in rat
  949. Dietary soybean peptides containing a low-molecular fraction can lower serum and liver triglyceride levels in rats
  950. Daily intake of cod or salmon for 2 weeks decreases the 18: 1n-9/18: 0 ratio and serum triacylglycerols in healthy subjects
  951. Recent advances in pharmacotherapy for hypertriglyceridemia
  952. effects of ω-3 Polyunsaturated Fatty Acids on Plasma Proteome in Rett Syndrome
  953. Walnuts and fatty fish influence different serum lipid fractions in normal to mildly hyperlipidemic individuals: a randomized controlled study
  954. Triglycerides and gallstone formation
  955. A Novel Lysosome-Mediated Degradation Mechanism for Hepatic Lipid Droplet Turnover
  956. Phenolic acid-rich extract of sweet basil restores cholesterol and triglycerides metabolism in high fat diet-fed mice: A comparison with fenofibrate
  957. Antihyperlipidemic effects of Sesamum indicum L. in Rabbits Fed a High-Fat Diet
  958. Decrease in blood triglycerides associated with the consumption of eggs of hens fed with food supplemented with fish oil
  959. Dietary lupin protein lowers triglyceride concentrations in liver and plasma in rats by reducing hepatic gene expression of sterol regulatory element-binding protein-1c
  960. effects of simultaneous dietary fish oil ingestion and sulfur amino acid supplementation on the lipid metabolism in hepatoma-bearing rats with hyperlipidemia
  961. effect of ardhabilva kvatha curna-an ayurvedic formulation on lipid profile after chronic administration
  962. Quercetin ameliorates hyperglycemia and dyslipidemia and improves antioxidant status in type 2 diabetic db/db mice
  963. Characterization of the Antidiabetic Role of Parkinsonia aculeata (Caesalpineaceae)
  964. Why it is necessary to translate curcumin into clinical practice for the prevention and treatment of metabolic syndrome?
  965. A randomized study to establish the effects of spirulina in type 2 diabetes mellitus patients
  966. Do statins beneficially or adversely affect glucose homeostasis?
  967. High-intensity interval aerobic training reduces hepatic very low-density lipoprotein-triglyceride secretion rate in men
  968. A single bout of brisk walking increases basal very low-density lipoprotein triacylglycerol clearance in young men
  969. The possible roles of food-derived bioactive peptides in reducing the risk of cardiovascular disease
  970. effect of rosuvastatin monotherapy or in combination with fenofibrate or ω‐3 fatty acids on lipoprotein subfraction profile in patients with mixed dyslipidaemia and …
  971. Concentration of docosahexaenoic and eicosapentaenoic acids by enzymatic alcoholysis with different acyl-acceptors
  972. Hepatoprotective effect of chicory (Chicorium intybus) root extract against orotic acid-induced fatty liver in rats
  973. Bezafibrate mildly stimulates ketogenesis and fatty acid metabolism in hypertriglyceridemic subjects
  974. A 12-week, prospective, open-label analysis of the effect of rosuvastatin on triglyceride-rich lipoprotein metabolism in patients with primary dyslipidemia
  975. Positional characteristics of triacylglycerol in soft-shelled turtle oil and its effects on lipid metabolism in hamsters fed a high fat diet
  976. Investigation of the cardioprotective and hypotriglyceridemic potential of Echium oil as a botanical source of long chain n-3 fatty acids
  977. Hypolipidemic effect of dichloromethane as well as methanolic fruit and leaf extract of Ethiopian alligator pear (persea americana mill.) on tyloxapol-induced …
  978. Novel black soy peptides with antiobesity effects: activation of leptin-like signaling and AMP-activated protein kinase
  979. Dietary proanthocyanidins: their effectiveness in dyslipidemic nutritional models and the role of liver and intestine in their hypotriglyceridemic action
  980. effect of Asmarihara kasaya curna (ASM)-an ayurvedic formulation on lipid profile after chronic administration
  981. Protective effect of polyphenol‐rich extract prepared from Malaysian cocoa (Theobroma cacao) on glucose levels and lipid profiles in streptozotocin‐induced diabetic …
  982. Role of n− 3 fatty acids in the treatment of hypertriglyceridemia and cardiovascular disease
  983. Omega 3 polyunsaturated fatty acids supplementation and blood pressure levels in hypertriglyceridemic patients with untreated normal-high blood pressure and with …
  984. Red mold dioscorea: a potentially safe traditional function food for the treatment of hyperlipidemia
  985. hypotriglyceridemic potential of fermented mixed tea made with third-crop green tea leaves and Camellia (Camellia japonica) leaves in Sprague–Dawley rats
  986. Evaluation of the effect of Anethum graveolens L. crude extracts on serum lipids and lipoproteins profiles in hypercholesterolaemic rats
  987. Understanding the role of the intestine in the molecular hypotriglyceridemic actions of a grape seed procyanidin extract
  988. A single 1-h bout of evening exercise increases basal FFA flux without affecting VLDL-triglyceride and VLDL-apolipoprotein B-100 kinetics in untrained lean men
  989. High incidence of reduced plasma HDL cholesterol in diabetic patients treated with rosiglitazone and fibrate
  990. Hypolipidemic and antioxidant effects of curcumin and capsaicin in high-fat-fed rats
  991. Fish-oil esters of plant sterols differ from vegetable-oil sterol esters in triglycerides lowering, carotenoid bioavailability and impact on plasminogen activator inhibitor-1 …
  992. The effect of coriander seed powder consumption on atherosclerotic and cardioprotective indices of type 2 diabetic patients
  993. The metabolic effects of omega-3 plant sterol esters in mixed hyperlipidemic subjects
  994. Bifidus fermentation increases hypolipidemic and hypoglycemic effects of red ginseng
  995. Vanillin rich fraction regulates LDLR and HMGCR gene expression in HepG2 cells
  996. Beyond blood lipids: phytosterols, statins and omega-3 polyunsaturated fatty acid therapy for hyperlipidemia
  997. effect of EPA and vitamin C on superoxide dismutase, glutathione peroxidase, total antioxidant capacity and malondialdehyde in type 2 diabetic patients
  998. FXR: a promising target for the metabolic syndrome?
  999. A ‘Desaturase Hypothesis’ for Atherosclerosis: Janus-Faced Enzymes in ω–6 and ω–3 Polyunsaturated Fatty Acid Metabolism
  1000. effectS OF FIBRATES ON THE ALTERED LIPOPROTEIN SYSTEM IN HYPERTRIGLYCERIDEMIA
  1001. RLIP76, a glutathione-conjugate transporter, plays a major role in the pathogenesis of metabolic syndrome
  1002. effects of sardine oil and milk lipids on oxidative stress and inflammation markers in diet-induced hypercholesterolaemic rats
  1003. Lipid metabolism and antioxidant status in sucrose vs. potato-fed rats
  1004. The effect of ginger consumption on glycemic status, lipid profile and some inflammatory markers in patients with type 2 diabetes mellitus
  1005. VLDL triglycerides inhibit HDL‐associated paraoxonase 1 (PON1) activity: in vitro and in vivo studies
  1006. Ameliorative effects of Mulberry (Morus alba L.) Leaves on Hyperlipidemia in Rats Fed a High-Fat Diet: Induction of Fatty Acid Oxidation, Inhibition of Lipogenesis …
  1007. Influence of extruded linseed supplementation on ass milk quality
  1008. The therapeutic potential of long-chain omega-3 fatty acids in nonalcoholic fatty liver disease
  1009. Beneficial effects of flaxseed oil and fish oil diet are through modulation of different hepatic genes involved in lipid metabolism in streptozotocin–nicotinamide induced …
  1010. Dill effect on lipid profile of mice
  1011. Upregulating APOAV expression by statins via PPAR-α activated pathway possibly contributes to their triglyceride-lowering effect
  1012. Modulation of the hepatic fatty acid pool in peroxisomal 3-ketoacyl-CoA thiolase B-null mice exposed to the selective PPARalpha agonist Wy14, 643
  1013. Mitochondria, PPARs, and cancer: is receptor-independent action of PPAR agonists a key?
  1014. Modifications of Apoprotein, Lipoprotein Parameters and HDL2 and HDL3 Subfractions During Treatment with Bezafibrate Retard
  1015. A diet rich in dietary fibre from cocoa improves lipid profile
  1016. Antihyperglycemic, antihyperlipidemic, and antioxidant effects of Chaenomeles sinensis fruit extract in streptozotocin-induced diabetic rats
  1017. MECHANISMS FOR PLASMA TRIGLYCERIDE REDUCTION BY ECHIUM OIL ARE DISTINCT FROM THOSE OF FISH OIL IN APOB100-ONLY LDL RECEPTOR …
  1018. Quercetin ameliorates metabolic syndrome and improves the inflammatory status in obese Zucker rats
  1019. effects of fatty and lean fish intake on blood pressure in subjects with coronary heart disease using multiple medications
  1020. Pharmacological concentrations of biotin reduce serum triglycerides and the expression of lipogenic genes
  1021. effects of anethum graveolens leave powder on lipid profile in hyperlipidemic patients
  1022. Omacor®, n-3 polyunsaturated fatty acid, attenuated albuminuria and renal dysfunction with decrease of SREBP-1 expression and triglyceride amount in the kidney of …
  1023. Proteínas y peptidos de origen vegetal en la reduccion de lipidos: potencial nutracéutico
  1024. Echium oil reduces plasma triglycerides by increasing intravascular lipolysis in apoB100-only low density lipoprotein (LDL) receptor knockout mice
  1025. effects of dietary soybean peptides on hepatic production of ketone bodies and secretion of triglyceride by perfused rat liver
  1026. effect of fish oil supplementation on serum triglycerides, LDL cholesterol and LDL subfractions in hypertriglyceridemic adults
  1027. Thyroid hormone contributes to the hypolipidemic effect of polyunsaturated fatty acids from fish oil: in vivo evidence for cross talking mechanisms
  1028. Honey promotes lower weight gain, adiposity, and triglycerides than sucrose in rats
  1029. Hypoglycemic and hypolipidemic effects of an aqueous extract of Chamaerops humilis leaves in obese, hyperglycemic and hyperlipidemic Meriones shawi rats.
  1030. effect of St. John’s Wort (Hypericum perforatum) on obesity, lipid metabolism and uterine epithelial proliferation in ovariectomized rats
  1031. Clofibrate causes an upregulation of PPAR-α target genes but does not alter expression of SREBP target genes in liver and adipose tissue of pigs
  1032. Anti-diabetic effect of Murraya koenigii (L) and Olea europaea (L) leaf extracts on streptozotocin induced diabetic rats
  1033. Dose-Response of n-3 Polyunsaturated Fatty Acids on Lipid Profile and Tolerability in Mildly Hypertriglyceridemic Subjects
  1034. effects of crude extract of Ageratum conyzoides, Moringa oleifera and Zanthoxylum zanthoxyloides on serum lipid profile in albino rats
  1035. Treatment options for hypertriglyceridemia: from risk reduction to pancreatitis
  1036. Hepatoprotective and hypolipidemic effects of Spirulina platensis in rats administered mercuric chloride
  1037. Metabolic effect of docosahexaenoic acid supplementation in different doses and formulations (ethyl-and glyceryl-) in hypercholesterolemic rats
  1038. effects of Omega-3 fatty acid supplement on serum lipid profile and markers of oxidative stress in women with polycystic ovary syndrome
  1039. Polymorphisms in the CD36 gene modulate the ability of fish oil supplements to lower fasting plasma triacyl glycerol and raise HDL cholesterol concentrations in …
  1040. Modulation of serum and liver triglyceride and abdominal fat pad weight by dietary garlic in male broilers
  1041. Long-term administration of inulin-type fructans has no significant lipid-lowering effect in normolipidemic humans
  1042. Investigation of the effect of short-term supplementation with curcuminoids on circulating small dense low-density lipoprotein concentrations in obese …
  1043. Physiological effects of roselle calyces extract in some blood parameters in laying hens
  1044. Clinical Study Metabolic Risk Susceptibility in Men Is Partially Related to Adiponectin/Leptin Ratio
  1045. Acute exercise-induced changes in basal VLDL-triglyceride kinetics leading to hypotriglyceridemia manifest more readily after resistance than endurance exercise
  1046. An interaction effect between glucokinase gene variation and carbohydrate intakes modulates the plasma triglyceride response to a fish oil supplementation
  1047. Long‐term curcumin administration protects against atherosclerosis via hepatic regulation of lipoprotein cholesterol metabolism
  1048. effect of 1-O-Alcylglycerols from sea hydrobionts on the metabolic status of rats with alimentary dyslipidemia
  1049. Peroxisome Proliferator-Activated Receptor β/δ (PPAR β/δ) as a Potential Therapeutic Target for Dyslipidemia
  1050. Green tea catechins prevent obesity through modulation of peroxisome proliferator-activated receptors
  1051. Serum omega-6/omega-3 ratio and risk markers for cardiovascular disease in an industrial population of Delhi
  1052. effects of age, sex, body mass index and APOE genotype on cardiovascular biomarker response to an n-3 polyunsaturated fatty acid supplementation
  1053. Ameliorative effect of Withania coagulans on Experimentally-Induced Hyperlipidemia in Rabbits
  1054. The role of apolipoprotein A 5 in obesity and the metabolic syndrome
  1055. Dietary krill oil supplementation reduces hepatic steatosis, glycemia, and hypercholesterolemia in high-fat-fed mice
  1056. Metabolic action of peroxisome proliferator-activated receptor γ agonism in rats with exogenous hypercorticosteronemia
  1057. Peroxisome Proliferator-Activated Receptor β/δ (PPAR β/δ) as a Potential Therapeutic Target for Dyslipidemia
  1058. effects of Methanol Extract of Breadfruit (Artocarpus altilis) on Atherogenic Indices and Redox Status of Cellular System of Hypercholesterolemic Male Rats
  1059. Antidiabetic and antiacetylcholinesterase effects of ethyl acetate fraction of Chaenomeles sinensis (Thouin) Koehne fruits in streptozotocin-induced diabetic rats
  1060. Novel anti-obesity drugs and plasma lipids
  1061. Lipid lowering effect of dietary supplementation with Nigella sativa L. in hyperlipidemic rabbits.
  1062. Gamma-oryzanol ameliorates insulin resistance and hyperlipidemia in rats with Streptozotocin/nicotinami-de-induced type 2 diabetes
  1063. Fish oil for the treatment of cardiovascular disease
  1064. Hypolipidemic effect of Smallanthus sonchifolius (yacon) roots on diabetic rats: Biochemical approach
  1065. Chemical composition and hypolipidemic effects of an aromatic water of Ziziphora tenuior L. in cholesterol-fed rabbits
  1066. In vitro antioxidant and antihyperlipidemic activities of Toddalia asiatica (L) Lam. leaves in Triton WR-1339 and high fat diet induced hyperlipidemic rats
  1067. Protective effect of linseed oil on hyperlipidemia in experimental animals
  1068. effect of high-intensity interval exercise on basal triglyceride metabolism in non-obese men
  1069. Liver heparan sulfate proteoglycans: old molecules provide new insights on lipoprotein metabolism
  1070. Combined Treatment with Dif1stat® and Diet Reduce Plasma Lipid Indicators of Moderate Hypercholesterolemia More effectively than Diet Alone: A Randomized …
  1071. The effects of Two Lactobacillus plantarum Strains on Rat Lipid Metabolism Receiving a High Fat Diet
  1072. effects of porcine hemoglobin on serum lipid content and fecal lipid excretion in rats
  1073. effect of Green Lean Body Capsules on Body Weight, Lipid Profile, and Renal Physiology and Histology in Albino Rats
  1074. Hypolipidemic effects of Monascus-Fermented Soybean Extracts in Rats Fed a High-Fat and -Cholesterol Diet
  1075. Hyperinsulinemia and insulin resistance are independently associated with plasma lipids, uric acid and blood pressure in non-diabetic subjects. The GISIR database
  1076. Lack of effect of sugar cane and sunflower seed policosanols on plasma cholesterol in rabbits
  1077. Momordica charantia Ameliorates Insulin Resistance and Dyslipidemia with Altered Hepatic Glucose Production and Fatty Acid Synthesis and AMPK Phosphorylation …
  1078. Purified chickpea or lentil proteins impair VLDL metabolism and lipoprotein lipase activity in epididymal fat, but not in muscle, compared to casein, in growing rats
  1079. effects of n-3 fatty acids on autoimmunity and osteoporosis
  1080. Semecarpus anacardium Linn.: a review
  1081. effect of PUFA on patients with hypertension: a hospital based study
  1082. Study the hypolipidemic effect of combination of pectin, niacin and apple cider vinegar supplied as Apple-cure effervescent tablets in rabbits.
  1083. Fish oil in combination with high or low intakes of linoleic acid lowers plasma triacylglycerols but does not affect other cardiovascular risk markers in healthy …
  1084. Multiscale structures of lipids in foods as parameters affecting fatty acid bioavailability and lipid metabolism
  1085. Beneficial effects of omega-3 fatty acids in the proteome of high-density lipoprotein proteome
  1086. Fish oil—how does it reduce plasma triglycerides?
  1087. Apolipoprotein AV: gene expression, physiological role in lipid metabolism and clinical relevance
  1088. The opposing effects of n− 3 and n− 6 fatty acids
  1089. Antidiabetic and genotoxic effects on Wistar rats treated with aqueous extract from Chrysobalanus icaco L
  1090. EVALUATION OF THE effect OF ANETHUM GRAVEOLENS L. CRUDE EXTRACTS ONSERUM LIPIDS AND LIPOPROTEINS PROFILES IN …
  1091. Antilipemic activity of ethanolic and hexane extracts from seeds of Bixa orellana Linn. In hyperlipidemic rats
  1092. The effect of Combined Administration of Fish Oil with Garlic to Lower Cholesterol in Hypercholesterolemic Subjects (Comparative Study)
  1093. Hypolipidemic effects of silymarin are not mediated by the peroxisome proliferator-activated receptor alpha
  1094. effect of daidzein and genistein on serum glucose, lipid profile and paroxonase activity in diabetic rats.
  1095. New LDL-cholesterol lowering therapies: pharmacology, clinical trials, and relevance to acute coronary syndromes
  1096. effect of marine protein supplementation on lipid profile of growing rats compared to soybean protein and casein
  1097. Targeting PPARβ/δ for the treatment of type 2 diabetes mellitus
  1098. Hypolipidemic effects of Starch and γ-Oryzanol from wx/ae Double-Mutant Rice on BALB/c.KOR-Apoe shl Mice
  1099. Dietary protein research trends
  1100. Synthetic FXR agonist GW4064 prevents diet-induced hepatic steatosis and insulin resistance
  1101. Anil K. GUPTA, Narinder KAUR, Maninder KAUR and Rangil SINGH Department of Biochemistry, Punjab Agricultural University, Ludhiana-141004, India
  1102. effects of Momordica charantia on insulin resistance and visceral obesity in mice on high-fat diet
  1103. Enzymatic hydrolysis of salmon oil by native lipases: optimization of process parameters
  1104. Validation of the antidiabetic and hypolipidemic effects of hawthorn by assessment of gluconeogenesis and lipogenesis related genes and AMP-activated …
  1105. Research Article Antihyperlipidemic effects of Sesamum indicum L. in Rabbits Fed a High-Fat Diet
  1106. Hypertriglyceridemia and hepatic steatosis in senescence-accelerated mouse associate to changes in lipid-related gene expression
  1107. Glucose regulates the expression of the apolipoprotein A5 gene
  1108. Apolipoprotein A5 gene− 1131T/C polymorphism is associated with the risk of metabolic syndrome in ethnic Chinese in Taiwan
  1109. ANGPTL4 is produced by entero-endocrine cells in the human intestinal tract
  1110. effects of genotype and dietary fish oil replacement with vegetable oil on the intestinal transcriptome and proteome of Atlantic salmon (Salmo salar)
  1111. The Target Organ and the Toxic Process Arch. Toxicol., Suppl. 12, 225–232 (1988) Springer-Verlag 1988
  1112. Proanthocyanidins modulate microRNA expression in human HepG2 cells
  1113. The effect of fatty or lean fish intake on inflammatory gene expression in peripheral blood mononuclear cells of patients with coronary heart disease
  1114. effects of soluble fiber (Plantago ovatahusk) on plasma lipids, lipoproteins, and apolipoproteins in men with ischemic heart disease
  1115. effects of dietary conjugated linoleic acid at high-fat levels on triacylglycerol regulation in mice
  1116. Highly purified eicosapentaenoic acid prevents the progression of hepatic steatosis by repressing monounsaturated fatty acid synthesis in high-fat/high-sucrose diet …
  1117. Polymorphisms in genes involved in the triglyceride synthesis pathway and marine omega-3 polyunsaturated fatty acid supplementation modulate plasma triglyceride …
  1118. The effects of rosuvastatin alone or in combination with fenofibrate or omega 3 fatty acids on inflammation and oxidative stress in patients with mixed dyslipidemia
  1119. Research Article effects of -3 Polyunsaturated Fatty Acids on Plasma Proteome in Rett Syndrome
  1120. Moderate doses of EPA and DHA from re-esterified triacylglycerols but not from ethyl-esters lower fasting serum triacylglycerols in statin-treated dyslipidemic subjects …
  1121. Glucose tolerance, lipids, and GLP‐1 secretion in JCR: LA‐cp rats fed a high protein fiber diet
  1122. Milk fat decreases inflammation biomarkers and ameliorates oxidative status in hypercholesterolemic rats
  1123. High-molecular-weight poly-gamma-glutamate protects against hypertriglyceridemic effects of a high-fructose diet in rat
  1124. Dietary fish oil exerts hypolipidemic effects in lean and insulin sensitizing effects in obese LDLR−/− mice
  1125. effect of omega 3 fatty acids family in human health
  1126. increase plasma LDL-cholesterol in man Mattson and Grundy, 1985!
  1127. Docosahexaenoic acid modulates the enterocyte Caco-2 cell expression of microRNAs involved in lipid metabolism
  1128. A high-fat diet and the threonine-encoding allele (Thr54) polymorphism of fatty acid–binding protein 2 reduce plasma triglyceride–rich lipoproteins
  1129. Eriobotrya japonica improves hyperlipidemia and reverses insulin resistance in high‐fat‐fed mice
  1130. effectiveness of omega-3 polysaturated fatty acids (fish oil) supplementation for treating hypertriglyceridemia in children and adolescents
  1131. Plasma n-3 polyunsaturated fatty acid and cardiovascular disease risk factors in Japanese, Korean and Mongolian workers
  1132. Evaluation of the effect of Spirulina against Gamma irradiation induced oxidative stress and tissue injury in rats
  1133. Protective effect of white-skinned sweet potato (Ipomoea batatas L.) from Indonesia on streptozotocin-induced oxidative stress in rats
  1134. Influence of sodium monoketocholate on the hypolipidemic activity of lovastatin in healthy and diabetic rats
  1135. Efficacy of silkworm (Bombyx mori L.) chrysalis oil as a lipid source in adult Wistar rats
  1136. Nonalcoholic hepatic steatosis in Zucker diabetic rats: spontaneous evolution and effects of metformin and fenofibrate
  1137. Health Promoting effect of Ghee Containing Palm Oil Fed in Rats
  1138. A potential ethnomedicinal plant Semecarpus anacardium Linn. A review
  1139. The total polyphenols and the antioxidant potentials of some selected cereals and pseudocereals
  1140. Dietary fructooligosaccharides and potential benefits on health
  1141. effects of atorvastatin and n− 3 fatty acid supplementation on VLDL apolipoprotein C-III kinetics in men with abdominal obesity
  1142. effectS OF SATURATED AND POLYUNSATURATED FATTY ACIDS ON
  1143. Beneficial effects of the RESMENA dietary pattern on oxidative stress in patients suffering from metabolic syndrome with hyperglycemia are associated to dietary TAC …
  1144. Agavins from Agave angustifolia and Agave potatorum affect food intake, body weight gain and satiety-related hormones (GLP-1 and ghrelin) in mice
  1145. Octacosanol ameliorates hyperlipidemia and oxidative stress in KKAy mice with type 2 diabetes
  1146. Genetics and causality of triglyceride-rich lipoproteins in atherosclerotic cardiovascular disease
  1147. BIOLOGICAL EVALUATION OF IRRADIATED CORIANDER FRUITS (Coriandrum sativum L.) AND IT’S ESSENTIAL OIL
  1148. Bioactive lipids in metabolic syndrome
  1149. GFT505 for the treatment of nonalcoholic steatohepatitis and type 2 diabetes
  1150. Unrefined and refined black raspberry seed oils significantly lower triglycerides and moderately affect cholesterol metabolism in male Syrian hamsters
  1151. Differential regulation of the human versus the mouse apolipoprotein AV gene by PPARalpha: Implications for the study of pharmaceutical modifiers of …
  1152. Nutritional composition and antioxidant activity of four tomato (Lycopersicon esculentum L.) farmer’varieties in Northeastern Portugal homegardens
  1153. effects of dietary fibers on disturbances clustered in the metabolic syndrome
  1154. Severe hypertriglyceridemia in pregnancy
  1155. Sex differences in lipid and lipoprotein metabolism: it’s not just about sex hormones
  1156. Enzymatic strategies for solvent‐free production of short and medium chain phytosteryl esters
  1157. The effect of Fenofibrate and Exercise on Metabolic Syndrome and Hepatic Steatosis in OLETF Rats.
  1158. Potentiation of hypolipidemic and weight-reducing influence of dietary tender cluster bean (Cyamopsis tetragonoloba) when combined with capsaicin in high-fat-fed …
  1159. Regulation of gene transcription by fatty acids
  1160. effects of two hypocaloric diets supplemented with white lupine or oats on lipid peroxidation, reverse cholesterol transport and paraoxonase activity in obese rat.
  1161. Tormentic Acid, a Major Component of Suspension Cells of Eriobotrya japonica, Suppresses High-Fat Diet-Induced Diabetes and Hyperlipidemia by Glucose …
  1162. Omega‐3 fatty acids and the cardiometabolic syndrome
  1163. Propionate reduces the cytokine-induced VCAM-1 and ICAM-1 expression by inhibiting nuclear factor-kappa B (NF-kappaB) activation
  1164. SYNTHESIS AND CHARACTERISATION OF FATTY ACID METHYL ESTER FROM CUCURBITA MIXTA (PUMPKIN) SEED OIL
  1165. Hydroxyeicosapentaenoic acids from the Pacific krill show high ligand activities for PPARs [S]
  1166. Activation of PPARα lowers synthesis and concentration of cholesterol by reduction of nuclear SREBP-2
  1167. Study effect of Supplementation of Two Types Omega 3 Fatty Acids on Lipid Profile of Asthmatics.
  1168. effect of heat treatment on the nutritive value and residues of some synthetic pesticides in fresh Bolti fish
  1169. Atorvastatin effects on SREBF1a and SCAP gene expression in mononuclear cells and its relation with lowering-lipids response
  1170. effect of ω-3 fatty acid ethyl esters on apolipoprotein B-48 kinetics in obese subjects on a weight-loss diet: a new tracer kinetic study in the postprandial state
  1171. Glucose Regulates the Expression of the Apolipoprotein A5 Gene
  1172. Baicalin improves antioxidant status of streptozotocin-induced diabetic Wistar rats
  1173. effects of age, sex, body mass index and APOE genotype on cardiovascular biomarker response to an n-3 polyunsaturated fatty acid supplementation
  1174. Hypertriglyceridemia and Hepatic Steatosis in Senescence-Accelerated Mouse Associate to Changes in Lipid-Related Gene Expression
  1175. Supercritical fluid extraction of lipids from broccoli leaves
  1176. effects of orlistat, alone or combined with hypolipidemic drugs, on cardiovascular risk factors
  1177. Pathophysiology and Management of Dyslipidemias Associated with Obesity, Type 2 Diabetes, and Other Insulin-Resistant States
  1178. Early and prolonged intake of partially hydrogenated fat alters the expression of genes in rat adipose tissue
  1179. Anti‐obesity effects of conjugated linoleic acid, docosahexaenoic acid, and eicosapentaenoic acid
  1180. Antioxidant potential of spices and their active constituents
  1181. Serum total l-carnitine levels in non-obese women with polycystic ovary syndrome
  1182. Ovarian follicular development, lipid peroxidation, antioxidative status and immune response in laying hens fed fish oil-supplemented diets to produce n-3-enriched …
  1183. Altered cholesterol and fatty acid metabolism in Huntington disease
  1184. effects of polyunsaturated fatty acid consumption in diabetic nephropathy
  1185. A review on the role of l-carnitine in the management of tamoxifen side effects in treated women with breast cancer
  1186. Rapid reduction of liver steatosis in ω3-depleted rats injected with a novel lipid emulsion
  1187. Biochemical effects of Some Peroxisome Proliferator Activated Receptor Ligands in Hyperhomocysteinemic-rats
  1188. effects of eicosapentaenoic acid and docosahexaenoic acid on chylomicron and VLDL synthesis and secretion in Caco-2 cells
  1189. Dietary anhydrous milk fat depletes essential fatty acids in wistar rats which can be corrected by blending with linoleic acid rich sunflower oil
  1190. Expression of apolipoprotein C-III in McA-RH7777 cells enhances VLDL assembly and secretion under lipid-rich conditions [S]
  1191. Soy protein and fish oil independently decrease serum lipid concentrations but interactively reduce hepatic enzymatic activity and gene expression involved in fatty …
  1192. effects of whole grain, fish and bilberries on serum metabolic profile and lipid transfer protein activities: a randomized trial (Sysdimet)
  1193. Lipid utilization pathways induced by early training in Standardbred trotters and Thoroughbreds
  1194. Antioxidant Potentials and Pharmacological Activities of Marking Nut (Semecarpus anacardium Lf)
  1195. Peroxisome proliferator-activated receptor α polymorphisms and postprandial lipemia in healthy men
  1196. Oral fish oil supplementation raises blood omega-3 levels and lowers C-reactive protein in haemodialysis patients—a pilot study
  1197. Mitochondria function and uncoupling protein-2 in rat kidney cortex; The effects of peroxisome proliferator receptor-α agonist clofibrate
  1198. Lipidomics analysis reveals efficient storage of hepatic triacylglycerides enriched in unsaturated fatty acids after one bout of exercise in mice
  1199. effect of mevalonate biosynthesis inhibitor on some biochemical parameters during pregnancy in rats.
  1200. Daily consumption of milk enriched with fish oil, oleic acid, minerals and vitamins reduces cell adhesion molecules in healthy children
  1201. Renoprotective effect of dietary fish oil on cyclosporine A: Induced nephrotoxicity in rats
  1202. Fructooligosaccharide intake alters the phospholipid and fatty acid composition of liver plasma membranes
  1203. Dose-response effects of omega-3 fatty acids on triglycerides, inflammation, and endothelial function in healthy persons with moderate hypertriglyceridemia
  1204. Attenuation of salt-loading induced cardiomegaly and dyslipidemia in Wistar rats by aqueous leaf extract of Chromolaena odorata
  1205. Ethanol and fish oil induce NFκB transactivation of the collagen α2 (I) promoter through lipid peroxidation–driven activation of the PKC‐PI3K‐Akt pathway
  1206. Natural lipid-lowering agents and their effects: an update
  1207. Hypoglycemic and hypolipidemic effects of Coriandrum sativum L. in Meriones shawi rats
  1208. Peroxisome proliferator-activated receptors and the metabolic syndrome
  1209. A Short Review on Common Plants with their Extraordinary Beneficial effect on the treatment of Diabetes Mellitus
  1210. Advanced analysis of nutraceuticals
  1211. Abnormalities in the serum phospholipids fatty acid profile in patients with alcoholic liver cirrhosis-a pilot study
  1212. Comparative study between the prophylactics effects of aqueous extract of Black Currant (Vitis vinferia. L) and vitamin E on some biological parameters related …
  1213. Combined phytosterol and fish oil therapy for lipid lowering and cardiovascular health
  1214. Feeding docosahexaenoic acid to pigs reduces blood triglycerides and induces gene expression for fat oxidation
  1215. Milk lipids and sardine oil intake modulate differently enzymatic antioxidant defense in rats fed an atherogenic diet
  1216. Cloning and characterization of a novel apolipoprotein gene, apolipoprotein AV, in tree shrews
  1217. Combination of dipeptidylpeptidase IV inhibitor and low dose thiazolidinedione: preclinical efficacy and safety in db/db mice
  1218. Omega-3 fatty acid ethyl esters (Omacor®) for the treatment of hypertriglyceridemia
  1219. Role of lipids and fatty acids in macrosomic offspring of diabetic pregnancy
  1220. Hypolipidemic effects of wx/ae double-mutant rice and its components in model mice
  1221. Peroxisome proliferator-activated receptor-γ regulates the expression and function of very-low-density lipoprotein receptor
  1222. effects of N-3 fatty acids on hepatic triglyceride content in humans
  1223. Cholic acid for hepatic steatosis in patients with lipodystrophy: a randomized, controlled trial
  1224. effect of vanillin on lipid profile in a model of hyperlipidemia, a preliminary study
  1225. Targeting PPARs in metabolic risk management: a pharmacological and nutritional approach
  1226. Caffeamide 36-13 regulates the antidiabetic and hypolipidemic signs of high-fat-fed mice on glucose transporter 4, AMPK phosphorylation, and regulated …
  1227. effect of rapeseed oil and dietary n-3 fatty acids on triacylglycerol synthesis and secretion in Atlantic salmon hepatocytes
  1228. effects of feeding regimen, fiber inclusion, and crude protein content of the diet on performance and egg quality and hatchability of eggs of broiler breeder …
  1229. Aqueous extract of the rhizomes of Sansevieria senegambica Baker (Agavaceae) moderated plasma biochemical and haematological indices in salt-loaded …
  1230. Deficiency in hepatic ATP-citrate lyase affects VLDL-triglyceride mobilization and liver fatty acid composition in mice [S]
  1231. Pharmacological potential of tocotrienols: a review
  1232. Herbal Medicines used in Diabetes mellitus
  1233. The effect of isosteviol on hyperglycemia and dyslipidemia induced by lipotoxicity in rats fed with high-fat emulsion
  1234. Systemic antioxidant properties of L-carnitine in two different models of arterial hypertension
  1235. Apolipoprotein C-III: understanding an emerging cardiovascular risk factor
  1236. Omega-3 Carboxylic Acids (Epanova®): A Review of Its Use in Patients with Severe Hypertriglyceridemia
  1237. Ácidos grasos n-3 en el metabolismo de la glucosa y la sensibilidad a la insulina
  1238. Omega-3 free fatty acids for the treatment of severe hypertriglyceridemia: the EpanoVa fOr Lowering Very high triglyceridEs (EVOLVE) trial
  1239. Two new Monascus metabolites with strong blue fluorescence isolated from red yeast rice
  1240. Omega-3 fatty acid concentrates in the treatment of moderate hypertriglyceridemia
  1241. Dietary fish oil supplementation affects serum fatty acid concentrations in horses
  1242. Hypolipidemic effect of vegetable and cereal dietary mixtures from Egyptian sources
  1243. effects of therapeutic lifestyle change diets high and low in dietary fish-derived FAs on lipoprotein metabolism in middle-aged and elderly subjects
  1244. Omega-3 fatty acid enriched chevon (goat meat) lowers plasma cholesterol levels and alters gene expressions in rats
  1245. A combination of nutriments improves mitochondrial biogenesis and function in skeletal muscle of type 2 diabetic Goto–Kakizaki rats
  1246. Niacin and fibrates in atherogenic dyslipidemia: pharmacotherapy to reduce cardiovascular risk
  1247. Moderation of hematological and plasma biochemical indices of sub-chronic salt-loaded rats by aqueous extract of the sclerotia of Pleurotus tuberregium (Fr) Sing’s …
  1248. Full-spectrum antioxidant therapy featuring astaxanthin coupled with lipoprivic strategies and salsalate for management of non-alcoholic fatty liver disease
  1249. Icosapent ethyl for the treatment of severe hypertriglyceridemia
  1250. Progress in nutritional immunology
  1251. Docosahexaenoic acid supplementation improved lipocentric but not glucocentric markers of insulin sensitivity in hypertriglyceridemic men
  1252. Nutraceutical functions of sesame: a review
  1253. Enzymatic synthesis of phosphatidylserine using bile salt mixed micelles
  1254. Lifestyle approaches and dietary strategies to lower LDL-cholesterol and triglycerides and raise HDL-cholesterol
  1255. Omega-3 polyunsaturated fatty acids in the treatment of hypertriglyceridaemia
  1256. Molecular pathways and agents for lowering LDL-cholesterol in addition to statins
  1257. Dietary omega-3 fatty acids modulate the eicosanoid profile in man primarily via the CYP-epoxygenase pathway [S]
  1258. effects of omega-3 on lipid profile and inflammation markers in peritoneal dialysis patients
  1259. effects of the new dual PPARα/δ agonist GFT505 on lipid and glucose homeostasis in abdominally obese patients with combined dyslipidemia or impaired glucose …
  1260. effects of prescription omega-3-acid ethyl esters on non—high-density lipoprotein cholesterol when coadministered with escalating doses of atorvastatin
  1261. Baseline triglyceride levels and insulin sensitivity are major determinants of the increase of LDL particle size and buoyancy induced by rosuvastatin treatment in …
  1262. Of mice and men: factors abrogating the antiobesity effect of omega-3 fatty acids
  1263. Diabetes and medicinal plants-A review
  1264. Alipogene tiparvovec: gene therapy for lipoprotein lipase deficiency
  1265. Early dissimilar fates of liver eicosapentaenoic acid in rats fed liposomes or fish oil and gene expression related to lipid metabolism
  1266. Farnesoid X receptor: from medicinal chemistry to clinical applications
  1267. Docosahexaenoic acid, but not eicosapentaenoic acid, lowers ambulatory blood pressure and shortens interval QT in spontaneously hypertensive rats in vivo
  1268. Development of Monascus fermentation technology for high hypolipidemic effect
  1269. Differences in Transcriptional Activation by the Two Allelic (L162V Polymorphic) Variants of PPAR after Omega-3 Fatty Acids Treatment
  1270. A defect in the activity of Δ6 and Δ5 desaturases may be a factor in the initiation and progression of atherosclerosis
  1271. Change in fatty acid composition of serum lipids in obese females after short-term weight-reducing regimen with the addition of n-3 long chain polyunsaturated …
  1272. Prostaglandins, Leukotrienes and Essential Fatty Acids
  1273. Family history of diabetes links impaired substrate switching and reduced mitochondrial content in skeletal muscle
  1274. Genotype-specific responses in Atlantic salmon (Salmo salar) subject to dietary fish oil replacement by vegetable oil: a liver transcriptomic analysis
  1275. The consumption of n-3 polyunsaturated fatty acids differentially modulates gene expression of peroxisome proliferator-activated receptor alpha and gamma and …
  1276. The hypolipidemic effect of an ethyl ester of algal-docosahexaenoic acid in rats fed a high-fructose diet
  1277. Altered erythrocyte membrane fatty acid profile in typical Rett syndrome: effects of omega-3 polyunsaturated fatty acid supplementation
  1278. Fish oil increases cholesterol storage in white adipose tissue with concomitant decreases in inflammation, hepatic steatosis, and atherosclerosis in mice
  1279. Association between glutathione S-transferase polymorphisms and triglycerides and HDL-cholesterol
  1280. Cardioprotective role of omega-3 polyunsaturated fatty acids
  1281. effects of CP-900691, a novel peroxisome proliferator-activated receptor α, agonist on diabetic nephropathy in the BTBR ob/ob mouse
  1282. Dietary Oleic and Palmitic Acids Modulate the Ratio of Triacylglycerols to Cholesterol in Postprandial Triacylglycerol-Rich Lipoproteins in Men and Cell …
  1283. Titrating lovaza from 4 to 8 to 12 grams/day in patients with primary hypertriglyceridemia who had triglyceride levels> 500 mg/dl despite conventional triglyceride …
  1284. Growth studies of a New Species of Xanthophyta: The Significance of Renewable Source of an Essential Lipid
  1285. Omega-3-fatty acid and triglyceride
  1286. Eicosapentaenoic acid lowers plasma and liver cholesterol levels in the presence of peroxisome proliferators-activated receptor alpha
  1287. Soybean protein hydrolysate improves plasma and liver lipid profiles in rats fed high-cholesterol diet
  1288. Prescription omega-3 fatty acids and their lipid effects: physiologic mechanisms of action and clinical implications
  1289. Hypoglycemic, hypolipidaemic and cytoprotective effects of lotus seeds (Nelumbo nucifera) in sprague-dawley rats
  1290. New Areas of Nutrition Research
  1291. Food and food supplements with hypocholesterolemic effects
  1292. Omega-3 fatty acids and atorvastatin affect connexin 43 expression in the aorta of hereditary hypertriglyceridemic rats
  1293. Down-regulation in muscle and liver lipogenic genes: EPA ethyl ester treatment in lean and overweight (high-fat-fed) rats
  1294. Trypanocidal activity of marine natural products
  1295. Basic mechanisms behind the effects of n-3 fatty acids on cardiovascular disease
  1296. NUCLEAR RECEPTORS AND HEPATIC LIPIDOGENIC ENZYMES RESPONSE 3 TO A DYSLIPIDEMIC SUCROSE RICH DIET AND ITS REVERTION BY FISH 4 OIL …
  1297. Phytosterols & Omega-3 Polyunsaturated Fatty Acids for Cardiovascular Health in Hyperlipidemia
  1298. The “Wild-Type” egg: An empirical approach to a reference pattern for dietary fatty acids in human nutrition
  1299. effects of omega-3 fatty acids supplementation on serum adiponectin levels and some metabolic risk factors in women with polycystic ovary syndrome
  1300. Eicosapentaenoic acid increases lipolysis through up-regulation of the lipolytic gene expression and down-regulation of the adipogenic gene expression in 3T3-L1 …
  1301. Marginal Vitamin C Deficiency, Lipid Metabolism
  1302. Is Triglyceride Atherogenic?
  1303. Genistein—A dietary compound inducing hormonal and metabolic changes
  1304. Elucidating the Molecular Mechanisms Underlying the Hepatic Farnesoid X Receptor (FXR)-mediated effects that Contribute to the Triglyceride-Lowering Ability of a …
  1305. Comparative evaluation of taurine and thiotaurine as protectants against diabetes-induced nephropathy in a rat model
  1306. Insulin-stimulated glucose uptake and pathways regulating energy metabolism in skeletal muscle cells: the effects of subcutaneous and visceral fat, and long-chain …
  1307. effects of dietary fish oil on thyroid hormone signaling in the liver
  1308. High fibre diets and Alzheimer’s disease
  1309. Food & Function
  1310. Protective effect of Chinese prescription Kangen-karyu and its crude drug Tanjin against age-related lipidosis in rats
  1311. Novel targets that affect high-density lipoprotein metabolism: the next frontier
  1312. effect of dietary saturated fatty acids on HNF-4α DNA binding activity and ApoCIII mRNA in sedentary rat liver
  1313. N-3 polyunsaturated fatty acids suppress insulin-induced SREBP-1c transcription via reduced trans-activating capacity of LXRα
  1314. Meta-analysis of the effects of n-3 polyunsaturated fatty acids on lipoproteins and other emerging lipid cardiovascular risk markers in patients with type 2 diabetes
  1315. Genetically Modified Rapeseed Oil Containing cis-9,trans-11,cis-13-Octadecatrienoic Acid Affects Body Fat Mass and Lipid Metabolism in Mice
  1316. Identification of a novel allele of peroxisome proliferator-activated receptor gamma (PPARG) and its association with resistance to Aeromonas salmonicida in Atlantic …
  1317. The role of antioxidants and other agents in alleviating hyperglycemia mediated oxidative stress and injury in liver
  1318. Fish as source of n-3 polyunsaturated fatty acids (PUFAs), which one is better-farmed or wild
  1319. Impairment of hepatic Stat‐3 activation and reduction of PPARα activity in fructose‐fed rats
  1320. effects of eicosapentaenoic acid and docosahexaenoic acid on low-density lipoprotein cholesterol and other lipids: a review
  1321. The impact of common gene variants on the response of biomarkers of cardiovascular disease (CVD) risk to increased fish oil fatty acids intakes
  1322. Lipids as delivery systems to improve the biological activity of bioactive ingredients
  1323. effect of dietary fat type on plasma lipid profile and leptin concentration in rats fed on high-sucrose diets
  1324. Atherosclerosis prevention: the role of biofunctional ingredients of plant foods
  1325. Role of bile acids and bile acid receptors in metabolic regulation
  1326. Fish consumption is inversely associated with the metabolic syndrome
  1327. Nutritional intervention to reduce the n− 6/n− 3 fatty acid ratio increases adiponectin concentration and fatty acid oxidation in healthy subjects
  1328. effect of coconut oil on lipid profile and antioxident status in rats
  1329. Nuclear receptors and hepatic lipidogenic enzyme response to a dyslipidemic sucrose-rich diet and its reversal by fish oil n-3 polyunsaturated fatty acids
  1330. The Metabolism of DOCOSenoic Acids in the
  1331. Approach to the diagnosis and management of lipoprotein disorders
  1332. effects of clofibric acid alone and in combination with 17β-estradiol on mRNA abundance in primary hepatocytes isolated from rainbow trout
  1333. Impact of omega-3 fatty acids and/or plant sterol supplementation on non-HDL cholesterol levels of dyslipidemic Indian adults
  1334. Docosahexaenoic acid content in plasma phospholipids and desaturase indices in obese children
  1335. The “Wild-Type” Egg
  1336. Serum lipid modification related to exercise and polyunsaturated fatty acid supplementation in jumpers and thoroughbred horses
  1337. Delta-5 and delta-6 desaturases: crucial enzymes in polyunsaturated fatty acid-related pathways with pleiotropic influences in health and disease
  1338. Alternative therapies to reduce enteric bacterial infections and improve the microbiological safety of pig and poultry production systems
  1339. THE MOLECULAR MECHANISMS OF SELECTED PATHOLOGICAL PROCESSES IN THE CELL
  1340. Role of the apoa5 gene in lipid and fat-soluble vitamin metabolism
  1341. Antioxidant action of soy isoflavones on oxidative stress and antioxidant enzyme activities in exercised rats
  1342. Isolated Hypertriglyceridemia in Indians
  1343. Beta glucan: health benefits in obesity and metabolic syndrome
  1344. Docosahexaenoic acid and eicosapentaenoic acid affect ovarian prostaglandin levels differently in rats
  1345. The stress response of the liver to physical exercise.
  1346. Treating mixed hyperlipidemia and the atherogenic lipid phenotype for prevention of cardiovascular events
  1347. effect of Monascus-fermentation on the content of GABA and free amino acids in soybean
  1348. The evolution of holistic foods and risk of cardiovascular disease: the Tsim Tsoum concept
  1349. effects of a soluble fraction of soybean on lipid profiles in ovariectomized rats fed a cholesterolemic diet
  1350. Differences in transcriptional activation by the two allelic (L162V polymorphic) variants of PPARα after omega-3 fatty acids treatment
  1351. Peroxisome proliferator-activated receptor gamma (PPAR {gamma}) regulates the expression and Function of very low density lipoprotein receptor
  1352. Mulberry leaf extract intake reduces hyperglycaemia in streptozotocin (STZ)-induced diabetic rats fed high-fat diet
  1353. Regulation of lipid metabolism-related gene expression in whole blood cells of normo-and dyslipidemic men after fish oil supplementation
  1354. N-3 Fatty Acids from Fish and Plants: Primary and Secondary Prevention of Cardiovascular Disease
  1355. effect OF SOME LEVELS FROM NIGELLA SATIVA AS SEEDS OR WATER EXTRACT ON RATS SUFFERING FROM HYPERLIPIDEMIA AND DIABETES.
  1356. Whole-body synthesis secretion of docosahexaenoic acid from circulating eicosapentaenoic acid in unanesthetized rats
  1357. Downregulation of hepatic lipoprotein assembly in rats by fermented products of Monascus pilosus
  1358. effect of some polyunsaturated fatty acids rich-oils on plasma lipid profiles using normal rats
  1359. Dietary n-3 LCPUFA from fish oil but not α-linolenic acid-derived LCPUFA confers atheroprotection in mice [S]
  1360. The addition of whole soy flour to cafeteria diet reduces metabolic risk markers in wistar rats
  1361. Can we change the functionality of HDL cholesterol with nonpharmacological and pharmacological agents?
  1362. The effect of dietary docosahexaenoic acid enrichment on the expression of porcine hepatic genes
  1363. Suppression of VLDL secretion by cultured hepatocytes incubated with chylomicron remnants enriched in n− 3 polyunsaturated fatty acids is regulated by hepatic …
  1364. Krill protein hydrolysate reduces plasma triacylglycerol level with concurrent increase in plasma bile acid level and hepatic fatty acid catabolism in high-fat fed mice
  1365. Circulating adiponectin in preterm infants fed long-chain polyunsaturated fatty acids (LCPUFA)-supplemented formula—a randomized controlled study
  1366. PPARα activation improves endothelial dysfunction and reduces fibrosis and portal pressure in cirrhotic rats
  1367. Impact of total parenteral nutrition including omega-3 fatty acids on the regulation of plasma lipoproteins and glycemic control after major abdominal surgery
  1368. Clinical use of genetic typing in human lipid disorders
  1369. Postprandial metabolism of docosapentaenoic acid (DPA, 22: 5n− 3) and eicosapentaenoic acid (EPA, 20: 5n− 3) in humans
  1370. The effects of low dose n-3 fatty acids on serum lipid profiles and insulin resistance of the elderly: a randomized controlled clinical trial
  1371. Omega-3 fatty acids and coronary heart disease risk: clinical and mechanistic perspectives
  1372. Cardiovascular disease and dyslipidemia: beyond LDL
  1373. effects of supplemental fish oil on resting metabolic rate, body composition, and salivary cortisol in healthy adults
  1374. Testosterone and progesterone, but not estradiol, stimulate muscle protein synthesis in postmenopausal women
  1375. Nutrition and risk for cardiovascular disease
  1376. Plant sterols, marine-derived omega-3 fatty acids and other functional ingredients: a new frontier for treating hyperlipidemia
  1377. The tsim tsoum approaches for prevention of cardiovascular disease
  1378. Identification of marker genes for lipid-lowering effect of a short-chain fructooligosaccharide by DNA microarray analysis
  1379. Parenteral fish-oil–based lipid emulsion improves fatty acid profiles and lipids in parenteral nutrition–dependent children
  1380. Cholesterol improvement effects of fermented defatted soybean grits added to Corchorus olitorius
  1381. Combining fish-oil supplements with regular aerobic exercise improves body composition and cardiovascular disease risk factors
  1382. Physiological effects of dietary fructans extracted from Agave tequilana Gto. and Dasylirion spp.
  1383. Meta-analysis of the effects of n-3 polyunsaturated fatty acids on haematological and thrombogenic factors in type 2 diabetes
  1384. Role of ω3 longchain polyunsaturated fatty acids in reducing cardio-metabolic risk factors
  1385. Polyunsaturated fatty acids and modulation of cholesterol homeostasis in THP-1 macrophage-derived foam cells
  1386. Regulation of chylomicron production in humans
  1387. Soy Peptides and Weight Management
  1388. Polymorphisms in Fatty Acid Desaturase (FADS) Gene Cluster: effects on Glycemic Controls Following an Omega-3 Polyunsaturated Fatty Acids (PUFA) …
  1389. Liver X receptors (LXRs). Part II: non-lipid effects, role in pathology, and therapeutic implications
  1390. Low n-6: n-3 fatty acid ratio, with fish-or flaxseed oil, in a high fat diet improves plasma lipids and beneficially alters tissue fatty acid composition in mice
  1391. Prescription omega-3-acid ethyl esters for the treatment of very high triglycerides
  1392. Isoflavones as a smart curer for non-alcoholic fatty liver disease and pathological adiposity via ChREBP and Wnt signaling
  1393. Hepatic steatosis in n-3 fatty acid depleted mice: focus on metabolic alterations related to tissue fatty acid composition
  1394. A systematic Review on Antidiabetic medicinal Plants
  1395. Krill powder increases liver lipid catabolism and reduces glucose mobilization in tumor necrosis factor-alpha transgenic mice fed a high-fat diet
  1396. Influence of a ketogenic diet, fish-oil, and calorie restriction on plasma metabolites and lipids in C57BL/6J mice
  1397. Concerted action of leptin in regulation of fatty acid oxidation in skeletal muscle and liver
  1398. Dose-dependent effects of docosahexaenoic acid-rich fish oil on erythrocyte docosahexaenoic acid and blood lipid levels
  1399. Probiotics: Live Medicines in Human Gut
  1400. The omega-3 index as a risk factor for coronary heart disease
  1401. Unavailability of liver triacylglycerol increases serum cholesterol concentration induced by dietary cholesterol in exogenously hypercholesterolemic (ExHC) rats
  1402. Omega-3 fatty acids and blood pressure
  1403. Omega-3 fatty acids and cardiovascular disease: a case for omega-3 index as a new risk factor
  1404. Orphan nuclear receptors as targets for drug development
  1405. Oxidation of marine omega-3 supplements and human health
  1406. Elevated lipogenesis and diminished cholesterol synthesis in patients with hepatitis C viral infection compared to healthy humans
  1407. A High Fat Diet and theThr54 polymorphism of FABP2 Reduces Plasma Triglyceride-Rich Lipoproteins
  1408. The omega-3 fatty acid content of krill protein concentrate influences bioavailability, tissue deposition, peroxidation, and metabolism in young rats
  1409. Beneficial effects of fish oil on human brain
  1410. effect of Porpoise Oil on Kidney of Rats Receiving High Fat Diet
  1411. Lipoprotein-lipase deficiency: treatment with omega-3 fatty acids and colestyramine for severe gestational hypertriglyceridaemia and follow up over twenty …
  1412. effect of using sector of fat on some chemical carcasse parameters.
  1413. The use of functional foods in the metabolic syndrome
  1414. Proteome Changes in Caco-2 Cells Treated with Monascus-Fermented Red Mold Rice Extract
  1415. Benefits of omega-3 fatty acids supplementation on serum paraoxonase 1 activity and lipids ratios in polycystic ovary syndrome
  1416. Role of Nutrition in the Pathophysiology, Prevention, and Treatment of Type 2 Diabetes and the Spectrum of Cardiometabolic Disease
  1417. Long chain omega-3 polyunsaturated fatty acids in pediatric metabolic syndrome
  1418. Fish oil and importance of its ingredients in human diet
  1419. 13 Psammomys Obesus: Nutritionally Induced Insulin Resistance, Diabetes, and Beta Cell Loss
  1420. Membrane bioreactor technology for the development of functional materials from sea-food processing wastes and their potential health benefits
  1421. Ingestion of Apios americana Medikus tuber suppresses blood pressure and improves plasma lipids in spontaneously hypertensive rats
  1422. Serum lipoprotein composition, lecithin cholesterol acyltransferase and tissue lipase activities in pregnant diabetic rats and their offspring receiving enriched n-3 …
  1423. Biological Activities of Pepper Alkaloids 45
  1424. Dietary modification of metabolic pathways via nuclear hormone receptors
  1425. The influence of EPA and DHA on markers of inflammation in 3T3-L1 cells at different stages of cellular maturation
  1426. Isoflavone glycitein diminished plasma cholesterol in female golden Syrian hamsters
  1427. Cytotoxic properties of clofibrate and other peroxisome proliferators: relevance to cancer progression
  1428. Saturated fat consumption may not be the main cause of increased blood lipid levels
  1429. In Vitro Dissoluion Study to Determine Drug–Drug Interaction of Atorvastatin Calcium
  1430. Changes in cholesterol homeostasis modify the response of F1B hamsters to dietary very long chain n-3 and n-6 polyunsaturated fatty acids
  1431. Chronic intake of fractionated yellow pea flour reduces postprandial energy expenditure and carbohydrate oxidation
  1432. Modulation of mir-33 and mir-122 by dietary polyphenols
  1433. effects of oxidation on structural stability and remodeling of human very low density lipoprotein
  1434. Gene-diet interactions with polymorphisms of the MGLL gene on plasma low-density lipoprotein cholesterol and size following an omega-3 polyunsaturated fatty acid …
  1435. Does genetic variation in the Δ6-desaturase promoter modify the association between α-linolenic acid and the prevalence of metabolic syndrome?
  1436. The effect of dietary fish oil in addition to lifestyle counselling on lipid oxidation and body composition in slightly overweight teenage boys
  1437. Atorvastatin prevents type 2 diabetes mellitus—an experimental study
  1438. Dietary conjugated linoleic acid decreases adipocyte size and favorably modifies adipokine status and insulin sensitivity in obese, insulin-resistant rats
  1439. effect of maternal dietary Omega-6 to Omega-3 polyunsaturated fatty acid ratios on lipid and lipoprotein metabolism of the offspring of C57BL/6 mice
  1440. 26 Omega-3 Fatty Acids
  1441. Dietary omega-3 fatty acid deficiency and high fructose intake in the development of metabolic syndrome, brain metabolic abnormalities, and non-alcoholic fatty liver …
  1442. Randomized trial of weight-loss-diets for young adults varying in fish and fish oil content
  1443. Pharmacological administration of the isoflavone daidzein enhances cell proliferation and reduces high fat diet-induced apoptosis and gliosis in the rat hippocampus
  1444. Marine omega-3 phospholipids: metabolism and biological activities
  1445. The evolution of low W-6/W-3 ratio dietary pattern and risk of cardiovascular disease and diabetes mellitus
  1446. Association of serum n-6 and n-3 polyunsaturated fatty acids with lipids in 3 populations of middle-aged men
  1447. Medicinal plants used for the treatment of diabetes and its long-term complications
  1448. Acute consumption of fish oil improves postprandial VLDL profiles in healthy men aged 50–65 years
  1449. Dietary fats and metabolic syndrome
  1450. Emerging Therapeutic Approaches for Dyslipidemias Associated with High LDL and Low HDL
  1451. Dietary n-3-polyunsaturated fatty acids and energy balance in overweight or moderately obese men and women: a randomized controlled trial
  1452. Reduction in serum glucose with garlic extracts
  1453. The regulation of leptin, leptin receptor and pro-opiomelanocortin expression by N-3 PUFAs in diet-induced obese mice is not related to the methylation of their …
  1454. The role of dietary fatty acids in the pathology of metabolic syndrome
  1455. High fat feeding induces hepatic fatty acid elongation in mice
  1456. Toxicological evaluation of 10% Solanum lycocarpum St. Hill fruit consumption in the diet of growing rats: Hematological, biochemical and histopathological effects
  1457. Should we treat a low serum HDL-c and what specific lifestyle changes and drugs can be used to raise a low HDL-c?
  1458. Enhanced antioxidant activity of Monascus pilosus fermented products by addition of ginger to the medium
  1459. Modification of blood antioxidant status and lipid profile in response to high-intensity endurance exercise after low doses of ω-3 polyunsaturated fatty acids …
  1460. Fish oil for primary and secondary prevention of coronary heart disease
  1461. Toxicology and safety of DHA
  1462. Supplementation with fish oil as a source of n–3 fatty acids does not downregulate mammary lipogenesis in lactating mice
  1463. Advances in the management of hyperlipidemia-induced atherosclerosis
  1464. Dietary fat, plasma triglycerides and de novo lipogenesis in type 2 diabetes
  1465. A short-term n-3 DPA supplementation study in humans
  1466. effects on metabolic markers are modified by PPARG2 and COX2 polymorphisms in infants randomized to fish oil
  1467. Long chain omega-3 dietary supplements: a review of the National Library of Medicine Herbal Supplement Database
  1468. Steady-state bioavailability of prescription omega-3 on a low-fat diet is significantly improved with a free fatty acid formulation compared with an ethyl ester formulation …
  1469. 3 Clinical and Experimental Evidence on Cardiovascular Benefits of Fish Oil
  1470. Impact of feeding bread enriched with flaxseed on plasma profile of hyperlipidemic rats
  1471. Krill oil versus fish oil in modulation of inflammation and lipid metabolism in mice transgenic for TNF-α
  1472. Functional food ingredients as adjunctive therapies to pharmacotherapy for treating disorders of metabolic syndrome
  1473. Prevention and reversion of nonalcoholic steatohepatitis in OB/OB mice by S-nitroso-N-acetylcysteine treatment
  1474. Enhanced Antioxidant and Anti-inflammatory Activities of Monascus pilosus Fermented Products by Addition of Turmeric to the Medium
  1475. H&N 1: Omega-3 Fatty Acids: Brain Health and Function
  1476. Functional foods for cardiovascular disease in women
  1477. Marjolijn CE Bragt-van Wijngaarden1, 2, Mark V. Boekschoten1, 3, Michael Müller1, 3
  1478. Prevention of alcoholic fatty liver and mitochondrial dysfunction in the rat by long-chain polyunsaturated fatty acids
  1479. Lipids as New Targets
  1480. Stearidonic acid increases the red blood cell and heart eicosapentaenoic acid content in dogs
  1481. Integrated physiology and systems biology of PPARα
  1482. New evidence for the cardiovascular benefits of long chain omega-3 fatty acids
  1483. Hepatic n-3 polyunsaturated fatty acid depletion promotes steatosis and insulin resistance in mice: genomic analysis of cellular targets
  1484. High-density lipoprotein-raising strategies: update 2010
  1485. Involvement of gut microbial fermentation in the metabolic alterations occurring in n-3 polyunsaturated fatty acids-depleted mice
  1486. Role of Fish Oil in Prevention of Cardiovascular Diseases: A Systematic Review
  1487. effect of cholestin on toxicity of vitamin A in rats
  1488. White mulberry (Morus alba): a brief phytochemical and pharmacological evaluations account.
  1489. Preparation and effects of cheap salad oil in the management of type 2 rural Indian diabetics
  1490. Protective effects of cholestin against carbon tetrachloride-induced hepatotoxicity in rats
  1491. Ice cream as a vehicle for incorporating health‐promoting ingredients: Conceptualization and overview of quality and storage stability
  1492. Kardiodiabetologia. Zespół metaboliczny Połączenie statyny z wielonienasyconymi kwasami omega-3 w leczeniu zaburzeń lipidowych–czy osiągniemy dodatkowe …
  1493. Omega-3 fatty acids: new insights into the pharmacology and biology of docosahexaenoic acid, docosapentaenoic acid, and eicosapentaenoic acid
  1494. Flavonoids and age-related disease: risk, benefits and critical windows
  1495. Berberine improves lipid dysregulation in obesity by controlling central and peripheral AMPK activity
  1496. An International Journal of Advances in Pharmaceutical Sciences
  1497. The omega-3 index: from biomarker to risk marker to risk factor
  1498. EAT 1: Lipid Crystallization
  1499. A combination of soy isoflavone supplementation and exercise improves lipid profiles and protects antioxidant defense‐systems against exercise‐induced oxidative …
  1500. Dyslipidaemia and cardiorenal disease: mechanisms, therapeutic opportunities and clinical trials
  1501. Positive impact of long-term lifestyle change on erythrocyte fatty acid profile after acute coronary syndromes
  1502. Intake of farmed Atlantic salmon fed soybean oil increases insulin resistance and hepatic lipid accumulation in mice
  1503. Metabolic syndrome (Does it have a common denominator?)
  1504. Levels of plasma insulin, leptin and adiponectin, and activities of key enzymes in carbohydrate metabolism in skeletal muscle and liver in fasted ICR mice fed dietary n …
  1505. The Atherogenic Dyslipidemia of Metabolic Syndrome-Are there New effective Therapeutic Options Beyond Statins?
  1506. PPARα: its role in the human metabolic syndrome
  1507. The role of marine n-3 fatty acids in improving cardiovascular health: a review
  1508. Fatty acids and their derivatives in cardiovascular disease: arachidonic, eicosapentaenoic, and docosahexaenoic acids and their byproducts, the eicosanoids and …
  1509. n-3 fatty acids in the treatment of diabetic patients: biological rationale and clinical data
  1510. Arachidonate 5-lipoxygenase gene variants affect response to fish oil supplementation by healthy African Americans
  1511. A systemic review of the roles of n-3 fatty acids in health and disease
  1512. Dietary cholestin (Red Yeast Extract) reduces toxicity of oxidized cholesterol in rats
  1513. Probiotic Dahi containing Lactobacillus acidophilus and Bifidobacterium bifidum alleviates age-inflicted oxidative stress and improves expression of biomarkers of …
  1514. The pharmacological activity of coffee fermented using Monascus purpureus mycelium solid-state culture depends on the cultivation area and green coffees variety
  1515. Anti-diabetic effects of globin digest and its active ingredient Leu-Ser-Glu-Leu in ICR mice, streptozotocin-induced diabetic mice and KK-Ay mice
  1516. effect of globin digest on the liver injury and hepatic gene expression profile in galactosamine-induced liver injury in SD rats
  1517. Incorporation of n-3 fatty acids by the liver of mice fed linseed oil as a function of feeding duration
  1518. The effects of omega-3 polyunsaturated fatty acids on AMPK activation and lipid metabolism in skeletal muscle
  1519. AN ASSESSMENT OF FATS OF PLANT AND ANIMAL ORIGIN IN RELATION TO THEIR ATHEROGENIC AND THROMBOGENIC INDICES OCENA …
  1520. Activation of protein kinase A and exchange protein directly activated by cAMP promotes adipocyte differentiation of human mesenchymal stem cells
  1521. Supplementary health benefits of soy aglycons of isoflavone by improvement of serum biochemical attributes, enhancement of liver antioxidative capacities and …
  1522. Egg n-3 fatty acid composition modulates biomarkers of choline metabolism in free-living lacto-ovo-vegetarian women of reproductive age
  1523. Fatty acid metabolism in diabetes
  1524. effects of seafood consumption and weight loss on fasting leptin and ghrelin concentrations in overweight and obese European young adults
  1525. Signaling pathways modulated by fish oil in salt-sensitive hypertension
  1526. Fatty acid ethanolamides modulate CD36-mRNA through dietary fatty acid manipulation in Syrian Golden hamsters
  1527. Cardiovascular risk and lipid management beyond statin therapy: the potential role of omega–3 polyunsaturated fatty acid ethyl esters
  1528. Physiological and biochemical impacts of radiation processed full-fat linseed
  1529. ANTIOXIDANT ACTIVITY AND PHENOLIC CONTENT OF FLOUR AND PROTEIN CONCENTRATE OF AMARANTHUS CRUENTUS SEEDS
  1530. Omega-3 Fatty Acids in Prevention of Cardiovascular Disease in Humans: Chemistry, Dyslipidemia
  1531. Specific Oligopeptides in Fermented Soybean Extract Inhibit NF-κB-Dependent iNOS and Cytokine Induction by Toll-Like Receptor Ligands
  1532. Differential effect of biotin on carboxylase activity and mice skeletal muscle metabolism
  1533. Omega-3 fatty acids and cognitive function in women
  1534. effects of feeding fermented fish on egg cholesterol content in hens
  1535. Influence of Dietary Polyunsaturated Fatty Acids on Glucose Sensitivity, Insulin Resistance and Cognitive Function in a Rat Model
  1536. Role of FXR in the Adaptive Response to Bile Acids During Pregnancy
  1537. effects of talinum paniculatum (jacq.) gaertn. extracts on reproductive functions in female rat
  1538. Regulation of mTORC1 and its impact on gene expression at a glance
  1539. Lipid management and cardiovascular risk reduction
  1540. Benefits of fats in diet on health of patients suffering from Type 2 diabetes (NIDDM)
  1541. Dietary fats and blood pressure
  1542. Fatty acid composition and degradation level of the oils used in canned fish as a function of the different types of fish
  1543. Association of an ACSL1 gene variant with polyunsaturated fatty acids in bovine skeletal muscle
  1544. Omega-3 fatty acids and exercise: a review of their combined effects on body composition and physical performance
  1545. Beneficial actions of polyunsaturated fatty acids in cardiovascular diseases: But, how and why?
  1546. The influence of different flocculants on the physiological activity and fucoxanthin production of Phaeodactylum tricornutum
  1547. A comprehensive dose-response study of the effects of pistachios on cardiovascular disease risk factors: A translational research approach integrating clinical …
  1548. Development of EPA-DHA microcapsules supplemented probiotic fermented milk
  1549. Chronic dietary n-3 PUFA intervention improves dyslipidaemia and subsequent cardiovascular complications in the JCR: LA-cp rat model of the metabolic syndrome
  1550. Research Article The effect of Dietary Fish Oil in addition to Lifestyle Counselling on Lipid Oxidation and Body Composition in Slightly Overweight Teenage …
  1551. Factors modulating fibrates response: therapeutic implications and alternative strategies
  1552. Antioxidant action of soy isoflavones on oxidative stress and antioxidant enzyme activities in exercised rats.
  1553. Diet and Lifestyle in CVD Prevention and Treatment
  1554. An assessment of fats of plant and animal origin in relation to their atherogenic and thrombogenic indices.
  1555. Soy protein–based compared with casein-based diets fed during pregnancy and lactation increase food intake and characteristics of metabolic syndrome less in …
  1556. Deconstructing the paleolithic diet: components that reduce cardiovascular disease risk
  1557. Modulation of the rat hepatic cytochrome P4501A subfamily using biotin supplementation
  1558. High fat, low carbohydrate weight loss diet and inflammation: the role of oxidative stress.
  1559. Aged male and female spontaneously hypertensive rats benefit from n-3 polyunsaturated fatty acids supplementation
  1560. Phytochemicals as potential agents for prevention and treatment of obesity and metabolic diseases
  1561. The molecular mechanisms involved in lipid metabolism during low intensity exercise
  1562. High-fat diets and body composition over two generations. An experimental study
  1563. Hepatic gene expression changes in an experimental model of accelerated senescence: the SAM-P8 mouse
  1564. Statins and polyunsaturated fatty acids for treatment of atrial fibrillation
  1565. The effects of a Diet Rich in Lean Beef on Multiple Risk Factors for Cardiovascular Disease: The Beef in an Optimal Lean Diet (bold) Study
  1566. Lipid metabolism in children and adolescents: Impact on vascular biology
  1567. Metabolic development in the liver and the implications of the n-3 fatty acid supply
  1568. Support of drug therapy using functional foods and dietary supplements: focus on statin therapy
  1569. Supplementation with vitamin E does not alter plasma leptin, adiponectin or corticosterone response to different high-fat diets in rats.
  1570. Modulation of Lipid Metabolism by Phytosterol Stearates and Black Raspberry Seed Oils
  1571. An overview of the recent developments on fructooligosaccharide production and applications
  1572. Influence of dietary docosahexaenoic acid in combination with other long-chain polyunsaturated fatty acids on expression of biosynthesis genes and phospholipid …
  1573. Author Archives: SNI
  1574. effects of a new dietary strategy in the treatment of the metabolic syndrome: the RESMENA diet
  1575. Molecular Mechanism of Age-Specific Hepatic Lipid Accumulation in PPARα (+/−): LDLR (+/−) Mice, an Obese Mouse Model
  1576. A new insight to bone turnover: role of-3 polyunsaturated fatty acids
  1577. N-3 polyunsaturated fatty acids in heart failure: mechanisms and recent clinical evidence
  1578. Regulation of Cholesterol Biosynthesis in Hepatocytes
  1579. Impact of dietary fat quantity and quality in type 2 diabetes with emphasis on marine n-3 fatty acids
  1580. Does genetic variation in the D6-desaturase promoter modify the association between a-linolenic acid and the prevalence of metabolic syndrome? 1-3
  1581. Nonalcoholic fatty liver disease and lipids
  1582. Pharmacological therapy for cardiovascular disease
  1583. Potential impact of omega-3 treatment on cardiovascular disease in type 2 diabetes
  1584. Intravenous injection of insulin for measuring insulin sensitivity in horses: effects of epinephrine, feeding regimen, and supplementation with cinnamon for fish …
  1585. Development of functional materials from seafood by-products by membrane separation technology
  1586. Associations between plasma fatty acids, dietary fatty acids and cardiovascular risk factors: The PURE study
  1587. Pharmacological Administration of the Isoflavone Daidzein Enhances Cell
  1588. Fish oil in the treatment of dyslipidemia
  1589. mTORC1 controls fasting-induced ketogenesis and its modulation by ageing
  1590. Generic and Product-Specific Health Claim Processes for Functional Foods across Global Jurisdictions3
  1591. The effects of the combination of dietary flaxseed oil or fish oil with cyclosporine in a rat cardiac allograft model
  1592. Lipid management in Type 2 diabetes: the case for combination therapy?
  1593. Pharmacological Therapy for Cardiovascular Disease: Current and Emerging Therapies
  1594. Factors modulating fibrates response: therapeutic implications and alternative stratagies.
  1595. University of Wollongong Thesis Collection
  1596. Long chain omega-3 fatty acids: micronutrients in disguise
  1597. Bile acids and their receptors
  1598. Exposure of juvenile female mice to isoflavone causes lowered expression of estrogen-related receptor gamma gene in vagina
  1599. Nutraceutical, pharmaceutical and surgical prevention of type 2 diabetes in the UC Davis type 2 diabetes mellitus rat
  1600. 3 Nutritional Regulation of Adipocyte Differentiation
  1601. Pre-Diabetes in Obese Adolescents: Pathophysiologic Mechanisms
  1602. Regulation of highly unsaturated fatty acid metabolism
  1603. Date Fruits (Phoenix dactylifera Linn): An Emerging Medicinal Food
  1604. Enhanced estrogenic responses and sensitivity to azoxymethane following dietary soy isoflavone supplementation in older female rats
  1605. Oryza sativa
  1606. Nutritional and bioactive compounds of soybean: Benefits on human health
  1607. DIETARY FAT, GENES, AND HUMAN HEALTH
  1608. Canola oil inhibits development and growth of breast cancer in vivo and in vitro
  1609. Glycine max
  1610. The Role of Diet in the Prevention and Treatment of Cardiovascular Disease
  1611. Restoration of Immunocompetence in Aging and Other Inflammatory Disease States by Dehydroepian-drosterone-3ẞ-Sulfate, an Activator of the Peroxisome …
  1612. DISCUSSION COMMENTS: Recent Progress In Omega-3 Fatty Acid Cancer Research
  1613. Links between insulin resistance, lipoprotein metabolism and amyloidosis in Alzheimer’s Disease
  1614. Endurance and resistance exercise: acute postprandial responses and chronic training adaptations
  1615. Nutrient regulation of energy metabolism in relation to obesity and type 2 diabetes
  1616. Red blood cell δ15N: a novel biomarker of dietary eicosapentaenoic acid and docosahexaenoic acid intake
  1617. Absorption of marine vs non-marine sources of EPA and DHA
  1618. effects of globin digest and its active ingredient Trp-Thr-Gln-Arg on galactosamine/lipopolysaccharide-induced liver injury in ICR mice
  1619. Fish Oils for Fat Loss
  1620. Antioxidant activity in cooked and gastrointestinal enzyme digested eggs
  1621. Nutritional assessment of mulberry (Morus alba L.) leaf hay in broilers.
  1622. effects of nutrients and exercise on skeletal muscle and adipose tissue
  1623. Multiple sclerosis is not a disease of the immune system
  1624. 33RD ANNUAL CONFERENCE OF THE MALAYSIAN SOCIETY FOR BIOCHEMISTRY AND MOLECULAR BIOLOGY
  1625. Macronutrients and obesity: views, news and reviews
  1626. Interactions between nutrition, obesity and the immune system
  1627. Docosahexaenoic acid supplementation: a need or a commercial hype?
  1628. Evaluation of Water Fern (Salvinia molesta) as an Alternative Source of Omega-3 Polyunsaturated Fatty Acids for Cultured Tilapia
  1629. Fibrates for primary prevention of cardiovascular disease events
  1630. 24Dietary Fats and Obesity
  1631. Fructooligosaccharides production-Ingredients for functional food
  1632. Development of the 4-3-2-1 Meibum Expressibility Scale and Omega-3 Fatty Acid Supplementation and Dry Eye
  1633. effects of alternative sanitizing techniques on nutritional quality of fresh-cut Bimi broccoli during shelf life
  1634. Characterization of Coal Combustion and Steam Temperature with Respect to Staged-Air Angle in a 600 MWe Down-Fired Boiler
  1635. The role of mammalian target of rapamycin complex 1 in hepatic physiology and disease
  1636. Comparison of Lipid Profile and Some Physico-Chemical Properties of Beef from Spain and Netherlands with Beef from National Production with Different Genetic …
  1637. Physiology of Monascus purpureus in relation to metabolite production and application as functional food
  1638. William E. Connor, MD
  1639. Applications of matrix assisted laser desorption/ionization Fourier transform mass spectrometry for phospholipid analysis
  1640. Lipid and phospholipid profiling of biological samples using MALDI Fourier transform mass spectrometry
  1641. The Antitumor Materials Produced by Bacillus amyloliquefaciens V656 and Monascus purpureus BCRC31499 Enzymes and Their..
  1642. A broad variety of antigens contribute to the pathogenesis of atherosclerosis: how to neutralize noxious reactions in the host
  1643. n-3 fatty acids modulate adipose tissue inflammation and oxidative stress
  1644. Drug–Nutrient Interactions in Transplantation
  1645. Iodine status of adolescent girls in a population changing from high to lower fish consumption
  1646. LC-PUFA from photosynthetic microalgae: occurrence, biosynthesis, and prospects in biotechnology
  1647. Polyunsaturated fatty acids as universal endogenious bioregulators
  1648. Assessment of iodine and mercury status of Icelandic adolescent girls
  1649. Sustainable production of omega-3 fatty acids
  1650. Research and application of marine microbial enzymes: status and prospects
  1651. Application of marine microbial enzymes in the food and pharmaceutical industries
  1652. Near-infrared (NIR) spectroscopy for food quality applications
  1653. Intentions to consume Omega-3 fatty acids: A comparison of protection motivation theory and ordered protection motivation theory
  1654. The development and evaluation of a nutrition education program to promote healthy lifestyle practices among African-American women in CA
  1655. Introduction to lipidomics: from bacteria to man
  1656. Chemical modification of colloidal masks for nanolithography
  1657. effect of Trifolium pratense extract on methionine-choline-deficient diet-induced steatohepatitis in C57BL/6 mice
  1658. Identification and characterization of a protein hydrolysate responsive guanine nucleotide-binding protein-coupled receptor
  1659. effect of omega-3 fish oil on cardiovascular risk in diabetes
  1660. Development of a” green process” for the isolation of natural functional extracts with anti-cancer activity-Application of high-pressure technology
  1661. Optimizing the submerged cultivation of Monascus Anka via a sequential pseudo-uniform design method
  1662. effects of defatted soybean grits on lipid metabolism in rats fed with high-fat diet
  1663. Hypocholesterolemic effects of dietary soybean vs. Casein proteins in a crossed over diets in rat.
  1664. Molecular mechanism of fatty acids impact on plasma lipid profile (part II)
  1665. effects of botanical dietary supplements on cardiovascular, cognitive, and metabolic function in males and females
  1666. Biological effects of pharmacological concentrations of biotin
  1667. Mechanism of PUFA in regulating of gene expression
  1668. Is Dietary Fatty Acid a Risk Factor for Obesity? A Review of the Literature
  1669. 3 Clinical and Experimental
  1670. Adipose Tissue Biology: An Update Review
  1671. an den.(2010, October 6)
  1672. Self-emulsifying drug delivery system of black seed oil with improved hypotriglyceridemic effect and enhanced hepatoprotective function
  1673. Estrogen and n-3 polyunsaturated fatty acid supplementation have a synergistic hypotriglyceridemic effect in ovariectomized rats
  1674. The hypotriglyceridemic effect of Sciadonic Acid is Mediated by the Inhibition of Δ9‐Desaturase Expression and Activity
  1675. Antilipolytic and hypotriglyceridemic effects of dietary Salvia triloba Lf (Lamiaceae) in experimental rats
  1676. hypotriglyceridemic effect of Kale―A Randomized, Double—blind, Parallel—group, Placebo—controlled Study―
  1677. The effects of phytochemicals on serum triglycerides in subjects with hypertriglyceridemia: A systematic review of randomized controlled trials
  1678. The hypotriglyceridemic effect of sciadonic acid is mediated by the inhibition of∆ 9-desaturase expression and activity
  1679. Chemically induced common bean (Phaseolus vulgaris L.) sprouts ameliorate dyslipidemia by lipid intestinal absorption inhibition
  1680. Estrogen and n-3 polyunsaturated fatty acid supplementation have a synergistic hypotriglyceridemic effect in ovariectomized rats.
  1681. Supersaturable self-emulsifying drug delivery system of Krill oil with improved oral absorption and hypotriglyceridemic function
  1682. effects of N-3 polyunsaturated fatty acids and estrogen on triglyceride metabolism in ovariectomized rats
  1683. SPIRULINA (ARTHROSPIRA) PLATENSIS-A REVIEW OF POSSIBLE hypotriglyceridemic effectS
  1684. Docosahexaenoic acid inhibits proteolytic processing of sterol regulatory element-binding protein-1c (SREBP-1c) via activation of AMP-activated kinase
  1685. Familial chylomicronemia syndrome (FCS): recent data on diagnosis and treatment
  1686. effect of supplementation of Purslane (Portulacaoleracea) in hypertriglyceridemic subjects
  1687. Microalgae as a safe food source for animals: nutritional characteristics of the acidophilic microalga Coccomyxa onubensis
  1688. Pharmacological PPARβ/δ activation upregulates VLDLR in hepatocytes
  1689. effects of the seed of phalaris canariensis and the change of diet on serum lipids in rats
  1690. Nutritional Aspects of Soybean (Glycine Max)
  1691. Influence of heating on chemical composition, antioxidant activity and protein quality of an advanced line Amaranthus cruentus L. seed flour
  1692. Docosahexaenoic acid inhibits proteolytic processing of sterol regulatory element-binding protein-1c (SREBP-1c) via activation of AMP-activated kinase.
  1693. Obese Childhood Dyslipidemia Management Beyond Statins—MUFA, PUFA, and Sea-buckthorn Supplements
  1694. Potential ecotoxicity of substrate-enriched zinc oxide nanoparticles to Physalaemus cuvieri tadpoles
  1695. An extract from date palm fruit (Phoenix dactylifera) acts as a co-agonist ligand for the nuclear receptor FXR and differentially modulates FXR target-gene expression …
  1696. Therapeutic effects of an aspalathin-rich green rooibos extract, pioglitazone and atorvastatin combination therapy in diabetic db/db mice
  1697. hypotriglyceridemic and hepatoprotective effect of pumpkin (Cucurbita moschata) seed flour in an experimental model of dyslipidemia
  1698. Aspalathin-rich green rooibos tea in combination with glyburide and atorvastatin enhances lipid metabolism in a db/db mouse model
  1699. Favorable effects of Globularia alypum on cardiometabolic markers in high fructose-fed rats
  1700. Hypolipidemic property of a new fermented tea made with third crop green tea (Camellia sinensis) leaves and unripe satsuma mandarin (Citrus unshiu) fruits
  1701. The Beneficial effects of Stingless Bee Honey from Heterotrigona itama against Metabolic Changes in Rats Fed with High-Carbohydrate and High-Fat Diet
  1702. Microalgae as a safe food source for animals: nutritional characteristics of the acidophilic microalga Coccomyxa onubensis
  1703. GC Determination of Fatty Acids in Fish Supplements
  1704. effects of quercetin supplementation on lipid profile: A systematic review and meta-analysis of randomized controlled trials
  1705. Anti-hypertriglyceridemic Activity of Cornus Mas in Diabetic Rats.
  1706. effects of cardamom supplementation on lipid profile: A systematic review and meta‐analysis of randomized controlled clinical trials
  1707. HYPOLIPIDEMIC effect OF THE DRY EXTRACT OF CULTIVATED (VITIS VINIFERA L). RED LEAVES
  1708. Xuezhikang contributes to greater triglyceride reduction than simvastatin in hypertriglyceridemia rats by up-regulating apolipoprotein A5 via the PPARα signaling …
  1709. Nutrient Interactions and Toxicity
  1710. Plasma lipids and vitamin C
  1711. Early effects on mitochondrial and peroxisomal p-oxidation by the hypolipidemic 3-thia fatty acids in rat livers
  1712. effects of fiber purified extract of carob fruit on fat digestion and postprandial lipemia in healthy rats
  1713. Triglyceride-lowering effects of two probiotics, Lactobacillus plantarum KY1032 and Lactobacillus curvatus HY7601, in a rat model of high-fat diet-induced …
  1714. Nutraceuticals and bioactive components from fish for dyslipidemia and cardiovascular risk reduction
  1715. Biochemical composition of Indian common small pelagic fishes indicates richness in nutrient capable of ameliorating malnutrition and age-associated disorders
  1716. Tamoxifen-and Triptorelin-Induced Major Hypertriglyceridemia: A Case Report
  1717. Honey does not adversely impact blood lipids of adult men and women: a randomized cross-over trial
  1718. Khat chewing and lipid profile in human and experimental animals
  1719. Squalene modulates fatty acid metabolism: Enhanced EPA/DHA in obese/diabetic mice (KK‐Ay) model
  1720. Range analysis, socio-economic accessibility and consumption of fibrates on the pharmaceutical market of Ukraine during 2017-2020
  1721. Okara, a by-product of tofu manufacturing, modifies triglyceride metabolism at the intestinal and hepatic levels
  1722. Role of media on discontinuation of statin therapy
  1723. Natural products for controlling hyperlipidemia
  1724. Omega-3 fatty acids and coronary artery disease: more questions than answers
  1725. Hypolipidemic effect of dietary water-soluble protein extract from chicken: impact on genes regulating hepatic lipid and bile acid metabolism
  1726. A grape seed procyanidin extract ameliorates fructose-induced hypertriglyceridemia in rats via enhanced fecal bile acid and cholesterol excretion and inhibition of …
  1727. effect of different pigmented cooked common beans on glucose and lipid metabolism in obese rats and 3T3 L1 cells
  1728. Polyphenol-rich peach (Prunus persica L.) by-product exerts a greater beneficial effect than dietary fiber-rich by-product on insulin resistance and hepatic steatosis in …
  1729. High-cocoa polyphenol-rich chocolate improves blood pressure in patients with diabetes and hypertension
  1730. Dietary protein restriction reduces circulating VLDL triglyceride levels via CREBH-APOA5–dependent and–independent mechanisms
  1731. Dietary impact on postprandial lipemia
  1732. effect of Ajuga iva on enzymes involved in the metabolism of cholesterol, in rat fed a cholesterol-enriched diet
  1733. Development of Rapid Multiplex PCR Detection Methods for Emetic and Enterotoxic Bacillus cereus in Food
  1734. Modifying the lipid content and composition of plant seeds: engineering the production of LC-PUFA
  1735. Rutin and curcumin reduce inflammation, triglyceride levels and ADA activity in serum and immune cells in a model of hyperlipidemia
  1736. Comparative analysis of the biochemical composition of wild caught penaeid shrimps (Penaeus indicus, Penaeus monodon and Penaeus vannamei) in Nellore …
  1737. Isolation and characterization of Boso fish (Oxyeleotris marmorata) oil and their recovery using enzymatic reaction
  1738. Omega-3 PUFA responders and non-responders and the prevention of lipid dysmetabolism and related diseases
  1739. Extracts of okra (Abelmoschus esculentus L.) improves dyslipidemia by amelioratinglipid profile while not affectinghs-CRP levelsin streptozotocin-induced rats
  1740. Icosabutate: targeting metabolic and inflammatory pathways for the treatment of NASH
  1741. effect of statin therapy on the progression of asymptomatic carotid stenosis
  1742. Procyanidins extracted from the litchi pericarp attenuate atherosclerosis and hyperlipidemia associated with consumption of a high fat diet in apolipoprotein-E …
  1743. Uncovering the role of apolipoprotein C-III in insulin resistance
  1744. Elevated of HDL-c in response to statin treatment is involved in the regression of carotid atherosclerosis
  1745. effect of dietary oil rich in docosahexaenoic acid-bound lysophosphatidylcholine prepared from fishery by-products on lipid and fatty acid composition in rat liver and …
  1746. Revealing the role of peroxisome proliferator-activated receptor β/δ in nonalcoholic fatty liver disease
  1747. Mechanisms related to the anti-diabetic properties of mango (Mangifera indica L.) juice by-product
  1748. Inulin improves postprandial hypertriglyceridemia by modulating gene expression in the small intestine
  1749. Evaluation of the effects of a Pinus Brutia Bark Extract on Biochemical Parameters and Blood Pressure in an Experimental Arterial Hypertension
  1750. Non-fat milk attenuates acute hypertriglyceridemia in obese individuals who consume a high fat diet: A randomized control trial
  1751. Clinical application of plant sterol and stanol products
  1752. Hypocholesterolemic effect of ethanolic extract of Scoparia dulcis in rats
  1753. Anti-hyperglycemic potential of Hyptis verticillata jacq in streptozotocin-induced diabetic rats
  1754. Biological Activities of Red Pepper (Capsicum annuum) and Its Pungent Principle Capsaicin: A Review
  1755. Docosahexaenoic acid enrichment in NAFLD is associated with improvements in hepatic metabolism and hepatic insulin sensitivity: a pilot study
  1756. Cucurbita ficifolia Bouché Regulates the Metabolism of Carbohydrates and Lipids in Liver by Activation of PPARα without Affectation on PPARγ in Vivo and in …
  1757. Antihypercholesterolemic and anti-atherogenic effects of lyophilized aqueous extract of Globularia alypum leaves in rats fed a high-cholesterol diet
  1758. Lycopene-Rich Extract from Red Guava (Psidium guajava L.) Decreases Plasma Triglycerides and Improves Oxidative Stress Biomarkers on Experimentally-Induced …
  1759. effect of the Aqueous Extract of Corchorus olitorius L. on the Lipid Parameters of Rats Subjected to a Hyperlipidic Diet
  1760. Low-fat diet for hypertriglyceridemic dogs and cats
  1761. Mechanistic insights into the effects of Astaxanthin on lipid profile and glucose homeostasis parameters: A systematic review of animal and clinical trial studies
  1762. Hypoglycemic, hypolipidemic, and wound healing potential of quercetin in streptozotocin-induced diabetic rats
  1763. Statin dose reduction with complementary diet therapy: A pilot study of personalized medicine
  1764. The effect of artichoke leaf extract supplementation on lipid and CETP response in metabolic syndrome with respect to Taq 1B CETP polymorphism: A randomized …
  1765. effects of K-877, a novel selective PPARα modulator, on small intestine contribute to the amelioration of hyperlipidemia in low-density lipoprotein receptor …
  1766. effects of Nigella sativa oil with a low-calorie diet on cardiometabolic risk factors in obese women: a randomized controlled clinical trial
  1767. Dietary long-chain unsaturated fatty acids acutely and differently reduce the activities of lipogenic enzymes and of citrate carrier in rat liver
  1768. Estimate effect Of Ocimum Basilicum L. Seeds Extract On Lipid Profile & Minerals In Hypomagnesemic Of Female Rats
  1769. Studying the effect of Anethum Graveolens extract on parameters of lipid metabolism in white rat males
  1770. New potential phytotherapeutics obtained from white mulberry (Morus alba L.) leaves
  1771. ANGPTL4 promotes bile acid absorption during taurocholic acid supplementation via a mechanism dependent on the gut microbiota
  1772. KHK, PNPLA3 and PPAR as novel targets for the anti-steatotic action of bempedoic acid
  1773. Oily fish consumption and the risk of dyslipidemia in Korean adults: a prospective cohort study based on the Health Examinees Gem (HEXA-G) study
  1774. Antidiabetic and antihyperlipidemic activities of Cucumis melo var. momordica fruit extract on experimental animals
  1775. Evaluation of acute and sub-acute toxicity of Pinus eldarica bark extract in Wistar rats
  1776. Omega‐3 fatty acid supplementation candidates can be selected using fatty acid profiling
  1777. Efficacy, Safety and Protective effects of Lipid Lowering Drugs in Patients with Diabetes
  1778. Fine mapping of genome-wide association study signals to identify genetic markers of the plasma triglyceride response to an omega-3 fatty acid …
  1779. effects of bee propolis on blood pressure record and certain biochemical parameter in healthy volunteers
  1780. effects of eicosapentaenoic acid on hepatic dyslipidemia and oxidative stress in high fat diet-induced steatosis
  1781. effect of dietary components from Antarctic krill on atherosclerosis in apoE‐deficient mice
  1782. Protective effect of curcumin in fructose-induced metabolic syndrome and in streptozotocin-induced diabetes in rats
  1783. Trichosanthes dioica Roxb.: A vegetable with diverse pharmacological properties
  1784. Severe hypertriglyceridemia: Existing and emerging therapies
  1785. The antiatherogenic effect of bixin in hypercholesterolemic rabbits is associated to the improvement of lipid profile and to its antioxidant and anti-inflammatory effects
  1786. A diet rich in menhaden oil has the hypolipidemic effect but increases plasma glucose and insulin levels in rats.
  1787. Anthocyanins of Hierbamora (Solanum nigrescens): Revealing their Nutraceutical Potential for Controlling Hypertriglyceridemia and Helicobacter pylori Viability
  1788. ON THE HYPOLIPIDEMIC effect OF TOTAL EXTRACTIVE PREPARATIONS CONTAINING FLAVONOIDS, TRITERPENE GLYCOSIDES AND …
  1789. Gallocatechin gallate-containing fermented green tea extract ameliorates obesity and hypertriglyceridemia through the modulation of lipid metabolism in adipocytes …
  1790. Garcinia cambogia Extract Increased Hepatic Levels of Lipolysis-Stimulated Lipoprotein Receptor and Lipids in Mice on Normal Diet
  1791. Evaluation of hypolipidemic activity of ethanolic extract of Trema orientalis L. Blume leaves
  1792. Antihypertriglyceridemia activities of naturally fermented green tea, Heukcha, extract through modulation of lipid metabolism in rats fed a high-fructose diet
  1793. Astaxanthin reduces hepatic lipid accumulations in high-fat-fed C57BL/6J mice via activation of peroxisome proliferator-activated receptor (PPAR) alpha and inhibition …
  1794. Cardio protective influence of dietary spices mediated through their hypolipidemic and antioxidant potential
  1795. Hepatocyte small heterodimer partner mediates sex-specific effects on triglyceride metabolism via androgen receptor in male mice
  1796. New insights into apolipoprotein A5 in controlling lipoprotein metabolism in obesity and the metabolic syndrome patients
  1797. Hypolipidemic activity and mechanisms of the total phenylpropanoid glycosides from Ligustrum robustum (Roxb.) Blume by AMPK‐SREBP‐1c pathway in hamsters …
  1798. The effect of Stevia rebaudiana on serum omentin and visfatin level in STZ-induced diabetic rats
  1799. Hypolipidemic effect of a Blue-Green Alga (Nostoc commune) Is Attributed to Its Nonlipid Fraction by Decreasing Intestinal Cholesterol Absorption in C57BL/6J Mice
  1800. Clinical Lipidology
  1801. Antiobesity and hypolipidemic effects of protease A-digested crude-chalaza hydrolysates in a high-fat diet
  1802. Combined effect of astaxanthin and squalene on oxidative stress in vivo
  1803. Tomato juice supplementation in young women reduces inflammatory adipokine levels independently of body fat reduction
  1804. HEALTH PROMOTING effect OF GREEN TEA MILK DRINK FED TO RATS
  1805. Porcine hemoglobin promotes lipid excretion to feces more strongly than globin protein in rats
  1806. effect of weight reduction diets containing fish, walnut or fish plus walnut on cardiovascular risk factors in overweight and obese women
  1807. NUTRACEUTICALS, A TOOL FOR PSYCHOPHYSICAL WELL-BEING ALSO IN THE OCCUPATIONAL FIELD.
  1808. The efficacy of squalene in cardiovascular disease risk-a systematic review
  1809. effect of dietary patterns on oxidative stress in Patiants with metabolic syndrome: Tehran Lipid and Glucose Study
  1810. effect of Roux-en-Y gastric bypass on lipoprotein metabolism and markers of HDL functionality in morbid obese patients
  1811. effect of hydroalcoholic extract of Berberis integerrima and resveratrol on ovarian morphology and biochemical parameters in Letrozole-induced polycystic …
  1812. Chia (Salvia hispanica L.) oil extraction using different organic solvents: oil yield, fatty acids profile and technological analysis of defatted meal.
  1813. A review on role of antioxidants in diabetes
  1814. The interaction of FTO-rs9939609 polymorphism with artichoke leaf extract effects on cardiometabolic risk factors in hypertriglyceridemia: a randomized clinical trial
  1815. Rutin and curcumin reduce inflammation, triglyceride levels and ADA activity in serum and immune cells in a model of hyperlipidemia
  1816. Antihyperglycemic and antihyperlipidemic activities of hydroethanolic extract of the fruit of Baillonella toxisperma in streptozotocin-induced diabetic rats
  1817. Hypolipidemic, antioxidant, and hepatoprotective effects of cucumber (Cucumis Sativus L.)-Supplemented diet in both sexes of sprague-dawley rats
  1818. Bitter almond gum reduces body mass index, serum triglyceride, hyperinsulinemia and insulin resistance in overweight subjects with hyperlipidemia
  1819. Influence of pomegranate peel (Punica granatum) extract on lipid oxidation in anchovy fish oil under heat accelerated conditions
  1820. effect of polysaccharide from Bacillus subtilis sp. on cardiovascular diseases and atherogenic indices in diabetic rats
  1821. Sesamum indicum diet prevents hyperlipidemia in experimental rats
  1822. High-fructose intake impairs the hepatic hypolipidemic effects of a high-fat fish-oil diet in C57BL/6 mice
  1823. In Vivo Interrelationship between Insulin Resistance and Interferon Gamma Production: Protective and Therapeutic effect of Berberine
  1824. Evaluation of the anti-hyperlipidemic effects of Triphala in high fat diet fed rats: Studies with two combinations
  1825. Stabilized soy protein emulsion enriched with silicon and containing or not methylcellulose as novel technological alternatives to reduce animal fat digestion
  1826. effects of ginger powder supplementation on glycemic status and lipid profile in newly diagnosed obese patients with type 2 diabetes mellitus
  1827. Protective effect of supplementation with biotin against high-fructose-induced metabolic syndrome in rats
  1828. Comparative effect of resveratrol, carnosic acid and hernandulcin on target enzymes and biochemical markers linked to carbohydrate and lipid metabolism in …
  1829. An improvement of cardiovascular risk factors by omega-3 polyunsaturated fatty acids
  1830. Bioactive compounds from Prosthechea karwinskii decrease obesity, insulin resistance, pro-inflammatory status, and cardiovascular risk in Wistar rats with metabolic …
  1831. Endurance exercise training programs intestinal lipid metabolism in a rat model of obesity and type 2 diabetes
  1832. Anti‐inflammatory effect of black raspberry seed oil in high‐fat diet‐induced obese mice
  1833. Fish consumption, long-chain omega-3 polyunsaturated fatty acid intake and risk of metabolic syndrome: a meta-analysis
  1834. Ameliorative effect of flaxseed (Linum usitatissimum) and its protein on ethanol‐induced hepatotoxicity in Wistar rats
  1835. Mechanisms underlying the beneficial effect of soy protein in improving the metabolic abnormalities in the liver and skeletal muscle of dyslipemic insulin resistant rats
  1836. Bioactive compounds as an alternative for drug co-therapy: Overcoming challenges in cardiovascular disease prevention
  1837. Chitosan-coated liposomes encapsulating curcumin: Study of lipid–polysaccharide interactions and nanovesicle behavior
  1838. Double blind exploratory study on de novo lipogenesis in preterm infants on parenteral nutrition with a lipid emulsion containing 10% fish oil
  1839. Plants used against diabetes by tribal communities: A review
  1840. effect of panax ginseng root powder on some biochemical parameters in rabbits
  1841. Hyperlipidemia-induced lipotoxicity and immune activation in rats are prevented by curcumin and rutin
  1842. The king of bitters,” Andrographis paniculata”: a plant with multiple medicinal properties
  1843. effects of rosuvastatin and/or β-carotene on non-alcoholic fatty liver in rats
  1844. Chronic consumption of dietary proanthocyanidins modulates peripheral clocks in healthy and obese rats
  1845. effect of Salmon Fish on Lipid Profile of Male and Female Albino Rats
  1846. Bioactive Compounds for the Management of Hypertriglyceridemia: Evidence From Clinical Trials and Putative Action Targets
  1847. effects of atorvastatin and rosuvastatin on blood lipids in Quaker parrots (Myiopsitta monachus)
  1848. Lipid profile and glucose changes after supplementation with astaxanthin: a systematic review and meta-analysis of randomized controlled trials
  1849. Aqueous Terminalia arjuna extract modulates expression of key atherosclerosis‐related proteins in a hypercholesterolemic rabbit: A proteomic‐based study
  1850. The effects of ginger supplementation on lipid profile: A meta-analysis of randomized clinical trials
  1851. Ergostatrien-3β-ol from Antrodia camphorata Inhibits Diabetes and Hyperlipidemia in High-Fat-Diet Treated Mice via Regulation of Hepatic Related Genes, Glucose …
  1852. Ameliorative potential of omega 3 fatty acids and HMG-CoA reductase inhibitors on experimentally-induced non-alcoholic steatohepatitis
  1853. Hypoglycemic and Hypolipidemic effects of Aqueous Extracts of Ajuga iva and Centaurium erythreae on a Rodent Model of Metabolic Syndrome
  1854. Common bean seeds obtained by plant water restriction ameliorates obesity-associated cardiovascular risk and insulin resistance
  1855. Lacticaseibacillus rhamnosus FM9 and Limosilactobacillus fermentum Y57 Are as effective as Statins at Improving Blood Lipid Profile in High Cholesterol, High-Fat …
  1856. effects of Olea europaea L. Polyphenols on the Animal Welfare and Milk Quality in Dairy Cows
  1857. effects of Süßstofftabletten on Some Physiological Parameters in Male Albino Rats and The Curative effects of Vitamin E
  1858. effect of fatty oil extract from seeds of Nigella damascena l. on lipid spectrum in rats with simulated dyslipidemia
  1859. effects of Morus alba L (Mulberry) leaf extract in hypercholesterolemic mice on suppression of cholesterol synthesis
  1860. The effect of Laminaria japonica on Metabolic Syndrome: A Systematic Review of Its Efficacy and Mechanism of Action
  1861. Common applications of black cumin Seed (Nigella sativa) oil in folk medicine
  1862. Molecular Docking of Anthocyanin Compound as Anti-Hyperlipidemia Against PPARα, HMG-CoA Reductase and ACAT Proteins
  1863. Modulatory effect of baicalein on gene expression and activity of antioxidant enzymes in streptozotocin-nicotinamide induced diabetic rats
  1864. Olive or salmon oils affect differently the storage and transport of fatty acids by VLDL in hypercholesterolemic rats fed different proteins
  1865. Beneficial effects of ω-3 PUFA in children on cardiovascular risk factors during childhood and adolescence
  1866. Omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and their mechanisms of action on apolipoprotein B-containing lipoproteins in humans: a …
  1867. Salicylic acid elicitation during cultivation of the peppermint plant improves anti-diabetic effects of its infusions
  1868. Nutritive Value and Quality of Sweet Basil Leaves in an Animal Model of Nonalcoholic Fatty Liver Disease
  1869. effects of Hydroxycitric Acid Supplementation on Body Composition, Obesity Indices, Appetite, Leptin, and Adiponectin of Women with NAFLD on a Calorie …
  1870. The effect of dietary patterns on oxidative stress in individuals with metabolic syndrome: Tehran Lipid and Glucose Study. Caspian J Intern Med 2018; 9 (4): 376 …
  1871. Plasma lipidome analysis by liquid chromatography-high resolution mass spectrometry and ion mobility of hypertriglyceridemic patients on extended-release nicotinic …
  1872. Therapeutic effect of alkaloids and glycosides of colocynth seeds on liver injury, associated with metabolic syndrome in wistar rats, subject to nutritional stress.
  1873. Antcin K, a Triterpenoid Compound from Antrodia camphorata, Displays Antidiabetic and Antihyperlipidemic effects via Glucose Transporter 4 and AMP …
  1874. effect of omega-3 fatty acids supplementation on cardio-metabolic and oxidative stress parameters in patients with chronic kidney disease: a systematic review and …
  1875. Clinical evaluation of a novel tablet formulation of traditional thai polyherbal medicine named nawametho in comparison with its decoction in the treatment of …
  1876. Modulating effects of omega-3 fatty acids and pioglitazone combination on insulin resistance through toll-like receptor 4 in type 2 diabetes mellitus
  1877. Silybum marianum (milk thistle) and its main constituent, silymarin, as a potential therapeutic plant in metabolic syndrome: A review
  1878. Baru (Dipteryx alata Vogel) almond and dairy desserts with baru regulates gastrointestinal transit in rats
  1879. Research Article effects of Methanol Extract of Breadfruit (Artocarpus altilis) on Atherogenic Indices and Redox Status of Cellular System of …
  1880. The effects of curcumin supplementation added to diet on anthropometric and biochemical status in women with polycystic ovary syndrome: A randomized, placebo …
  1881. Farnesoid-X receptor (FXR) as a promising pharmaceutical target in atherosclerosis
  1882. effects of Supplementation of Diet with Olea europaea L. Polyphenols on the Animal Welfare and Milk Quality in Italian Holstein-Friesian Dairy Cows
  1883. GDF15 mediates the metabolic effects of PPARβ/δ by activating AMPK
  1884. Vegetable lecithins: A review of their compositional diversity, impact on lipid metabolism and potential in cardiometabolic disease prevention
  1885. Lipid-lowering properties of protein-rich mucuna product
  1886. effect of omega-3 polyunsaturated fatty acids on inflammatory status, lipid levels, and severity of peripheral artery disease measured using ankle-brachial index-A …
  1887. Totum-070, a Polyphenol-Rich Plant Extract, Prevents Hypercholesterolemia in High-Fat Diet-Fed Hamsters by Inhibiting Intestinal Cholesterol Absorption
  1888. Dietary anhydrous milk fat depletes essential fatty acids in wistar rats which can be corrected by blending with linoleic acid rich sunflower oil
  1889. Bisphenol A‑induced oxidative damage in the hepatic and cardiac tissues of rats: The modulatory role of sesame lignans
  1890. Comparative efficacy of omega-3 polyunsaturated fatty acids on major cardiovascular events: A network meta-analysis of randomized controlled trials
  1891. Biochemical study on the regenerative effect of bee venom on experimentally induced diabetes
  1892. Scholars Academic Journal of Pharmacy (SAJP) ISSN 2347-9531 (Print)
  1893. Omega 3 improves both apoB100-containing lipoprotein turnover and their sphingolipid profile in hypertriglyceridemia
  1894. Starch sources influence lipidaemia of diabetic dogs
  1895. effects of Moringa oleifera leaf extracts on lipid profile of rats: a meta-analysis and systematic review
  1896. Krill oil improved osteoarthritic knee pain in adults with mild to moderate knee osteoarthritis: a 6-month multicenter, randomized, double-blind, placebo …
  1897. Genetics of triglyceride-rich lipoproteins guide identification of pharmacotherapy for cardiovascular risk reduction
  1898. Pathophysiology and management of dyslipidemias associated with insulin-resistant states
  1899. effects of taurine supplement in conjunction with exercise on body weight, organ weights and blood chemistry parameters in aged rats
  1900. Growth Performance and carcass characteristics of broiler chicken fed diet supplemented with ginger (Zingiber officinale), garlic (Allium sativum), roselle …
  1901. Enhanced and Selective Lipid Extraction from the Microalga P. tricornutum by Dimethyl Carbonate and Supercritical CO2 Using Deep Eutectic Solvents and …
  1902. Recent developments in pharmacotherapy for hypertriglyceridemia: what’s the current state of the art?
  1903. Does Omega-3 Fatty Acid Supplementation Have Beneficial effects on Plasma Homocysteine, Insulin Resistance and Lipid Profile of Type 2 Diabetic Patients …
  1904. Role of Omega-3 Fatty Acids in Metabolic Syndrome
  1905. Preventive effects of the Marine Microalga Phaeodactylum tricornutum, Used as a Food Supplement, on Risk Factors Associated with Metabolic Syndrome in Wistar …
  1906. Essential fatty acid-rich diets protect against striatal oxidative damage induced by quinolinic acid in rats
  1907. Dietary fiber: An opportunity for a global control of hyperlipidemia
  1908. Apple cider vinegar attenuates oxidative stress and reduces the risk of obesity in high-fat-fed male wistar rats
  1909. Antidiabetic potential of herbal plants
  1910. effect of Garlic and Mackerel Fish on Rats Suffering From Obesity
  1911. Different effects of maternal low-isoflavone soy protein and genistein consumption on hepatic lipid metabolism of 21-day-old male rat offspring
  1912. Biochemical screen correction possibilities in patients with non-alcoholic fatty liver disease with diabetes mellitus
  1913. Hypolipidemic effects of wx/ae double-mutant rice and its components i
  1914. MPharmacological potential of Lactura taraxacifolia leaf on blood glucose levels, lipid profile, and oxidative stress parameters in diabetic rats
  1915. Physicochemical, potential nutritional, antioxidant and health properties of sesame seed oil: a review
  1916. Spices: a review on diabetes mellitus
  1917. The suitability of chili pepper (Capsicum annuum L.) for alleviating human micronutrient dietary deficiencies: A review
  1918. Lipid-lowering properties of protein-rich mucuna product
  1919. Role of nutraceuticals in prevention of nonalcoholic fatty liver
  1920. Fatty acids profile of meat, mucosal sIgA concentration and production index of broiler as a response to Chlorella sp. administration in the diet
  1921. Amaranth: Potential source for flour enrichment
  1922. Phytochemical Composition and Biochemical Studies of the Aqueous Leaf Extracts of Brillantaisia guianensis P. beauv on Alloxan Treated Wistar Albino Rats
  1923. effect OF GARCINIA CAMBOGIA AND ST. JOHN’S WORT (HYPERICUM PERFORATUM) EXTRACTS ON OBESITY IN MALE RATS
  1924. A multifunctional ingredient for the management of metabolic syndrome in cafeteria diet-fed rats
  1925. Synergistic effect of omega-3 fatty acids and oral-hypoglycemic drug on lipid normalization through modulation of hepatic gene expression in high fat diet with low …
  1926. Dietary fat influences the expression of genes related to sterol metabolism and the composition of cecal microbiota and its metabolites in rats
  1927. The effect of ginger (Zingiber officinale) on improving blood lipids and body weight; a systematic review and multivariate meta-analysis of clinical trials
  1928. Pharmacological targeting of the atherogenic dyslipidemia complex: the next frontier in CVD prevention beyond lowering LDL cholesterol
  1929. Date Palm Fruit (Phoenix dactylifera): effects on Vascular Health and Future Research Directions
  1930. effect of omega-3 supplementation on cardiometabolic indices in diabetic patients with non-alcoholic fatty liver disease: a randomized controlled trial
  1931. Eicosapentaenoic acid inhibits intestinal β-carotene absorption by downregulation of lipid transporter expression via PPAR-α dependent mechanism
  1932. effects of K-877, a novel selective PPARa modulator, on small intestine contribute to the amelioration of hyperlipidemia in low-density lipoprotein receptor …
  1933. EPA and DHA, but not ALA, have antidepressant effects with 17β-estradiol injection via regulation of a neurobiological system in ovariectomized rats
  1934. Nutrition with pumpkin (Cucrbita pepo) cake as lowering cholesterol in rats
  1935. Pharmacological effects of biotin in animals
  1936. How does high DHA fish oil affect health? A systematic review of evidence
  1937. effect of seabuckthorn seed oil in reducing cardiovascular risk factors: A longitudinal controlled trial on hypertensive subjects
  1938. Flaxseed oil rich in omega-3 protects aorta against inflammation and endoplasmic reticulum stress partially mediated by GPR120 receptor in obese, diabetic and …
  1939. Advances in Cardiovascular Pharmacology in Atherosclerotic-Related Therapeutic Areas: Addressing Patients’ Clinical Needs
  1940. Dietary Management of Nonalcoholic Fatty Liver Disease (NAFLD) by n-3 Polyunsaturated Fatty Acid (PUFA) Supplementation: A Perspective on the Role of n-3 PUFA …
  1941. In-vivo anti-inflammatory activity and safety assessment of the aqueous extract of Algerian Erica arborea L.(Ericaceae) aerial parts
  1942. Oral administration of Lactobacillus fermentum post-weaning improves the lipid profile and autonomic dysfunction in rat offspring exposed to maternal dyslipidemia
  1943. Chemistry and pharmacology of flavonoids-A review.
  1944. Apple cider vinegar administration on carcass characteristics and meat quality of broiler chickens
  1945. effect of omega-3 supplementation on fatty liver and visceral adiposity indices in diabetic patients with non-alcoholic fatty liver disease: A randomized controlled trial
  1946. Double-Edged Metabolic effects from Short-Term Feeding of Functionalized Wheat Bran to Mouse Revealed by Metabolomic Profiling
  1947. The possible role of nutraceuticals in the prevention of cardiovascular disease
  1948. REV-ERBα agonist SR9009 promotes a negative energy balance in goldfish
  1949. The effect of fish oil supplements on serum levels of albumin, lipid profiles, and kidney function in patients with hypoalbuminemia admitted to an intensive care unit …
  1950. Is Attributed to Its Nonlipid Fraction by Decreasing Intestinal Cholesterol Absorption in C57BL/6J Mice
  1951. Arachidonic acid and eicosapentaenoic acid metabolism in juvenile Atlantic salmon as affected by water temperature
  1952. Hypothalamic fatty acid sensing in Senegalese sole (Solea senegalensis): response to long-chain saturated, monounsaturated, and polyunsaturated (n-3) fatty acids
  1953. Antidiabetic potential of plants from the Caribbean basin
  1954. Bioscience Research
  1955. Hypoglycemic and hypocholesterolemic properties of Fenugreek: A comprehensive assessment
  1956. Possible protective effect of the algae spirulina against nephrotoxicity induced by cyclosporine A and/or gamma radiation in rats
  1957. Targeting FGF21 for the treatment of nonalcoholic steatohepatitis
  1958. Dietary fat intake and metabolic syndrome in adults: A systematic review
  1959. effects of omega-3 carboxylic acids on lipoprotein particles and other cardiovascular risk markers in high-risk statin-treated patients with residual hypertriglyceridemia …
  1960. Grape seed procyanidins and cholestyramine differentially alter bile acid and cholesterol homeostatic gene expression in mouse intestine and liver
  1961. effect of omega-3 supplementation on lipid profile in children and adolescents: a systematic review and meta-analysis of randomized clinical trials
  1962. Omega-3 polyunsaturated fatty acids: Anti-inflammatory and anti-hypertriglyceridemia mechanisms in cardiovascular disease
  1963. Fine mapping of GWAS signals to identify genetic markers of the plasma triglyceride response to an omega-3 fatty acid supplementation
  1964. effect of 10% Pomegranate Juice on Lipid Metabolism and Body Fat in Rats
  1965. α-Amylase and α-glucosidase inhibitor effects and pancreatic response to diabetes mellitus on Wistar rats of Ephedra alata areal part decoction with …
  1966. effect of omega-3 supplements on plasma apolipoprotein C-III concentrations: a systematic review and meta-analysis of randomized controlled trials
  1967. Antihypercholesterolemic effect of Murbei (Morus alba L.) Leaves and Its Combination with Simvastatin in Rats Induced by Propyltiouracil and High Fat Diet
  1968. Causes, clinical findings and therapeutic options in chylomicronemia syndrome, a special form of hypertriglyceridemia
  1969. Insulin-sensitizing effects of omega-3 fatty acids: lost in translation?
  1970. with peroxisome proliferation
  1971. Salvia hispanica L.(chia) seed promotes body fat depletion and modulates adipocyte lipid handling in sucrose-rich diet-fed rats
  1972. Impact of Silicon Addition on the Development of Gelled Pork Lard Emulsions with Controlled Lipid Digestibility for Application as Fat Replacers
  1973. The effects of fluid milk in attenuating postprandial hyperglycemia and hypertriglyceridemia
  1974. Appraisal of antimicrobial medicinal plants with potential therapeutic effect on diabetes and sickle cell trait
  1975. Lipid metabolism in dyslipidemia and familial hypercholesterolemia
  1976. Sex-based differences in hepatic and skeletal muscle triglyceride storage and metabolism
  1977. Anti-diabetic effects of excipients: possibility of formulation of an anti-diabetic dosage form using pharmaceutical excipients or their constituents, or food …
  1978. Profound modification of fatty acid profile and endocannabinoid-related mediators in PPARα agonist fenofibrate-treated mice
  1979. A REVIEW: NUTRITION, FOOD SAFETY, PROCESS AND WASTE OF FISH
  1980. The differential effects of eicosapentaenoic acid and docosahexaenoic acid on cardiometabolic risk factors: a systematic review
  1981. Use of plant sterol and stanol fortified foods in clinical practice
  1982. Adipokines at the crossroad between obesity and cardiovascular disease
  1983. Prehispanic functional foods and nutraceuticals in the treatment of dyslipidemia associated to cardiovascular disease: A mini-review
  1984. Systematic review/Meta-analysis Lipid profile and glucose changes after supplementation with astaxanthin: a systematic review and meta-analysis of randomized …
  1985. THE TREATMENT OF METABOLIC DISORDERS
  1986. Regulating hypothalamus gene expression in food intake: dietary composition or calorie density?
  1987. Intermittent fasting two days versus one day per week, matched for total energy intake and expenditure, increases weight loss in overweight/obese men and women
  1988. An insight to treat cardiovascular diseases through phytochemicals targeting PPAR-α
  1989. Dietary fatty acid metabolism is affected more by lipid level than source in Senegalese sole juveniles: interactions for optimal dietary formulation
  1990. Omega-3 supplementation effects on polycystic ovary syndrome symptoms and metabolic syndrome
  1991. Nutraceutical and dietary resources for breast cancer prevention–Highlighting strategies for suppressing breast aromatase expression
  1992. Eugenia uniflora L.
  1993. Anti-obesity and hypolipidemic effects of Morus alba-A review
  1994. Risk and benefits of statins in glucose control management of type II diabetes
  1995. Pharmacologic approaches for the management of patients with moderately elevated triglycerides (150–499 mg/dL)
  1996. Testing the Feasibility and Dietary Impact of Macaroni Fortified with Green Tea and Turmeric Curcumin Extract in Diabetic Rats
  1997. effects of Torreya Grandis Kernel and Sciadonic Acid on Lipid Profile in Hyperlipidemic Experimental Model
  1998. The effect of omega-3 polyunsaturated fatty acids on fibrin and thrombin generation in healthy subjects and subjects with cardiovascular disease
  1999. Lipid-lowering drugs and cancer: an updated perspective
  2000. Rosmarinic acid-rich extract from Ocimum basilicum L. decreases hyperlipidemia in high fat diet-induced hyperlipidemic mice and prevents plasma lipid oxidation
  2001. Lycopene in the prevention of cardiovascular diseases
  2002. The effect of Krill Oil and Krill Hydrolysate Protein on Fat Storage and Metabolic health in Male Wistar Rats
  2003. effect of Omega 3 (Aquamarine) on Primary Hypertriglyceridemia in Libyan Patients
  2004. Essential fatty acid-rich diets protect against striatal oxidative damage induced by quinolinic acid in rats
  2005. effects of rosuvastatin and/or# 946;-carotene on non-alcoholic fatty liver in rats.
  2006. Fish oil and fenofibrate inhibit pancreatic islet hypertrophy, and improve glucose and lipid metabolic dysfuntions with different ways in diabetic KK mice
  2007. The effect of Manalagi and Fuji Apple Juice on Triglyceride Level in Elderly
  2008. IMPROVING THE QUALITYOF LOWFAT UF-WHITE SOFT PICKLED CHEESE
  2009. Protective effects of ω-3 PUFA in anthracycline-induced cardiotoxicity: a critical review
  2010. Phytochemistry, pharmacology, and clinical trials of Morus alba
  2011. Whole oats supplementation in a low calorie diet efficiently reduces cardio-metabolic disorders in obese rats.
  2012. The functional nutritional and regulatory activities of calcium supplementation from eggshell for obesity disorders management
  2013. Development of 3D-printed, liquisolid and directly compressed glimepiride tablets, loaded with black seed oil self-nanoemulsifying drug delivery system: In Vitro and In …
  2014. Double-blind randomized placebo-controlled clinical trial of omega 3 fatty acids for the treatment of diabetic patients with nonalcoholic steatohepatitis
  2015. Drug Therapy for Hypertriglyceridemia and Familial Chylomicronemia Syndrome: Focus on Volnesorsen
  2016. Nutritional Evaluation of an EPA-DHA Oil from Transgenic Camelina sativa in Feeds for Post-Smolt Atlantic Salmon (Salmo salar L.)
  2017. effects of dietary biotin supplementation on glucagon production, secretion, and action
  2018. effects of drying methods on quality attributes of murta (ugni molinae turcz) berries: bioactivity, nutritional aspects, texture profile, microstructure and functional …
  2019. Taurine can enhance the protective actions of metformin against diabetes-induced alterations adversely affecting renal function
  2020. SALVIA AND ITS POTENTIAL TO TREAT METABOLIC DISORDERS
  2021. Reduction of de novo lipogenesis mediates beneficial effects of isoenergetic diets on fatty liver: mechanistic insights from the MEDEA Randomized Clinical Trial
  2022. Administration of Protein Hydrolysates from Anchovy (Engraulis Encrasicolus) Waste for Twelve Weeks Decreases Metabolic Dysfunction-Associated Fatty Liver …
  2023. Nutritional, bioactive components and health properties of the milpa triad system seeds (corn, common bean and pumpkin)
  2024. effects of soy isoflavones on glycemic control and lipid profile in patients with type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials
  2025. effect of Nut Consumption on Blood Lipids, Lipoproteins, and Apolipoproteins–Summary of the Evidence
  2026. Fatty acids consumption: the role metabolic aspects involved in obesity and its associated disorders
  2027. Flaxseed and diabetes
  2028. effects of dietary fish oil supplementation on performance, meat quality, and cecal fermentation of growing rabbits
  2029. effects of fermented beverage in subjects with metabolic syndrome
  2030. Research Article Omega-3 Fatty Acid Enriched Chevon (Goat Meat) Lowers Plasma Cholesterol Levels and Alters Gene Expressions in Rats
  2031. effectiveness of omega-3 fatty acid for polycystic ovary syndrome: a systematic review and meta-analysis
  2032. High‐dose biotin restores redox balance, energy and lipid homeostasis, and axonal health in a model of adrenoleukodystrophy
  2033. Triglycerides and Risk for Atherosclerotic Disease
  2034. Lipids and lipid mediators associated with the risk and pathology of ischemic stroke
  2035. Icosapent ethyl: safely reducing cardiovascular risk in adults with elevated triglycerides
  2036. effect of low dose docosahexaenoic acid-rich fish oil on plasma lipids and lipoproteins in pre-menopausal women: a dose–response randomized placebo-controlled …
  2037. Sciadonic acid derived from pine nuts as a food component to reduce plasma triglycerides by inhibiting the rat hepatic Δ9-desaturase
  2038. Congruent assessment of human hypoglycemic effect through STZ-induced diabetic rats fed Dromedary Camel (Camelus dromedarius) milk
  2039. Bioactive lipids in metabolic liver disease
  2040. Antihypertensive effect of Dietary β-Conglycinin in the Spontaneously Hypertensive Rat (SHR)
  2041. Serum lipid profile modification related to polyunsaturated fatty acid supplementation in thoroughbred horses
  2042. The Role of Globularia alypum Explored Ex Vivo In Vitro on Human Colon Biopsies from Ulcerative Colitis Patients
  2043. The effect of omega-3 on the level of serum lipid profile, adipocytokines, and indicator of vascular inflammation in patients diagnosed with myocardial infarction
  2044. effects of dietary n-3 PUFA levels in early life on susceptibility to high-fat-diet-induced metabolic syndrome in adult mice
  2045. FISH OIL
  2046. Ethanolic Extracts of Mulberry (Morus alba Linn) Leaf Prevent Hyperlipidemia and Oxidative Stress-induced Steatohepatitis in Rats
  2047. Functional and Therapeutic Potential of γ-Oryzanol
  2048. Hepatoprotective and anti-obesity properties of sardine by-product oil in rats fed a high-fat diet
  2049. A randomized, double-blind, placebo-controlled clinical trial to assess the efficacy and safety of ethyl-ester omega-3 fatty acid in Taiwanese hypertriglyceridemic …
  2050. Coffee consumption, obesity and type 2 diabetes: a mini-review
  2051. Metabolic indices of polyunsaturated fatty acids: current evidence, research controversies, and clinical utility
  2052. Phytochemistry and bioactivity of (Mulberry) plant: A comprehensive Morus alba
  2053. Triglyceride lowering drugs
  2054. Beneficial effects of Apple Cider Vinegar on weight management, Visceral Adiposity Index and lipid profile in overweight or obese subjects receiving restricted calorie …
  2055. Fish oil-derived n-3 polyunsaturated fatty acids downregulate aquaporin 9 protein expression of liver and white adipose tissues in diabetic KK mice and 3T3-L1 …
  2056. The chylomicron saga: time to focus on postprandial metabolism
  2057. In type 1 diabetics, high-dose biotin may compensate for low hepatic insulin exposure, promoting a more normal expression of glycolytic and gluconeogenic …
  2058. Omega-3 Eicosapentaenoic Acid (EPA) Rich Extract from the Microalga Nannochloropsis Decreases Cholesterol in Healthy Individuals: A Double-Blind, Randomized …
  2059. Krill oil reduces plasma triacylglycerol level and improves related lipoprotein particle concentration, fatty acid composition and redox status in healthy young adults-a …
  2060. Self-emulsifying formulations to augment therapeutic efficacy of nutraceuticals: From concepts to clinic
  2061. Bioactive peptides from meat proteins as functional food components
  2062. effects of dietary fatty acid composition on lipid metabolism and body fat accumulation in ovariectomized rats
  2063. High dietary ω-6: ω-3 PUFA ratio is positively associated with excessive adiposity and waist circumference
  2064. The protective effect of hydroalcoholic extracts of olive and morus alba leaves on liver enzymes of male rats treated with streptozotosin
  2065. Metabolic effects of a Grape Seed Procyanidin Extract on Risk Factors of Cardiovascular Disease
  2066. The Efficacy of Seluang Fish Oil (Rasbora agrotynea) Related Body Weight, Lipid Profile, Adiponectin and Leptin in Wistar Rats-Induced High Fat Diet
  2067. Neuroprotective potential of Spirulina platensis against aluminium chloride-induced neural degeneration.
  2068. Combined bioactive approach over atherosclerosis risk biomarkers
  2069. effects of citrus latifolia extract on dyslipidemia and tissues redox status in rats fed a high-cholesterol diet
  2070. effects of fat type and exogenous bile acids on growth performance, nutrient digestibility, lipid metabolism and breast muscle fatty acid composition in broiler chickens
  2071. DHA reduces hypothalamic inflammation and improves central leptin signaling in mice
  2072. effects of DHA-enriched fish oil on gene expression levels of p53 and NF-κB and PPAR-γ activity in PBMCs of patients with T2DM: A randomized, double-blind, clinical …
  2073. effect Of Nigella Sativa Seed Extract On Glucose, Lipid Profile, Liver Function Tests, Oxidative Stress and Histological Changes In Pancreas, Kidney, Liver and Tibial …
  2074. The effects of herring-roe lyophilized powder on lipid metabolism
  2075. Metabolic effects of a Grape Seed Procyanidin Extract and its Relation to Bile Acid Homeostasis
  2076. effect of the inclusion of extruded flaxseed in the diet of fattening pigs on lipid metabolism and tissue redox status
  2077. Investigational drugs in development for hypertriglyceridemia: a coming-of-age story
  2078. Monascus ruber-Fermented Buckwheat (Red Yeast Buckwheat) Suppresses Adipogenesis in 3T3-L1 Cells
  2079. Changes in lipoprotein particle subclasses, standard lipids, and apolipoproteins after supplementation with n-3 or n-6 PUFAs in abdominal obesity: A …
  2080. PRODUCTIVE AND PHYSIOLOGICAL effectS OF PROBIOTICS AND APPLE VINEGAR ON BROILER CHICKENS UNDER HIGH STOCKING DENSITY
  2081. Beneficial flavonoid in foods and anti-obesity effect
  2082. effects of dietary CLA on n-3 HUFA score and N-acylethanolamides biosynthesis in the liver of obese Zucker rats
  2083. The molecular mechanistic effects of a grape seed procyanidin extract in regulating hepatic lipid metabolism
  2084. The effects of a low calorie ketogenic diet on glycaemic control variables in hyperinsulinemic overweight/obese females
  2085. and Management of Dyslipidemias Associated with Insulin-Resistant States
  2086. effect of the double bond conjugation on the vascular physiology and nitric oxide production of isomers of eicosapentaenoic and docosahexaenoic acids prepared …
  2087. Onion peel extract increases erythrocyte membrane n-3 fatty acids in overweight and obese Korean subjects
  2088. Consumption of alpha-linolenic acid-enriched diacylglycerol induces increase in dietary fat oxidation compared with alpha-linolenic acid-enriched …
  2089. Dyslipidemia management update
  2090. The effects of fish oil omega-3 fatty acid supplementation on mental health parameters and metabolic status of patients with polycystic ovary syndrome: a randomized …
  2091. effect of Garlic and Mackerel Fish on Rats Suffering From Obesity
  2092. Transcriptional control of physiological and pathological processes by the nuclear receptor PPARβ/δ
  2093. The effect of Eicosapentaenoic Acid on Hepatic Metabolism and Intracellular Lipid Droplet Dynamics in An in Vitro Model of Hepatic Steatosis
  2094. Evaluation of acute toxicity, genotoxicity and inhibitory effect on acute inflammation of an ethanol extract of Morus alba L.(Moraceae) in mice
  2095. Dietary egg yolk supplementation improves low-protein-diet-induced fatty liver in rats
  2096. Does omega-3 fatty acid supplementation have beneficial effects on plasma homocysteine, insulin resistance and lipid profile of type 2 diabetic patients? A …
  2097. effects of omega-3 fatty acids and pioglitazone combination on insulin resistance through fibroblast growth factor 21 in type 2 diabetes mellitus
  2098. Iron reduces the anti-inflammatory effect of Omega-3 polyunsaturated fatty acids on the heart of STZ-and HFD-induced diabetic rats
  2099. Pengaruh pemberian variasi konsentrasi biotin terhadap kadar kolesterol total dan kolesterol ldl pada tikus dengan resiko dislipidemia: The effect of giving variant …
  2100. effects of omega-3 supplementation on endothelial function, vascular structure, and metabolic parameters in adolescents with type 1 diabetes mellitus: A …
  2101. The protective role of l-carnitine on oxidative stress, neurotransmitter perturbations, astrogliosis, and apoptosis induced by thiamethoxam in the brains of male rats
  2102. Hypertriglyceridemia-Induced Acute Pancreatitis During Pregnancy: A Case Report
  2103. The influence of eicosapentaenoic acid and docosahexaenoic acid on expression of genes connected with metabolism and secretory functions of ageing 3T3-L1 …
  2104. Self-emulsifying systems for delivery of bioactive compounds from natural origin
  2105. Biological transformation of medicine and food homology hawthorn with Monascus ruber to enhance lipid-lowering function
  2106. Chylomicronaemia—current diagnosis and future therapies
  2107. Physiological effects of γ-linolenic acid and sesamin on hepatic fatty acid synthesis and oxidation
  2108. Different Sources of Omega-3 Fatty Acid Supplementation vs. Blood Lipid Profiles—A Study on a Rat Model
  2109. A review of recent evidence in human studies of n-3 and n-6 PUFA intake on cardiovascular disease, cancer, and depressive disorders: does the ratio really matter?
  2110. Beneficial effects of Omega-3 Fatty Acids on Cardiovascular Disease
  2111. Morus alba L. Diminishes visceral adiposity, insulin resistance, behavioral alterations via regulation of gene expression of leptin, resistin and adiponectin in rats fed a …
  2112. Vitamin E supplementation modulates the biological effects of omega-3 fatty acids in naturally aged rats
  2113. Shrimp oil extracted from shrimp processing by-product is a rich source of omega-3 fatty acids and astaxanthin-esters, and reveals potential anti-adipogenic effects in …
  2114. effect of the inclusion of extruded flaxseed in the diet of fattening pigs on performance parameters and blood parameters
  2115. Role of Phytoestrogen-Rich Bioactive Substances (Linum usitatissimum L., Glycine max L., Trifolium pratense L.) in Cardiovascular Disease Prevention in …
  2116. Whole alga, algal extracts, and compounds as ingredients of functional foods: composition and action mechanism relationships in the prevention and treatment of type …
  2117. Influence of biotin intervention on glycemic control and lipid profile in patients with type 2 diabetes mellitus: A systematic review and meta-analysis
  2118. effects of omega-3 on lipid and liver function tests
  2119. Omega-3 carboxylic acids monotherapy and combination with statins in the management of dyslipidemia
  2120. Lean fish consumption is associated with beneficial changes in the metabolic syndrome components: a 13-year follow-up study from the Norwegian Tromsø study
  2121. Natural cholesterol busters
  2122. The effect of adenosine monophosphate-activated protein kinase on lipolysis in adipose tissue: an historical and comprehensive review
  2123. ROLE OF TREATMENTS AND GENETIC ALTERATIONS ON ATHEROSCLEROSIS AND CHOLESTEROL METABOLISM: STUDIES IN ANIMAL MODELS
  2124. The Anti-Obesogenic effect of Lean Fish Species Is Influenced by the Fatty Acid Composition in Fish Fillets
  2125. Omega-3 fatty acids supplementation improve nutritional status and inflammatory response in patients with lung cancer: a randomized clinical trial
  2126. effect of long-term consumption of oxidized polyunsaturated fatty acids on atherosclerotic lesion in LDL receptor knockout mice
  2127. N-3 polyunsaturated fatty acids: An innovative strategy against obesity and related metabolic disorders, intestinal alteration and gut microbiota dysbiosis
  2128. Unsaturated Fatty Acids Supplementation Reduces Blood Lead Level in Rats
  2129. Network pharmacology approach to evaluate the therapeutic effects of mulberry leaf components for obesity
  2130. effects of the Antihistamine Fexofenadine on Body Fat, Glucose and Body Weight: Impact of Dietary Fat Type and Pre-Drug Run-in Period
  2131. Dough rheological properties and macronutrient bioavailability of cereal products fortified through legume proteins
  2132. The emerging role of icosapent ethyl in patients with cardiovascular disease: mechanistic insights and future applications
  2133. n-3 PUFA sources (precursor/products): A review of current knowledge on rabbit
  2134. Physicochemical, potential nutritional, antioxidant and health properties of sesame seed oil
  2135. A new nutraceutical (Livogen Plus®) improves liver steatosis in adults with non-alcoholic fatty liver disease
  2136. Bioavailability of long chain omega-3 polyunsaturated fatty acids from phospholipid-rich herring roe oil in men and women with mildly elevated triacylglycerols
  2137. Investigated treatments for lipoprotein lipase deficiency and related metabolic disorders
  2138. Incorporation of whole oat, especially bran, into a high-fat diet, improves cardio-metabolic risk factors in type 2 diabetic rats
  2139. Dietary energy density, metabolic parameters, and blood pressure in a sample of adults with obesity
  2140. Association between the index of nutritional quality and lipid profile in adult women
  2141. Association of blood fatty acid composition and dietary pattern with the risk of non-alcoholic fatty liver disease in patients who underwent cholecystectomy
  2142. Chemistry and Pharmacology of Flavonoids-A
  2143. Impairment of gut microbial biotin metabolism and host biotin status in severe obesity: effect of biotin and prebiotic supplementation on improved metabolism
  2144. Canola oil in lactating dairy cow diets reduces milk saturated fatty acids and improves its omega-3 and oleic fatty acid content
  2145. Changes on meat fatty acid profile, cholesterol and hepatic metabolism associated with antioxidants and canola oil supplementation for Nellore cattle
  2146. KARDİYOVASKÜLER HASTALIKLARDA NUTRASÖTİKLER
  2147. Potential bioactive peptides obtained after in vitro gastrointestinal digestion of wine lees from sequential fermentations
  2148. Flaxseed oil containing flaxseed oil ester of plant sterol attenuates high-fat diet-induced hepatic steatosis in apolipoprotein-E knockout mice
  2149. AMPK‐dependent signaling modulates the suppression of invasion and migration by fenofibrate in CAL 27 oral cancer cells through NF‐κ B pathway
  2150. Extract enriched in flavan-3-ols and mainly procyanidin dimers improves metabolic alterations in a mouse model of obesity-related disorders partially via …
  2151. Differential secretion of adipokines from subcutaneous and visceral adipose tissue in healthy dogs: association with body condition and response to troglitazone
  2152. A preliminary assessment of the effects of dietary black cumin seed cake on growth performance, serum biochemical parameters and fatty acid composition of …
  2153. Physiological activities of the combination of fish oil and α-lipoic acid affecting hepatic lipogenesis and parameters related to oxidative stress in rats
  2154. Association between obesity and omega-3 status in healthy young women
  2155. Biological, Nutritive, Functional and Healthy Potential of Date Palm Fruit (Phoenix dactylifera L.): Current Research and Future Prospects
  2156. Unsaturated fatty acids supplementation reduces blood lead level in rats
  2157. Omega-3-carboxylic acids provide efficacious anti-inflammatory activity in models of crystal-mediated inflammation
  2158. Risk Factor Modification in the Management of Critical Limb Ischemia
  2159. Role of Phytoestrogen-Rich Bioactive Substances (Linum usitatissimum L., Glycine max L., Trifolium pratense L.) in Cardiovascular Disease Prevention in …
  2160. A modified Mediterranean diet score is inversely associated with metabolic syndrome in Korean adults
  2161. Lycopene and vascular health
  2162. Intermittent Fasting Two Days per Week versus One Day per Week, Matched for Total Energy Intake and Expenditure, Increases Weight Loss in Overweight/Obese …
  2163. A prospective study of erythrocyte polyunsaturated fatty acid, weight gain, and risk of becoming overweight or obese in middle-aged and older women
  2164. Roseane Maria Maia Santos & Darcy
  2165. An Ethyl Acetate Extract of Eryngium carlinae Inflorescences Attenuates Oxidative Stress and Inflammation in the Liver of Streptozotocin-Induced Diabetic Rats
  2166. Impact of Polyunsaturated Fatty Acids on Body Mass Index-ACorrelation Study in Type 2 Diabetic Postmenopausal Women
  2167. Biotin improves relaxation of rat aortic rings in combination with antihypertensive drugs
  2168. effect of Omega 3 and Zinc on Glycemic Indices, Serum Zinc, and Blood Pressure in Diabetic Patients
  2169. Prunus persica by-products: A source of minerals, phenols and volatile compounds
  2170. Increased omega-3 fatty acid intake is inversely associated with sarcopenic obesity in women but not in men, based on the 2014–2018 Korean national health and …
  2171. Suppression of cancer stem-like phenotypes in NCI-H460 lung cancer cells by vanillin through an Akt-dependent pathway
  2172. Nutraceutical and Dietary Measures with Potential for Preventing/Controlling Non-Alcoholic Fatty Liver Disease and Its Complications
  2173. New era of lipid-lowering drugs
  2174. Molecular mechanisms of the anti-obesity and anti-diabetic properties of flavonoids
  2175. Roles of proanthocyanidin rich extracts in obesity
  2176. Initial studies towards new activators of the BK channel
  2177. effects of omega-3 fatty acids and pioglitazone combination on insulin resistance through fibroblast growth factor 21 in type 2 diabetes mellitus
  2178. An increase in the omega-6/omega-3 fatty acid ratio increases the risk for obesity
  2179. Ketogenic diet attenuates NMDA-induced damage to rat’s retinal ganglion cells in an age-dependent manner
  2180. Masoud Khorshidi, Aliakbar Sayyari, Naheed Aryaeian*, Beheshteh Olang, Mohammadreza Alaei, Mitra Khalili, Amirhossein Hosseini and Masoud Salehi
  2181. 7 Omega-3 Fish Oils and
  2182. Therapeutic Applications of Plant and Nutraceutical-Based Compounds for the Management of Type 2 Diabetes Mellitus: A Narrative Review
  2183. Fish Oil Fatty Acids for Aging Disorders
  2184. effects of Magnesium Biotinate Supplementation on Serum Insulin, Glucose, and Lipid Parameters Along with Gene Expressions of Intermediary Metabolism in Rats
  2185. The interactions between dietary fats intake and Caveolin 1 rs 3807992 polymorphism with fat distribution in overweight and obese women: a cross-sectional study
  2186. Lipid accumulation and chronic kidney disease
  2187. An oil rich in γ-linolenic acid differently affects hepatic fatty acid oxidation in mice and rats
  2188. effects of low ω6: ω3 ratio in sow diet and seaweed supplement in piglet diet on performance, colostrum and milk fatty acid profiles, and oxidative status
  2189. Dietary Supplements and Functional Foods in the Management of Endocrine Disorders
  2190. Lipid metabolism and the risk factors of cardiovascular disease: implication of dietary omega-3 polyunsaturated fatty acids
  2191. From Garden To Health: An Exquisite Examination Of Hyperlipidemic Plants As Nature’s Solution To High Cholesterol
  2192. Evaluation of the Feed Nutritional Value of Noni (Morinda citrifolia) Meal for Holstein Dairy Cows
  2193. Dietary High-Dose Biotin Intake Activates Fat Oxidation and Hepatic Carnitine Palmitoyltransferase in Rat
  2194. Methodological Optimization of Supercritical Fluid Extraction of Valuable Bioactive Compounds from the Acidophilic Microalga Coccomyxa onubensis
  2195. GDF15 Mediates the Metabolic effects of PPARβ/δ by Activating AMPK
  2196. Omega-3 fatty acids part I: metabolic effects of omega-3 fatty acids and essentiality
  2197. Vital Potential Of Multiple Herbs In Prophylaxis Of Obesity
  2198. Supplements for Lipid Lowering: What Does the Evidence Show?
  2199. Intestinal microbiota mediates the beneficial effects of n-3 polyunsaturated fatty acids during dietary obesity
  2200. Glutathione S-Transferase Enzyme Gene Polymorphisms and Cardiovascular Diseases
  2201. Coriander (Coriandrum sativum): A promising functional food toward the well-being
  2202. Ameliorative impact of Morus alba leaves’ aqueous extract against embryonic ophthalmic tissue malformation in streptozotocin-induced diabetic rats
  2203. Synergistic effects of natural product combinations in protecting the endothelium against cardiovascular risk factors
  2204. effects of long-term DHA supplementation and physical exercise on non-alcoholic fatty liver development in obese aged female mice
  2205. Marine oils: Complex, confusing, confounded?
  2206. Supplementation with fish oil improves meat fatty acid profile although impairs growth performance of early weaned rabbits
  2207. Relationship between dietary omega-3 and omega-6 polyunsaturated fatty acids level and sarcopenia. A meta-analysis of observational studies
  2208. Cardioprotective role of omega-3 polyunsaturated fatty acids through the regulation of lipid metabolism
  2209. Gallic acid inhibits bladder cancer cell proliferation and migration via regulating fatty acid synthase (FAS)
  2210. Epigenetic reprogramming mediated by maternal diet rich in omega-3 fatty acids protects from breast cancer development in F1 offspring
  2211. Lower ω-6/ω-3 polyunsaturated fatty acid ratios decrease fat deposition by inhibiting fat synthesis in gosling
  2212. Dietary fatty acid quality affects systemic parameters and promotes prostatitis and pre-neoplastic lesions
  2213. The influence of a meal replacement formula on leptin regulation in obese adults
  2214. An update on pharmacotherapy of dyslipidemia for adults
  2215. Saccharina japonica fermented by Monascus spp. inhibit adipogenic differentiation and gene expression analyzed by real-time PCR (Q-PCR) in 3T3-L1 cell
  2216. effects of magnesium biotinate supplementation on serum insulin, glucose, and lipid parameters along with liver protein levels of intermediary metabolism in rats
  2217. Correlation between dietary intake and obesity risk factors among healthy adults
  2218. The role of diet in the prevention and treatment of cardiovascular disease
  2219. Eicosapentaenoic Acid Based Therapies: Fish Facts and Stories
  2220. Regulation of adipose tissue biology by long-chain fatty acids: metabolic effects and molecular mechanisms
  2221. Efficiency of the algae Spirulina platensis as antidiabetic agent
  2222. Treatment of nonalcoholic fatty liver disease with long-chain n-3 polyunsaturated fatty acids in humans
  2223. Performance of hybrid chickens as influenced by phytogenic extracted meal-supplemented diet as antibiotic alternatives during summer
  2224. PHYSIOLOGICAL AND HISTOPATHOLOGICAL STUDY OF SULFANILAMIDE DERIVATIVE ON MALE RABBITS
  2225. Mechanisms of lipid metabolism and transport underlying superior performance of Senegalese sole (Solea senegalensis, Kaup 1858) larvae fed diets containing n-3 …
  2226. Role of vitamins in the metabolic syndrome and cardiovascular disease
  2227. Targeting abdominal obesity and its complications with dietary phytoestrogens
  2228. Exposure to oxyfluorfen-induced hematobiochemical alterations, oxidative stress, genotoxicity, and disruption of sex hormones in male African catfish and the potential …
  2229. Dietary fat quantity and quality in relation to general and abdominal obesity in women: a cross-sectional study from Ghana
  2230. Research Article Unsaturated Fatty Acids Supplementation Reduces Blood Lead Level in Rats
  2231. Fish and Fish Oil and the Metabolic Syndrome
  2232. Characteristics of metabolic changes in adipocytes of growing rats
  2233. Dietary polyunsaturated fatty acids (PUFAs): Uses and potential health benefits
  2234. Sex-specific responses in glucose-insulin homeostasis and lipoprotein-lipid components after high-dose supplementation with marine n-3 PUFAs in …
  2235. A soy-yoghurt-honey product as a therapeutic functional food: mode of action and narrative review
  2236. Omega-3 enriched chocolate milk: A functional drink to improve health during exhaustive exercise
  2237. Enrichment of Omega-3 from Anchovy (Stolephorus sp.) Fish Oil by Enzymatic Hydrolysis
  2238. Plasma biochemistry, gene expression and liver histomorphology in common carp (Cyprinus carpio) fed with different dietary fat sources
  2239. TGH: Trans-Generational Hormesis and the Inheritance of Aging Resistance
  2240. Medicinal & traditional uses of Shahtoot (Morus indica Linn): A review
  2241. Advances in understanding of the role of lipid metabolism in aging
  2242. Phoenix dactylifera products in human health–A review
  2243. Immunomodulatory and anti-inflammatory strategies to reduce comorbidity risk in people with HIV
  2244. PHYSIOLOGICAL AND HISTOPATHOLOGICAL STUDY OF SULFANILAMIDE DERIVATIVE ON MALE RABBITS
  2245. Impact of varying dosages of fish oil on recovery and soreness following eccentric exercise
  2246. Changes in liver proteins of rats fed standard and high-fat and sucrose diets induced by fish omega-3 PUFAs and their combination with grape polyphenols according …
  2247. effect of dietary incorporation of Chlorella vulgaris and CAZyme supplementation on the hepatic proteome of finishing pigs
  2248. effects of dietary carbohydrate to lipid ratios on growth performance, muscle fatty acid composition, and intermediary metabolism in juvenile black seabream …
  2249. Impact of Fish Oil and Vitamin D on Human Health
  2250. Tissue antioxidant status and lipid peroxidation are related to dietary intake of n-3 polyunsaturated acids: A rabbit model
  2251. Scope of nanotechnology in nutraceuticals
  2252. Short term effect of omega-3 products on biomarkers of oxidative stress in healthy volunteers: a randomized controlled trial
  2253. Identification of effect and exposure biomarkers in human dietary intervention studies: Using various omics approaches
  2254. Bioavailability of lipids in fish and fish oils
  2255. Torreya grandis oil attenuates cognitive impairment in scopolamine-induced mice
  2256. Natural products, the new intervention regime of metabolic disorders
  2257. Eicosapentaenoic Acid Ethyl Esters Prevent Obesity Associated Metabolic Impairments in Male and Female Mice
  2258. Preclinical evidence for the pharmacological actions of glycyrrhizic acid: A comprehensive review
  2259. effectiveness of utilizing fish oil and phosphatidylcholine in ameliorating the progression of metabolic syndrome in pigs consuming a Western diet
  2260. Natural products and cardiovascular health
  2261. Gastric injury induced by Non-steroidal Anti-inflammatory Drugs and therapeutic strategies for prevention
  2262. Kinetics of omega-3 polyunsaturated fatty acids when co-administered with saturated or omega-6 fats
  2263. Anti-oxidant Activity of Novel Compound (AVO) Derived from L-arginine
  2264. The Possibility of Using Fruit-Bearing Plants of Temperate Climate in the Treatment and Prevention of Diabetes
  2265. Preclinical Safety Evaluation of Rathi Nagara Rasa Mezhugu
  2266. Usage possibilities of mulberry leaves in poultry nutrition.
  2267. Mediators of Impaired Adipogenesis in Obesity-Associated Insulin Resistance and T2DM
  2268. Marine lipids on cardiovascular diseases and other chronic diseases induced by diet: An insight provided by proteomics and lipidomics
  2269. Intake of a Western diet containing cod instead of pork alters fatty acid composition in tissue phospholipids and attenuates obesity and hepatic lipid accumulation in …
  2270. Omega‐3 supplementation for enhancement of egg functional properties
  2271. In-vitro digestion of flaxseed oil encapsulated in phenolic compound adducted flaxseed protein isolate-flaxseed gum complex coacervates
  2272. Assessment of the effect of Chicken Dung on the Growth of Mulberry (Morus Alba)
  2273. Scientific Validation of Anti-Cancerous, Wound Healing, Anti-Inflammatory activities of Herbo-mineral Formulation Rathinagara Rasa Mezhugu
  2274. Long-chain omega-3 polyunsaturated fatty acids modulate mammary gland composition and inflammation
  2275. Advances on delta 5-unsaturated-polymethylene-interrupted fatty acids: Resources, biosynthesis, and benefits
  2276. Dietary biotin supplementation impairs testis morphology and sperm quality
  2277. Crocodile meat meal as a fishmeal substitute in juvenile dusky kob (Argyrosomus japonicus) diets: Feed utilization, growth performance, blood parameters …
  2278. Coffee consumption, health benefits and side effects: a narrative review and update for dietitians and nutritionists
  2279. Cervical cancer cell proliferation inhibition by vanillin oxime through HIF‑1α expression inhibition, ERK1/2 and Akt protein down-regulation
  2280. Chronic supplementation of omega-3 can improve body composition and maximal strength, but does not change the resistance to neuromuscular fatigue
  2281. Modulation of gut microflora in the prevention of atherosclerosis and cancer using probiotics and prebiotics
  2282. Standardization on purification process of Cherangkottai (Semecarpus anacardium-Dried Fruit)
  2283. Bioactive carbohydrates: safety regulations and applications for dairy-based functional foods
  2284. Nutritional impact on health in patients with Rheumatoid Arthritis
  2285. Relationship between erythrocyte phospholipid fatty acid composition and obesity in children and adolescents
  2286. A REVIEW OF SELF-EMULSIFYING DRUG DELIVERY SYSTEM-A NOVEL APPROACH TO DRUG
  2287. 14 Soy and Soy-Based Products
  2288. Nutritional properties of protein sources on diet-induced obesity, hepatic lipid accumulation, and fatty acid composition in mice
  2289. 20 (S)-Ginsenoside Rg2 amino acid derivatives for anti hemorrhagic shock: Synthesis, characterization and evaluation
  2290. Investigating the effects of Feeding Two Sources of Omega-3 on Feed Intake, Digestibility, and Blood Metabolites of Horses
  2291. Health benefits of nuts and dried fruits
  2292. Recent industrials extraction of plants seeds oil used in the development of functional food products: A Review
  2293. Study of traditionali African foods useful for the preparation of functional foods and food supplements.
  2294. Impact of biotin supplemented diet on mouse pancreatic islet β-cell mass expansion and glucose induced electrical activity
  2295. Regulatory functions of fatty acids with different chain lengths on the intestinal health in pigs and relative signaling pathways
  2296. DEVELOPMENT OF NUTRITION PRACTICE GUIDELINES AND ITS EFFICACY IN COMBINATION WITH N3-LCPUFA SUPPLEMENT FOR THE MANAGEMENT …
  2297. Seafood Consumption and Fasting Leptin and Ghrelin in Overweight and Obese
  2298. Garcinia cambogia
  2299. Diet-induced obesity, energy metabolism and gut microbiota in C57BL/6J mice fed Western diets based on lean seafood or lean meat mixtures
  2300. Lipidome abnormalities and cardiovascular disease risk in HIV infection
  2301. The high-dose fish oil supplementation increased Mfsd2a expression without altering DHA levels in the retina of healthy mice
  2302. A new nutraceutical (Livogen Plus
  2303. Determination of allosteric and active sites responsible for catalytic activity of delta 12 fatty acid desaturase from Geotrichum candidum and Mortierella alpina …
  2304. Association between different types of plant-based diets and leptin levels in healthy volunteers
  2305. Polyunsaturated Fatty Acids as Nutraceuticals
  2306. Seafood intake and the development of obesity, insulin resistance and type 2 diabetes
  2307. Immunohistochemistry of PPARα, PPARγ and IFNγ in kidney tissues of african catfish (clarias gariepinus) at different seasons
  2308. Nutraceutical Prevention of Diabetic Complications—Focus on Dicarbonyl and Oxidative Stress
  2309. In vivo studies on bioavailability, toxicity, and antioxidant defense of organic selenium-enriched microalga biomass in Wistar rats
  2310. Expression of genes involved in regulation of polyunsaturated fatty acid metabolism in liver of Atlantic salmon (Salmo salar) undergoing parr-smolt transformation
  2311. Dough Rheological Properties and Macronutrient Bioavailability of Cereal Products Fortified through Legume Proteins. Processes 2023, 11, 417
  2312. An overview of phytochemical and pharmacological profile of Morus alba Linn
  2313. Identification and Characterization of Double-Edged Metabolic effects of Functional Foods by Metabolomics-Based Biochemical Analysis
  2314. Self-emulsifying drug delivery systems: a novel approach to deliver drugs
  2315. Factors and advances on fermentation of Monascus sp. for pigments and monacolin K production: a review.
  2316. Freshwater, Landlocked Grand Lake Strain of Atlantic Salmon (Salmo salar L.) as a Potential Genetic Source of Long Chain Polyunsaturated Fatty Acids …
  2317. Red Yeast Rice
  2318. Dietary fiber and aging
  2319. Dietary biotin supplementation increases proliferation pathways in mice testes without affecting serum follicle-stimulating hormone levels and stem cell factor …
  2320. Some Health Problems among Aquatic Food Product Workers
  2321. Self-micro emulsifying drug delivery system: An approach to improve the solubility of Itraconazole
  2322. Spermidine–an old molecule with a new age-defying immune function
  2323. Risk Assessment and Characterization in Tuna Species of the Canary Islands According to Their Metal Content
  2324. Silver ion assisted urea complexation for the enrichment of sciadonic acid from Torreya fargesii kernel oil
  2325. Breeding Strategy for Improvement of Omega-3 Fatty Acid through Conventional Breeding, Genetic Mapping, and Genomics in Soybean
  2326. Natural medicines: categories, comebacks and catalysts
  2327. Evaluation of response corellation using chemometrics analysis for pre-optimization quercetin–self emulsion formulation
  2328. Feeding Strategy and effect on Fillet Quality of Atlantic Salmon (Salmo salar)
  2329. Association of seafood consumption with cardiovascular disease among adults in Qingdao, China
  2330. Comparing three different Phaeodactylum tricornutum strains for the production of chrysolaminarin in flat panel airlift photobioreactors
  2331. Biotin supplementation alters root system architecture and development in Arabidopsis thaliana
  2332. Peroxisome proliferator-activated receptor alpha1 in yellow catfish Pelteobagrus fulvidraco: Molecular characterization, mRNA tissue expression and transcriptional …
  2333. The effects of dietary fatty acids on microglial immune responses
  2334. Mexican traditional medicine: Traditions of yesterday and phytomedicines for tomorrow
  2335. ANOVEL CHROMOPHORIC TEST FOR QUANTIFYING CHOLESTEROL AND THE MAJOR POLYUNSATURATED FATTY ACIDS IN FOOD AND BIOLOGICAL …
  2336. Micro and nanoemulsions in colorectal cancer
  2337. Preliminary prediction of lipase 3D protein structure and function in Rhodococcus sp. NAM81 using bioinformatics approach
  2338. Nutrients, herbal bioactive derivatives and commensal microbiota as tools to lower the risk of SARS-CoV-2 infection
  2339. Intersections of pathways involving biotin and iron relative to therapeutic mechanisms for progressive multiple sclerosis
  2340. Both Determinants of Allosteric and Active Sites Responsible for Catalytic Activity of Delta 12 Fatty Acid Desaturase by Domain Swapping
  2341. Inclusion of enzymes in Kalahari melon based broiler diets: effects on growth performance and meat quality
  2342. Bioactive Compounds from Multifarious Natural Foods for Human Health: Foods and Medicinal Plants
  2343. OPEN ACCESS EDITED BY
  2344. Stefanie M. Colombo1*, Mohamed Emam2, Brian C. Peterson3, Jennifer R. Hall4, Gary Burr3, Zeyu Zhang1 and Matthew L. Rise2
  2345. Deletion of Estrogen Receptor α in Skeletal Muscle Results in Impaired Contractility in Female Mice
  2346. An investigation of nutritional quality changes and microbial safety of preserved-salted fish of the Benue River
  2347. Deletion of estrogen receptor α in skeletal muscle results in impaired contractility in female mice
  2348. A step to shell biorefinery—Extraction of astaxanthin-rich oil, protein, chitin, and chitosan from shrimp processing waste
  2349. Shared Pathophysiology between Depression, Obesity and Metabolic Disturbances: Novel Antidepressant Targets?
  2350. Water-Soluble Vitamins
  2351. Nanosystèmes hybrides pour la délivrance intestinale
  2352. Annotated Bibliography of Selected Papers Dealing with the Health Benefits and Risks of Fish and Seafood Consumption
  2353. Current trends in drug delivery system of curcumin and its therapeutic applications
  2354. Complexation between flaxseed proteins, polyphenols and gums: mechanism and application
  2355. Bioprospects of microbial enzymes from mangrove-associated fungi and bacteria
  2356. Estradiol deficiency impairs satellite cell function and causes muscle weakness via an estrogen receptor alpha mediated mechanism
  2357. Conversion of Biomass-derived 5-(Chloromethyl) furfural into Fuels and Chemicals
  2358. Intravenous lipid emulsions in kidney transplant patients requiring parenteral nutrition
  2359. The ability of carnitine to act as a type 1Histone deacetylase inhibitor may explain the favorable impact of carnitine supplementation on mitochondrial biogenesis in the …
  2360. Framingham risk score of metabolically unhealthy obese individuals defined by insulin resistance and metabolic components
Related Posts

Restore Insulin Sensitivity

Fear Extinction

Mitohormesis

Mandatory FDA Disclaimer: Not intended to diagnose, treat, cure or prevent any disease.

Mandatory FDA Disclaimer: Not intended to diagnose, treat, cure or prevent any disease.

0
    0
    Your Cart
    Your cart is emptyReturn to Shop
    Continue Shopping